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ABSTRACT

Misregulation of cellular copper and iron can increase labile pools of these metal
ions, increasing oxidative damage and leading to neurodegeneration in Wilson’s,
Parkinson’s, and Alzheimer’s diseases.

Chapter 1 of this dissertation provides an

overview of the thermodynamic stability constants of Cu(II), Cu(I), Fe(II), and Fe(III)
with weakly binding amino acid ligands, including sulfur- and selenium-containing
amino acids and drugs such as methimazole and penicillamine. Understanding these
metal-amino-acid interactions provides insight into the role of cellular amino acids as
ligands for labile metals.
Stability constants of Cu(II) and Fe(II) with the sulfur- and selenium-containing
amino acids methionine, selenomethionine, methylcysteine, methylselenocysteine, and
penicillamine are reported in Chapter 2. Potentiometric titration data and characterization
by X-ray structural analysis, infrared spectroscopy, and mass spectrometry indicate that
the coordination modes and stabilities of thio- and selenoether-amino acids with Cu(II)
are similar to glycine and do not involve coordination of the sulfur or selenium atom.
Fe(II) stability constants with these amino acids were considerably lower than those with
Cu(II), indicating that Fe(II) complexes of these amino acids likely do not form under
biological conditions. Fe(II) binding to the thiol penicillamine, used to treat copper
overload in Wilson’s disease, is significantly more stable, suggesting potential
competition with Cu(II) for penicillamine binding.
The thione methimazole is a redox-active, hyperthyroid drug that strongly
coordinates copper. Reactions of methimazole with Cu(II) or Cu(I) and the effects of

ii

oxidation state and oxygen availability on the resulting copper-coordinated products
were explored (Chapter 3). Dinuclear, polymeric, and mononuclear complexes are
obtained that involve redox reactions of both copper and methimazole, some of which
result from sulfur elimination from the oxidized methimazole disulfide ligand. An
updated mechanism is proposed for this unusual reaction.
Under air-free conditions, treating Cu(I) with methimazole disulfide results in
disulfide bond cleavage to afford a copper-bound methimazole complex (Chapter 4). The
analogous selenomethimazole complex forms from methimazole diselenide, and copper
coordination chemistry of selenomethimazole is even more complex than that of
methimazole. The remarkable diversity of copper methimazole and selenomethimazole
complexes highlights the redox chemistry of metal and ligand and is highly dependent
upon reaction time, solvent, and oxygen availability.
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CHAPTER ONE
STABILITY CONSTANTS OF BIOLOGICALLY RELEVANT, REDOX-ACTIVE
METALS WITH AMINO ACIDS: THE CHALLENGES OF
WEAKLY BINDING LIGANDS

1.1 Introduction
Metal uptake and transfer in biological systems is essential to enzyme function,1
oxygen and electron transfer,1 infection control,2 and redox balance.3 Biological
mechanisms for metal transfer and redox activity are often poorly understood due to the
complexities of biological environments and a limited understanding of the quantities and
localization of high-affinity and weakly binding ligands present in cells. For example, misregulation of copper and iron homeostasis is implicated in initiation and/or progression of
Parkinson’s and Alzheimer’s diseases,4,5 but the role of weakly chelating biomolecules in
these diseases has not been addressed. It is often assumed that non-protein-bound metal
ions are coordinated to low-molecular-weight oxygen- and nitrogen-containing ligands, but
the nature of these ligands and how these interactions affect cellular processes is unknown.
Determination of in vitro stability constants is used to predict equilibria that may
occur in more complex systems6-12 and to model speciation in biological fluids.7 The goals
of this review are to 1) examine weakly coordinating ligand interaction with copper and
iron under biological conditions, with an emphasis on sulfur and selenium amino acids, 2)
examine the methods and method limitations for determination of stability constants
describing complexation of redox-active metal ions with weakly binding ligands, and 3)
emphasize specific needs for methods development and further research on these systems.

1

A comprehensive discussion of stability constants for weakly binding ligands
present in significant quantities in the cell is lacking and is presented in this review. The
Smith and Martell database (NIST v.46)8 is a large set of externally evaluated stability
constants that involves some of the iron and copper complexes of interest to this review.
However, the database is no longer being critically analyzed and curated. Specifically, this
review focuses on the stability constants of amino acids with the biologically relevant,
redox-active metals copper and iron. Copper and iron are of particular interest due to their
availability in the cell, potential for chelation by wide variety of ligands, and known
contribution to reactive oxygen species generation and oxidative damage. Ligand
coordination to these metal ions can be difficult to assess, due to their variable oxidation
states and coordination geometries.
This review places special emphasis on sulfur and selenium amino acids, since
coordination of these ligands with copper and iron is of particular biological interest, and
thiol and thioether coordination can stabilize the reduced forms of copper and iron.6-8 A
range

of

stability

constant

determination

methods

including

potentiometric,

spectrophotometric, and voltammetric analyses have been used to quantify formation of
iron and copper complexes with amino acids under biologically relevant conditions. The
review discusses and identifies the limitations of each method as it pertains to each metal
and oxidation state and will evaluate the potential impact of amino acids on biologically
relevant metal interactions by modeling of more complex systems.
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1.2 Cellular Redox-Active Metal Ions and Amino Acids
Copper, iron, zinc, manganese, and cobalt are essential redox-active metal ions in
biological systems that play crucial biochemical roles as cofactors in enzymes. Iron and
copper of are particular interest due to their stability in multiple oxidation states which are
often essential to biological processes,9,10 but this activity makes assessing the validity of
in vitro ligand coordination difficult. The association and distribution of copper and iron,
not only within the highly selective binding pockets of proteins, but also with more weakly
binding ligands such as single amino acids has implications for the uptake, transfer, and
redox states of these metal ions throughout the cell.
Complex formation is dependent on amino acid concentration, metal concentration,
and the thermodynamic driving forces controlling complex formation. In human plasma,
free amino acid concentrations can be divided into three categories: high abundance (200500 μM), low abundance (10-200 μM), and trace abundance (less than 10 μM).11-13
Alanine, glutamine, glycine, leucine, lysine, proline, threonine, and valine fall into the high
abundance category. With the exception of threonine, these amino acids have non-polar or
positively charged side chains at pH 7, which limit their cation binding abilities to bidentate
binding of the amine nitrogen and carboxylate oxygen groups. Arginine, aspartic acid,
asparagine,

cysteine,

glutamic

acid,

histidine,

isoleucine,

serine,

methionine,

phenylalanine, tryptophan, and tyrosine fall into the low abundance category, and most of
these have polar or negatively charged side chains at pH 7 that may allow tridentate
coordination through the amine, carboxylate, and side chain groups. Trace-level amino
acids

include

methylcysteine

and

the

3

selenoamino

acids,

selenmethionine,

selenomethylcysteine, and selenocysteine. Methylcysteine concentrations in urine are
reported to be 0.2-5 μM;14 plasma or cellular concentrations are not reported. Selenoamino
acid concentrations are also not reported, but total selenium concentration in human plasma
averages 1.5-1.6 μM, with an estimated 90% incorporated into selenoprotein as
selenocysteine or selenomethionine.15 Although the abundance of selenoamino acids is
extremely low, soft selenoether or selenolate groups may strongly interact with softer
metals such Cu(I) and Fe(II) according to the Pearson hard-soft acid-base theory.
Penicillamine is an amino acid not naturally found in cells, but it bears close
structural resemblance to cysteine. It is a highly effective copper chelator used routinely to
treat Wilson’s disease.16,17 With a typical dosage of 750 mg/day, serum penicillamine
levels can reach 100 μM.18 Although it is known to bind copper, it may also influence iron
homeostasis.19,20
Stability constant determination is discussed with Cu(I) and Cu(II) and Fe(II) and
Fe(III) as separate ions due to their unique cellular roles and significantly different
coordination characteristics. Each of these metal ions serves essential biological roles in
electron transfer, oxygen transport, and catalysis.21 Iron and copper are two of the most
abundant transition metal ions in cells, and control of these potentially toxic ions is heavily
regulated by metallochaperones and storage proteins such as ferritin.22,23 Total copper
concentrations are in the range of 10-25 μM in human serum24 and up to 100 μM in human
brain tissue.25 Labile (non-protein-bound) copper pools are also identified in cells,
primarily as Cu(I).26 Cellular concentrations of labile copper are not quantified, but
significant recent strides have been made in the development of methods to detect this
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labile copper.27-29
Total iron concentrations are 20 to 30 μM in human serum,30 but are approximately
300 times higher in human liver (6315 μM).31 Jhurry and coworkers quantified labile iron
concentrations in the cytosol of human cells at 30 μM and in mitochondria at 210 μM.32
Mis-regulation of copper and iron homeostasis can lead to increased oxidative damage and
protein misfolding or aggregation and is implicated in the development of
neurodegenerative diseases such as Parkinson’s and Alzheimer’s diseases.3,33-36 In
addition, redox cycling between Cu(I) and Cu(II) that is critical for the function of most
copper enzymes is often controlled by amino acid coordination and protonation state.37-39
In conjunction with reliable and complete stability constant determination and species
identification, as well as the biological concentrations of the amino acids and metal ions,
the extent of biological amino-acid-metal complex formation under equilibrium conditions
can be predicted. The work in this chapter was completed in collaboration with Dr. Brian
A. Powell of Clemson University.

1.3 Amino Acids as Weakly Binding Ligands
Biological regulation of metal ions is dominated by strong chelation in highly
specific binding pockets of proteins, often contributing to protein structural support and/or
enzyme activation. It is more difficult to ascertain the role of metal-coordinating, small
molecules, particularly at high metal concentrations resulting from loss of
homeostasis.26,40-44 These small, coordinating molecules may play a number of roles
including: 1) cellular signaling, such as various hormones, 2) molecules required for
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metabolism, such as sugars, 3) molecules needed for anabolism, such as amino acids or
lipids, and 4) exogenous molecules, such as drugs, antioxidants, or toxins. Entire databases
in bioinformatics and cheminformatics are committed to sorting, analyzing, and predicting
chemical properties and biomolecular pathways for these types of coordinating small
molecules.45 We focus on the coordination and stability of amino-acid-metal complexes,
since amino acids coordinate strongly enough to Cu(I)/Cu(II) and Fe(II)/Fe(III) to infer that
these complexes may form within the cell.46

Potentially Bidentate Amino Acids
Because amino acids have varied potential metal-binding modes, discussion of
amino acid coordination will be grouped according to their predicted denticity. Most amino
acids only have the capability for bidentate coordination, through the α-carboxylate oxygen
and α-amine nitrogen atoms, forming a five-membered chelate ring with the metal ion
(Figure 1.1). Since glycine is the simplest amino acid and primarily binds metals with
bidentate coordination, this type of bidentate metal-amino-acid coordination is often
referred as glycine-like binding.47
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Figure 1.1. Amino acids with non-coordinating aliphatic or aromatic side chains that have the capability to
coordinate metal ions in a bidentate fashion. In box: complex showing bidentate binding to a metal ion (M)
through the carboxylate oxygen and amine nitrogen, using glycine as an example.

Potentially Tridentate Amino Acids
Amino acids with polar or charged side chains may have the capability to bind in a
tridentate fashion (Figure 1.2), but often do not achieve full tridentate coordination.
Alcohol, amine, and carboxylate groups all can potentially coordinate metals, but the
influence of thermodynamic factors such as pKa, steric strain, and entropy cost can lessen
or prevent metal interactions. Predicting the likelihood of an amino acid binding in a
tridentate fashion is not straightforward. For example, the polar side chains of arginine and
lysine are positively charged at pH 7 (Figure 1.2), with pKa values above 10 properties that
inhibit metal binding.
Perhaps the best measure of the ability of an amino acid side chain to bind copper
and iron is to consider the amino acid residues most often found in metalloprotein binding
pockets. In a 2007 survey of the Protein Database, the three amino acids most commonly
found in copper metalloprotein binding pockets were histidine, cysteine, and
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Figure 1.2. Amino acids with polar or charged side chains that have the capability to bind metals in a
tridentate fashion. In box: complex showing potential tridentate binding to a metal ion (M) through the αcarboxylate oxygen and α-amine nitrogen as well as a side chain atom, using binding to the oxygen atom of
the deprotonated alcohol group in serine as an example.

methionine, respectively.48 Aspartic acid, glutamic acid, serine, threonine, glutamine, and
asparagine also bind copper but much less commonly. For iron metalloproteins, histidine,
glutamic acid, cysteine, aspartic acid, methionine, and tyrosine were the primary ironbinding amino acids, with serine and asparagine as minor players. Based these reports, it
is reasonable to assume that these free amino acids also would potentially bind copper and
iron.

Higher stability constants are expected for metal-amino acid complexes with

tridentate binding compared to those with only bindentate coordination, since greater
chelation confers higher thermodynamic stability.
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Figure 1.3. Amino acids with sulfur- or selenium-containing side chains; all have the capability to bind
metals in a tridentate fashion. In box: complex showing potential tridentate binding to a metal ion (M) through
the α-carboxylate oxygen and α-amine nitrogen atoms as well as a side chain atom, using deprotonated sulfur
in cysteine or penicillamine as an example

Sulfur- and Selenium-Containing Amino Acids
In this review, special emphasis is given to iron and copper interactions with sulfurand selenium-containing amino acids, including penicillamine, methylcysteine, and
selenomethylcysteine (Figure 1.3). These amino acids not only show preferential binding
to soft and borderline metal ions, such as Cu(I), Cu(II), and Fe(II), but they also influence
redox activity of these metals.49 Metal-sulfur and -selenium redox interactions can make it
difficult to clearly interpret stability constant data for these systems, especially for
thiol/selenol-containing amino acids with reduced metal ions.50
Because of the S/Se atom in the side chain, these amino acids can potentially act as
tridentate chelators to metal ions. Although selenoamino acids are less prevalent in the cell
than their sulfur analogs, metal-selenocysteine binding is required for the activity of
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enzymes such as NiFeSe hydrogenases.51 Selenoether-containing amino acids are not
known to have primary metal-binding roles in metalloproteins. Selenomethionine can
substitute indiscriminately for methionine when Se levels are high,52 and has been wellstudied for its ability to prevent metal-mediated oxidative damage.53

1.4 Comparing Apples to Apples: Defining Parameters of Stability Constant
Determination
The sheer volume of stability constant data for transition metal ions with amino
acids is overwhelming and has been the subject of databases54 and extensive reviews.47,50,5557

Previous reviewers50,58 noted that the wide range and seemingly inconsistent reports of

these stability constants is attributable to the sensitivity of these systems to the specific
conditions under which determinations are performed. Even when using the same
analytical method, variables including the nature and concentration of supporting
electrolyte, pH range, temperature, and solvent significantly affect the resulting stability
constants. Whenever possible in this review, stability constants were chosen that represent
the most consistent results, both with each other and with biological conditions. Thus,
typical experimental conditions are 25-37 ˚C with 0.1-3.0 M supporting electrolyte. If
limited data are available, the best or only reported metal-amino-acid stability constants
are provided.
Clearly defining equilibrium constants is crucial to correctly interpreting stability
constant data and identifying species formed across various analyses, especially for amino
acids where charges can differ. In this review, amino acids are divided into three categories:
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1) those likely to bind as bidentate ligands, composed of aliphatic or aromatic amino acids
with nonpolar side chains (Figure 1.1), 2) those that can potentially bind as tridentate
ligands, composed of amino acids with polar or charged side chains (Figure 1.2), and 3)
sulfur- and selenium-containing amino acids (Figure 1.3). Since the sulfur and seleniumcontaining amino acids have greater potential for redox activity compared to other amino
acids, especially upon iron or copper coordination, it is useful to treat these amino acids
separately.
For all the amino acids, proton association constants can be expressed as stepwise
protonation constants shown in equilibrium expressions 1 and 2.
H+ + L-

HL

H+ + HL

H2L+

protonation of –NH2 group

(1)

protonation of –COO- group

(2)

The equilibrium constant KHL relates to the first protonation (equation 1) according to
equation 3 and the equilibrium constant KH2L relates to the second protonation (equation 2)
according to equation 4.

KHL

=

[HL]
(3)
−
[L ][H+]

KH2L

=

[H2L+]
[HL][H+]

(4)

Equilibrium constants 3 and 4 apply for all amino acids that do not have side chains
that can protonate or deprotonate, such as those shown in Figure 1.1 and the thioethers
shown in Figure 1.3. The remaining amino acids have ionizable side chains that must be
accounted for in additional equilibrium expressions.
For amino acids that are positively charged at pH 7, such as lysine, arginine, and
histidine, the protonation equilibrium reactions 5, 6, and 7 apply.
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H+ + LH+ + HL
H+ + H2L+

HL
H2L+
H3L2+

protonation of –NH2 group

(5)

protonation of side chain

(6)

protonation of –COO- group

(7)

Thus, for protonation reactions of amino acids with ionizable side chains, equilibrium
constants (3) and (4) apply, along with the additional equilibrium constant KH3L (8).

KH3L

=

+
[H3L2 ]
[H2L+][H+]

(8)

For amino acids that are negatively charged at pH = 8, including glutamic acid, aspartic
acid, cysteine, homocysteine, and penicillamine, the representative equilibria are 9, 10, and
11.
H+ + L2-

HL-

protonation of –NH2 group

(9)

H+ + HL-

H2L

protonation of side chain

(10)

H+ + H2L

H3L+

protonation of –COO- group

(11)

The related association constants are similar to those defined in equations 3, 4, and 8,
although it is important to note that the charge on each species is different.
Association constants for metal-amino-acid coordination are defined in a similar
manner. Because the charge of the metal ions (M) studied varies from +1 to +3 and the
charges of the amino acids (L) also vary, charges on the species are typically not indicated
in these general equilibrium expressions. When discussing specific species, charges will
be shown whenever possible. Equilibrium equations for mono- and bis-coordinated
complexes as well as their formation constant () expressions are represented by equations
12 and 13, respectively. The formation constant β is related to the thermodynamic stability
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of a complex, the association constant K, for each stepwise addition of a new ligand. At
lower pH, the side chain of the amino acid may or may not be protonated, as shown in
equation 14 and 12, respectively. At higher pH, some metal-amino acid systems coordinate
a hydroxyl ligand, or deprotonate a coordinated water molecule, resulting in the ternary
metal-ligand-hydroxide species MLOH (15).

M + L

ML

βML

=

M + 2L

ML2

βML2=

M + HL

MLH

βMLH

ML + OH

MLOH

βMLOH

=
=

[ML]
[L][M]

(12)

[ML2]
[L]2[M]

(13)

[ML]
[H][ML]
[ML]
[OH][ML]

(14)

(15)

The thermodynamic parameter for each stepwise formation constant, K can then be
related to the standard free energy change (ΔG° ) at constant pressure (16). The total
enthalpy change ΔH0 can be determined from the temperature dependence of K according
to the van’t Hoff equation (17). Although potentiometry is commonly used to determine
metal-ligand formation constants, calorimetry is often used for enthalpy determinations,
since potentiometric measurements may not be stable across the full temperature range
needed to calculate a free energy change. The thermodynamic parameters free energy and
enthalpy are not discussed in detail in this review.
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ΔG̥ ° = -RT lnK
𝑑(ln 𝐾)
𝑑𝑇

=

𝛥𝐻°
𝑅𝑇 2

(16)

(17)

To determine stability constants for metal-amino-acid complexes, any method can
be used that can actively measure the formation and elimination of the species present, and
books dedicated to methods development and analysis have been published.59-61 General
problems associated with determining metal-amino-acid stability constants for all metals
are thoroughly reviewed,47,56,62-65 although these reviews are data-heavy and do not include
new methods development. This review will focus specifically on the best methods for
amino acid stability constant determination with Cu(I), Cu(II), Fe(II) and Fe(III), and the
particular experimental limitations associated with these ions. Common methods are
introduced here, and less common methods are discussed in each metal-specific section as
relevant.
The three most common methods for stability constant determination are
potentiometric, voltammetric, and spectrophotometric titrations. Potentiometric analyses
are the most frequently used method for amino acid-metal binding constant determinations.
The precision and stability of this method makes it the ideal choice of method, when
conditions allow, and permits detection of minor species when coupled with the
computational abilities of modeling software.47,50,57,66 While many of these species are
inconsequential under biologically relevant titration conditions for simple systems,
incorporation of these species into studies of more complex systems is imperative and can
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have significant effects, since their formation may influence formation of competitive
species.67
Potentiometric analyses are not always an option, and independent analyses are
helpful, and in some cases necessary, in confirming complex speciation. Voltammetric or
polargraphic techniques permit measurements at a constant pH for pH-sensitive systems.68
Often the resulting data are not as precise or as consistent as potentiometric methods, since
only changes to the metal ion are typically measured. Spectrophotometric analyses work
well with metal ions, ligands, and/or complexes that absorb in UV or visible wavelengths,
but these methods do not indicate binding mode of multidentate interactions. Development
of methods such as paper electrophoresis, involving solvent-extraction of species, is a
growing area. Table 1.1 provides an overview of the most common methods and their
advantages and limitations.
For amino-acid-metal complex determinations, potentiometry is the most common
method utilized, because the uptake and release of protons can be measured
precisely.47,56,63-65,69-71 Electrode stability limits the analysis range, and data can be
questionable at pH extremes (typically pH < 2 and pH > 12).47,65 Although robust and
precise, potentiometric analyses are limited to ligands or hydrolyzed metals with protons
that associate and dissociate in the pH range investigated and can be limited by ligand
and/or complex solubility across this pH range.
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Table 1.1. Advantages and limitations of stability constant determination methods
Method
Advantages
Limitations
Potentiometric titration

High precision
High accuracy

Ligands must protonate/deprotonate
Species must be soluble across wide pH range
Disproportionation issues with Cu(I)
Curve fitting technique with no direct measurement
of the metal or metal-ligand complex

Spectrophotometric titration

Can be run at narrow pH
Direct probe of metal and metalligand complex
Simple detection
Easy to identify species charges

Either metal or ligand must be UV-vis active

Redox titration

Redox-active metals can be
controlled

Species identification must be confirmed using
independent methods

Solubility

Low solubility systems such as
Fe(III)

Lengthy experiments due to slow equilibria
between solid and solution

Electrophoresis
(paper or solution)

Low precision
Temperature and oxygen control more difficult
Conditions differ from solution determination
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The IUPAC stability constant database contains a comprehensive list of all stability
constant and associated thermodynamic data available for metal-amino-acid stability
constant data reported up through 1989.54 Stability constants for most of the amino acids
with a variety of metals are available for a wide range of temperatures and supporting
electrolyte concentrations. Various reviews present a more selective list of stability
constants of metals with amino acids up until 1997.47,50,55-57 While the database and reviews
are comprehensive for the time periods indicated, they are cumbersome in the quantity of
analyses given for some metals such as Cu(II) and reflect the lack of data for other metals
such as Cu(I). Our analysis draws on these data and also comprehensively covers iron and
copper data with amino acids up until early 2018.

1.5 The Gold Standard: Proof of Speciation
Unambiguous identification of the thermodynamically stable species present in
solution is required to understand the solution equilibria of a metal-ligand complex.59,60 For
potentiometric determinations, glass electrodes are used to track the change in potential as
acid/base titrations are performed. Before the advent of modeling programs, best fit
analyses were determined for the most likely species formed in the given system using
graphical methods documented by Bjerrnum72,73 and Fronaeus.74 More recently, programs
such as SCOGS,75 HYSS,76 HYPERQUAD,77 and MINIQUAD78 have made modeling and
model-matching much easier to perform and have allowed for more precise data analysis.
As a result of computational modeling methods and perhaps a more comprehensive
understanding of solution equilibria for metal-amino acid complexes, the number of
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identified species in recent reports has expanded. While incorporation of additional species
certainly improves model fit to the data, due to their low concentration and limited
influence on metal complex formation, the existence of such species are often difficult to
confirm from titration data alone. For example, minor species such as complexes with
protonated, unbound side chains may not play an active role in metal binding, but they may
contribute to buffering in the cell.50,79 Thus, the gold standard for species determination
should incorporate secondary methods to unambiguously identify these minor species. In
this review, we describe the most consistent reported species, particularly emphasizing
investigations that have demonstrated a high level of control of experimental conditions or
used multiple methods of analysis to independently confirm the identified species.

1.6 Stability Constants of Non-Sulfur and -Selenium-Containing Amino Acids
with Cu(II)
Cu(II) Complexes of Potentially Bidentate Amino Acids
Whether or not labile Cu(II) exists in the cell, Cu(II) plays a major role in organisms
since activity and stability of Cu(II) metalloproteins depend on copper-amino acid
interactions.1 Compared to Cu(I), Fe(II), and Fe(III), Cu(II) is the most chemically wellbehaved ion for analytical measurements. Most Cu(II) salts are soluble in aqueous solution
and are not sensitive to air oxidation. It is not surprising, therefore, that hundreds of
analyses to determine Cu(II)-amino-acid stability constants are reported47,50,56,62-64 using a
wide variety of methods: polarography,80 spectrophotometry,81 circular dichroism,82
optical rotary dispersion,83 and electrophoresis.84,85 Although solubility of Cu(II)-amino
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acid complexes with hydrophobic side chains is limited in the basic pH range, this issue is
not always discussed in published reports.
Table 1.2 shows a summary of the stability constants for Cu(II) for amino acids
with non-coordinating side chains that are limited to bidentate coordination through the
carboxylate oxygen and amine nitrogen of the amino acid (Figure 1.1). Due to the plethora
of available data for Cu(II)-amino-acid stability constants,54 the selected stability constants
in Table 1.2 are those “recommended” in previous reviews due to their data quality and
reproducibility,47,50,55-57,66 where possible. Beyond that, selected constants were 1) reported
with errors, 2) determined within 25-37 ˚C, and 3) were conducted in a constant ionic
strength medium (range 0.1-3 M).86
Analysis of Cu(II)-amino-acid stability constants with bidentate-coordinating
amino acids (Figure 1.1) is fairly straightforward and consistent. Coordination is typically
through the α-carboxylate oxygen and α-amine for both ML and ML2 species and is
supported by solid-state structures. The structure of Cu(Gly)2, a representative bidentateML2 species, is square planar with bidentate glycine ligands creating two five-membered,
equatorial chelate rings around Cu(II) (Figure 1.4A).87 The axial positions are vacant,
with occasional coordination of water molecules or supporting electrolyte, such as in
Cu(Gly2)(H2O) (Figure 1.4B).87-90
No trend in stability constants relating to side chain hydrophobicity is observed for
the aliphatic amino acids. Potential intermolecular interactions of aromatic side chains
(e.g., phenylalanine) also do not impart added stability to the complexes, since all of the
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Table 1.2. Stability constants for Cu(II) and Cu(I) with potentially bidentate amino acids
Stability Constants for Cu(II)
Ligand
ML
ML2
Temp.
Ionic Strength
Method
Ref.
(log βML)a
(log βML2)b
(°C)
(M)
91
Alanine
8.17(3)
14.94(5)
30
0.1 KNO3
Potentiometry
92
Glycine
8.07(2)
14.86(3)
30
0.1 NaClO4
Potentiometry
93
Isoleucine
8.50(6)
15.79(8)
25
0.1 NaNO3
Potentiometry
62
Leucine
8.276(1)
15.174(1)
25
0.1 KNO3
Potentiometry
62
Phenylalanine
7.93(1)
14.83(1)
25
0.1 KNO3
Potentiometry
c
c
94
Proline
8.60(3)
15.09(7)
25
0.1 NaNO3
Potentiometry
62
Tryptophan
8.02(1)
15.56(1)
25
0.1 KNO3
Potentiometry
95
Valine
8.05(2)
14.91(2)
30
0.1 NaClO4
Potentiometry
Stability Constants for Cu(I)
96
Alanine
9.6c
25
0.3 K2SO4
Redox
96
Glycine
10.0c
25
0.3 K2SO4
Redox
a
b
2
c
log βML = [M][L]/[ML]
log βML2 = [M][L] /[ML2] Authors also reported the minor species Cu(Pro)(OH)
(log β = 1.29(4)) and [Cu(Pro)(OH)2]- (log β = -8.58(3)).
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Figure 1.4. A) Crystal structure diagram for Cu(Gly)2 showing carboxylate and amine coordination with
square planar geometry around the central Cu(II) ion.87 B) Crystal structure diagram of Cu(Gly)2(H2O) also
showing carboxylate and amine coordination in the equatorial position, but with a water molecule coordinated
in the axial position of the square pyramidal geometry.88,90 The Cu(II) ion is shown in orange, oxygen atoms
are red, carbon atoms are grey, and nitrogen atoms are blue. Hydrogen atoms are not shown.

Cu(II) stability constants with bidentate amino acids are within one log unit of each other
(Table 1.1). This stability constant uniformity indicates glycine-like ML and ML2 complex
formation for all these amino acids with Cu(II).
Minor species have also been identified for these relatively simple systems. Blais
and coworkers67 claim to have identified [Cu(HVal)]2+ and [Cu(HVal)(Val)]+ as well as
[Cu(HGly)]2+, [Cu(HGly)(Gly)]+, and [Cu(HGly)2]3+ in their Val and Gly analyses,
respectively. Because the side chains of Val and Gly cannot protonate, it can be assumed
that these species arise from amine protonation and monodentate binding of the metal
through the carboxylate oxygen. All of these species form below pH 3 and represent only
a very small change in buffering of the system. While these species are chemically
reasonable in terms of competition between a high proton concentration and Cu(II) for
amino acid binding, they are formed at the accuracy limits of potentiometric measurements
when formed at low pH and remain to be independently confirmed.
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On the other end of the pH range, species with hydroxyl coordination, such as
MLOH and ML2OH, are reasonable and expected, especially since water is known to
coordinate in the axial position in the solid state (Figure 1.4B).87,97 However, Cu(II)-amino
acid complexes typically precipitate in the alkaline range (pH > 9). Arena and coworkers
note that signal drift can occur in potentiometric measurements at more basic pH when
precipitation is seeding,98 and this signal drift can be misinterpreted as new species
formation.99

Thus, distinguishing between signal drift and minor hydroxyl species

formation at basic pH is a core issue in determining accurate speciation.
Analyses across methods also are consistent for Cu(II) titrations with potentially
bidentate amino acids, a promising sign for methods development, particularly for the
determination of stability constants for ligands that may not have the ionizable protons
needed for potentiometric analysis. Paper electrophoresis is an excellent method for
separating species, although it is limited in precision and may not accurately represent
“solution” equilibria. For potentiometric and paper electrophoresis results for the Cu(II)alanine system, the paper electrophoresis stability constants reported by Jokl100 are slightly
higher: 8.5 and 15.2 for the [Cu(Ala)]+ and Cu(Ala)2 species (no errors are reported),
respectively, compared to 8.17(3) and 14.94(5) using potentiometric methods.91 Singh’s
[Cu(Val)]+ and Cu(Val)2 electrophoresis determinations84 are consistent with or slightly
lower than potentiometrically determined values (8.02 and 14.62, respectively, compared
to 8.05(2) and 14.91(2), respectively).95 Separately, Tewari101 reported paper
electrophoresis stability constants for the Cu(II)-isoleucine system: 8.41(7) for [Cu(Ile)]+
and 14.84(3) for Cu(Ile)2, values consistent with or slightly lower than the potentiometric
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results of 8.50(6) and 15.79(8), respectively.93 While this is not a comprehensive list of
paper electrophoresis determinations, these representative data demonstrate method
viability. Indications of the charge of species due to electrophoretic movement is an
advantage of electrophoresis. If the detection limits are suitable, electrophoresis may be a
method worth exploring for establishing existence of minor species.
Spectrophotometric analyses also are an option for spectrophotometrically active
metals such as Cu(II) or ligands with aromatic groups that absorb or fluoresce in the UV
or visible spectrum. However, concentrations required for species detection in the UVvisible range can be a factor of ten higher for spectrophotometric analyses compared to the
precision determination of protons in potentiometric analyses. Effects of metalcoordinating solvents or supporting electrolyte can also contribute to error in
spectrophotometric methods. For example, a spectrophotometric analysis of the Cu(II)leucine system by Bretton102 with no supporting electrolyte results in considerably higher
stability constants than those obtained by potentiometric analyses with a supporting
electrolyte of 0.1 M NaNO3 by Ivicic (Table 1.1).93 Other optical methods such as
circular dichroism and optical rotary dispersion have also been used to determine stability
constants with Cu(II), with results similar to those from potentiometric analyses, but it can
be difficult to identify minor species using these methods.82,83 Perhaps the most compelling
use of spectrophotometric methods to determine stability constants is in conjunction with
potentiometric methods, since species identification can be supported by two independent
methods. This combination is demonstrated by Davis103 in determining the stability
constants for Cu(II)-valine-pyridoxal complexes.
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Stability constants of Cu(II) with aliphatic amino acids are one of the most widely
studied of all metal-amino-acid combinations. The relative stability of this metal ion with
non-redox active ligands makes the resulting data easy to interpret, as long as the method
is reliable in collecting quantifiable changes to the system, whether the release of protons
or spectral changes. As a result, these systems provide the best arena for development of
methods to examine metal coordination with weakly binding ligands.

Cu(II) Complexes of Potentially Tridentate Amino Acids
Amino acids with polar side chains, including serine, histidine, threonine, tyrosine,
aspartic acid, glutamic acid, asparagine, and glutamine, may coordinate not only through
the carboxylate oxygen and amine nitrogen atoms, but also through the polar side chain
atoms. Although polar, the side chains of lysine and arginine are typically positively
charged in aqueous solution with pKa values of 10.54 and 12.48,55 respectively, and
therefore are not expected to coordinate positively charged Cu(II). Methionine and cysteine
also have electronegative side chains with the potential for binding Cu(II), but these sulfurcontaining amino acids have unique redox properties that present potential complications
for stability constant determination and are discussed separately.
Due to the thermodynamic nature of stability constants, tridentate binding to Cu(II)
should be reflected in considerably higher stability constants compared to bidentate
binding. With Cu(II), stability constants for asparagine, glutamine, serine, threonine, and
tyrosine (Table 1.3) are not significantly different from those for the bidentate amino acids
(Table 1.2), suggesting only carboxylate and amine binding. Not surprisingly, the lowest
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stability constants for Cu(II) binding are observed for Lys and Arg (Table 1.3), likely
indicating electrostatic repulsion between the positively charged amino acid and Cu(II). In
contrast, Cu(II) stability constants of histidine (ML = 9.75, ML2 = 17.49) and aspartic acid
(ML = 8.83, ML2 = 15.93) are considerably higher than the other tridentate amino acids
(Table 1.3), indicating side chain coordination.
Tridentate coordination to Cu(II) by aspartic acid104 and histidine are supported by
solid-state structures (Figure 1.5).105-108 Stability constants for glutamic acid (ML = 8.30,
ML2 = 15.03) are slightly elevated compared to the other potentially tridentate amino acids,
suggesting weaker side-chain coordination than for His or Asp. However, the only solidstate structure to support this tridentate binding mode is the glutamate complex with
cadmium, [Cd(Glu)(H2O)]H2O.109 In general, most of the stability constants for the
potentially tridentate ligands with Cu(II) do not indicate tridentate binding, and it is
reasonable to assume that Cu(II) coordination by these amino acids is

Figure 1.5. Crystal structure diagram for the Cu(His)2 complex, showing both tri- and bidentate binding of
histidine to the Cu(II) center. The Cu(II) ion is shown in orange, oxygen atoms are red, carbon atoms are
grey, and nitrogen atoms are blue. Hydrogens are omitted for clarity.
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Table 1.3. Stability constants for Cu(II) and Cu(I) with potentially tridentate amino acids
Stability Constants for Cu(II)
Ligand
ML
ML2
MLOH
Other
Temp
Ionic
Method
(log βML)a (log βML2)b (log βMLOH )c
Species
(°C) Strength
(M)
Arginine
7.555(4) 14.007(5)
25 0.1 KNO3 Potentiometry

Ref.
62

14.142(4)

4.17(2)

MLH 10.08(3)
ML2H 17.44(3)

37 0.15 NaClO4 Potentiometry

110

Aspartic acid 8.83(3)

15.93(2)

24.0(1)

MLH 12.52(2)
ML2H 19.8(3)
M2L 10.34(6)
M2L2 19.5(1)

25

0.1 KNO3

Potentiometry

111

Glutamine
7.71(1)
Glutamic acid 8.30(4)

14.12(1)
15.03(3)

25
25

0.1 KNO3
0.1 KNO3

Potentiometry
Potentiometry

Histidined

9.75(1)

17.49(1)

MLH 13.78(1)
ML2H 23.05(1)
ML2H2 26.29(6)
ML2OH 6.3(1)

37

0.15 NaCl

Potentiometry

112

Lysine

7.62(2)

13.94(2)

MLH 10.361(5)
ML2H 10.84(1)

25

0.1 KNO3

Potentiometry

62

Serine

7.748(2)

14.083(5)

4.285(13)

MLH 10.030(16) 37 0.15 NaClO4 Potentiometry

110

Threonine

7.98(4)

14.66(5)

4.81(3)

ML2H-2 -6.0(1)

Tyrosine

7.90(2)

15.17(3)

Asparagine

7.788(3)
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MLH 12.52(2)
ML2H 19.6(3)
M2L 10.41(5)
M2L2 18.6(2)
2.2(2)

98
111

25

0.1 KNO3

Potentiometry

107 113 62,11

25

0.1 KNO3

Potentiometry

115

Stability Constants for Cu(I)
Histidine
12.80d
25.20d
25
0.2 KNO3
a
log βML = [M][L]/[ML] b log βML2 = [M][L2]/[ML2] c log βMLOH = [ML][OH]/[MLOH]
assumes the histidine has one ionizable proton.
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Redox
The protonation state for His in the ML and ML2 species

very similar to the bidentate amino acids. Changes in side-chain protonation state, however,
can complicate stability constant determination and make identifying minor species more
difficult.

Challenges in Determining Cu(II)-Amino Acid Stability Constants
Determining the speciation of metal complexes with potentially tridentate amino
acids is especially troublesome for modeling stability constants. These difficulties are
primarily caused by reported potential minor species due to 1) inconsistency of identified
species, 2) failure to independently characterize these species, and 3) absence of
meaningful discussion about the relative importance or implications of the reported minor
species. Thus, researchers may be adding minor species solely to optimize their model
fitting to titration data, a particular issue given the unreliability of Cu(II)-amino acid
titration data at pH > 9 due to precipitation. Collection of titration data is usually limited
to the pH range over which all complexes remain in solution, but these pH limits are not
always explained, and precipitation is rarely mentioned.
As an example, most studies describing binding constants for Cu(II)-serine
complexes report only two species, ML and ML2.50 More recent work reports two
additional species, ML2OH and MLH.110 The difficulties surrounding identification of
additional, minor species is demonstrated by comparing the simulated titration data based
on reported constants110,117 for 1) a titration that incorporates just two primary species,
Cu(Ser)2 and [Cu(Ser)]+, and 2) a titration that incorporates the additional minor species
[Cu(HSer)]2+ and Cu(Ser)(OH), for a total of four species (Figure 1.6). Under typical
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titration conditions with a 1:2 Cu(II)-to-serine ratio, [Cu(SerH)]2+ is present at less than
2% of total Cu and only present below pH ~4, as modeled in Figure 1.6B. Including this
minor species results in no differences between the modeled two-species and four-species
titration data at these concentrations at pH 4-8 (Figure 1.6A). In contrast, adding the

A

B

Figure 1.6. A) Simulated titration with a strong base of Cu(II) and Ser with a 1:2 metal to ligand ratio. The
“two-species” (red) line shows the modeled titration with only the Cu(Ser) (log β = 7.92(1)) and Cu(Ser)2
(log β2 = 14.57(1)) species.118 The “four-species” (black) line shows the modeled titration with four species,
Cu(Ser) (log β = 7.57), Cu(Ser)2 (log β = 14.02), Cu(Ser)2OH (log β = 4.29), and Cu(Ser)H (log β = 10.03).110
B) A speciation diagram for the Cu(II) and Ser titration over the pH range 3-10.5 fit with two (red line) and
four (black line) species.
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[Cu(Ser)2OH]- species significantly affects titration buffering above pH 8. Including this
additional species may improve the model fit to experimental data; however, many Cu(II)amino-acid complexes precipitate above neutral pH as the concentration of the ML2 species
increases, although this precipitation is often unreported, resulting in significant
electrode drift and data inaccuracy. Under these conditions, the limited accuracy of the
experimental data may not support including minor species to increase modeling accuracy,
and in the absence of independent characterization, these species may even be artefactual.
The Cu(II) to amino ratio used in stability constant determinations also has a
significant effect on complex speciation, as demonstrated with the four-species Cu(II)-Ser
model titration (Figure 1.6; modeled at a 1:2 ratio) at metal-to-ligand ratios of 1:1 (Figure
1.7A) and 1:10 (Figure 1.7B). Concentrations of the two minor, potentially disputed, MLH
and ML2OH species are amplified by at least two-fold in the 1:10 simulation. These MLH
and ML2OH species are only present under very acidic or basic conditions, respectively,
minimizing their impact in biological systems.
To emphasize the inconsistency in identifying minor species, one can consider the
example of Cu(II)-threonine titrations. From the wide range of data available, the primary
ML and ML2 species are confirmed, and no MLH species is reported. Multiple studies
identify the minor dihydroxide species, ML2(OH)2,62,107,111,114 but the presence and
contribution of this hydroxide species is disputed given the conflicting data and lack of
independent characterization.
Despite their uncertainties, the Cu(II)-Ser and Cu(II)-Thr systems are
straightforward compared to Cu(II)-His titration modeling, where anywhere from four to
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thirteen species are identified (Table 1.2).112,119-121 Understanding histidine-copper binding
is of primary importance, since it is the most common amino acid in the binding pockets
of copper metalloproteins and is the predominant non-protein-bound copper complex in
blood plasma.48,122,123 Reports of so many species, including dinuclear complexes, is
indicative of inherent variability in His-Cu(II) coordination. The major species at pH 6-8

Figure 1.7. A) Modeled speciation diagrams for the Cu(II)-Ser four-species system from Figure 1.6 A) at a
1:1 Cu(II):Ser ratio and B) at a 1:10 Cu(II):Ser ratio.

are [Cu(His)2H]+ and Cu(His)2; however, minor species, such as [CuHis]+, are present that
could influence cellular speciation.56 Kamyabi and coworkers provided independent
confirmation of [Cu(His)]+, Cu(His)H, Cu(His)2, [Cu(His)2H]+, and Cu(His)(OH)
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complexes using spectroscopic methods.124 The complexity and difficulties of determining
Cu(II)-histidine speciation highlight core issues for stability constant determination. Even
when the metal-ligand interaction is well-behaved and a variety of methods are available
for analysis, confirmation of relevant species must be achieved for the data to be useful in
large-scale modeling projects.

1.7 Stability Constants of Non-Sulfur and -Selenium-Containing Amino Acids
with Cu(I)
Cu(I) is the least studied and the most poorly understood of the common copper
and iron oxidation states in biological systems. In humans, cellular copper intake is tightly
controlled through the membrane transport protein hCTR1,125-127 which has methionine-,
cysteine-, and histidine-rich amino acid sequences in the Cu(I) binding site.6,128 Although
hCTR1 and other copper transport proteins preferentially bind Cu(I) over Cu(II), Cu(I)
stability constants are vastly underexamined due to the difficulties of working with this ion.
Cu(I) is highly unstable in aqueous systems and disproportionates to Cu(II) and Cu0
in the presence of dioxygen. Cu(I) is also spectrophotometrically inactive, limiting
spectrophotometric titrations to ligands that have absorbances in the UV or visible
spectrum. In addition, the most commonly used Cu(I) salt, CuCl, is only sparingly soluble
in aqueous systems, narrowly defining the parameters for which potentiometric methods
can be utilized. Sharma and coworkers129 used potentiometric methods to determine that
Cu(I) is stabilized in aqueous systems with sufficient Cl- support (1.0 M). Using
potentiometric methods, they identified three species: CuCl, [CuCl2]-, and [CuCl3]2-, with
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step-wise stability constants of 2.68, 5.07, and 4.78, respectively.129 Given these difficulties
with Cu(I) instability and solubility, reliable data for Cu(I) stability constants with amino
acids lags far behind that of Cu(II) despite its biological importance.
Due to the significant limitations of potentiometric methods with Cu(I), stability
constants have been primarily determined using redox methods. Since Cu(I) is unstable in
aqueous solution, redox methods are preferred because metal oxidation state is controlled
at the electrode surface. This method is dependent on predicting the potential at which half
of the concentration is Cu(I) and half is Cu(II), and activity due to ionic strength is
sometimes ignored in the calculations. Stability constants for Cu(I) with only three nonsulfur or -selenium amino acids are reported; Cu(I) stability constants with sulfur- and
selenium-containing amino acids will be discussed separately in the Stability constants of
Cu(I) and Cu(II) with sulfur and selenium amino acids section.
Using redox analyses, stability constants of 9.6, 10.0, and 10.4 were found for
Cu(Ala), Cu(Gly), and Cu(His), respectively.96 Since alanine and glycine have noncoordinating side chains, and stability constants for all three complexes are very similar,
these data suggest that all three amino acids are binding in bidentate fashion to Cu(I). It is
surprising that His would show such weak Cu(I) binding, considering the role that histidine
plays in stabilizing copper in metalloproteins.130 The only other Cu(I)-His determination
identifies formation of Cu(HHis) and [Cu(HHis)2]- species with stability constants of 12.80
and 25.20, respectively (Table 1.3),116 where “HHis” indicates protonation of the amine or
imidazole nitrogen atom, implying only bidentate binding. These Cu(I)-His results seem
contradictory not only because the identified species are not the same, but because the
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Cu(I) species with a potentially tridentate-binding His ligand has a significantly lower
stability constant than the Cu(I) species with only a bidentate-binding His ligand.
Considering the importance of Cu(I) in biological systems, the fact that methods and
stability constant data for Cu(I)-amino-acid complexes are not reliable enough to compare
with similar Cu(II) data highlights the extreme difficulties inherent in studying this ion. To
add these difficulties, even if reliable titration methods are identified, the propensity of
Cu(I) to form multinuclear species131-133 will provide an additional challenge for these
measurements.

1.8 Stability Constants of Sulfur- and Selenium-Containing Amino Acids
with Copper
Similar to histidine, sulfur-containing amino acids have been credited for the
stability and redox activity of a wide variety of copper metalloproteins. Both methionine
and cysteine are recognized for the structural and electronic stability that they contribute
to blue copper proteins.134,135 Thiols have such a high stability with copper, that the drug
penicillamine is administered in the treatment of Wilson’s disease as a copper chelator.16,17
Selenium compounds, such as selenocysteine, are crucial to the function of
selenoproteins.136-138 Selenocysteine coordinates nickel in NiFeSe hydrogenases,139 and
selenomethionine is non-specifically incorporated into proteins in place of methionine.51
In addition, many sulfur and selenium species have been identified and extensively studied
as antioxidants by in vitro, in vivo, and epidemiological studies,135,140-144 in part due to their
copper-binding properties. Selenium-containing supplements have been the subject of

33

human studies for their potential as antioxidants, although results are limited and
conflicting.53,145-148
All of the sulfur- and selenium-containing amino acids have the potential for
tridentate binding through the carboxylate oxygen, the amine nitrogen, and the S/Se atom
in the side chain. Table 1.4 summarizes the available data for stability constants of Cu(II)
and Cu(I) with these amino acids; unsurprisingly, data for Cu(II) are much more complete
than for Cu(I).

Cu(II) Complexes of Sulfur- and Selenium-Containing Amino Acids
Thiol-containing cysteine, homocysteine, and penicillamine are redox-active in the
presence of Cu(II), forming the respective disulfides and reducing Cu(II) to Cu(I).149,150
This redox activity impacts the validity of stability constant determinations with these
amino acids.

Although Cu(II)-Cys stability constants have been errantly reported,54

previous reviewers50 have explained the misidentification of species present in these
analyses, and Pinto151 suggested that these complexes are stable at ligand:metal ratios
below one. The potential for redox reactions casts a shadow over the reliability of
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Table 1.4. Stability constants of Cu(II) and Cu(I) with sulfur- and selenium-containing amino acids
Cu(II) Stability Constants
Ligand
ML
ML2
Other Species Temp Ionic Strength
Method
(log βML)a (log βML2)b
(°C)
(M)
Homocysteine
11.92(1) 13.54(2) 7.57(1) (MLOH) 25
0.1 KNO3
Potentiometry
Methionine
7.85(2)
14.52(1)
25
0.1 KNO3
Potentiometry
c
c
Methylcysteine
7.65
14.13
25
0.2 KCl
Potentiometry
Methylselenocysteine 8.2(1)
14.5(2)
25
0.1 NaClO4
Potentiometry
c
c
Penicillamine
16.5
21.7
25
0.15 KNO3
Potentiometry
Selenomethionine
7.77c
14.50c
25
0.1 NaNO3
Potentiometry
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Cu(I) Stability Constants
Cysteine
10.164(6) 18.36(1) 20.34(2) (ML3)
25
1.0 NaCl
Methionine
9.1c
20
0.1 NaClO4
Penicillamine
12.41(5)
18.72(1) (MLH)
25
1.0 NaCl
22.29(2) (M2LH)
34.44(1) (M2L2H)
a
log βML = [M][L]/[ML] b log βML2 = [M][L2]/[ML2] c Error not reported
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Potentiometry
Potentiometry
Potentiometry

Ref.
151
62,152,153

154
155
156
157

158

12,159
158

Cu(II)-thiol stability constant data and emphasizes the need for proof of speciation in these
systems.
Pencillamine has the highest Cu(II) stability constants of the amino acids in Table
1.4, forming Cu(Pen) (log β = 16.5) and [Cu(Pen)2]2- (log β2 = 21.7) species.156 The high
affinity of penicillamine for Cu(II) is not surprising, since a primary use of penicillamine
is as a copper chelator. Of the other sulfur and selenium amino acids examined, the thiolcontaining homocysteine has a higher MLspecies stability constant (11.92(1))151 than the
others (~7.8), but the ML2 species is slightly less stable at 13.54(2) than the ML2 species
of methionine, methylcysteine, and selenomethionine. Pinto151 suggested that the amine
and the soft thiolate of homocysteine binds borderline Cu(II) in the ML species, either in
addition to the hard carboxylate oxygen or in place of it. This is reasonable, since EPR
analysis of [Cu(hCys)2]2- indicates tetrahedral geometry around Cu(II), with the thiolate
sulfur replacing carboxylate oxygen binding.151 The [Cu(HhCys)] species has a
significantly higher stability constant than the thio- or selenoethers, potentially indicating
stability afforded by tridentate binding. When sterically hindered by a second ligand
coordinating in the ML2 species, the carboxylate oxygen coordination may be lost, and the
two ligands likely coordinate in a bidentate fashion through the amine nitrogen and thiolate
sulfur atoms. 151
The presence of a thioether or selenoether group does not contribute to
thermodynamic stability of Cu(II) complexes, since stability constants for Cu(II) with
methionine, methylcysteine, and selenomethionine are similar to those of the bidentatecoordinating Cu(II)-amino acids in Table 1.2. Solid-state structures also show no thioether
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or selenoether coordination in the ML2 complexes, including Cu(Met)2,160,161
Cu(SeMet)2,155 and Cu(MCys)2,162 but tridentate binding to Co(III)163,164 and softer metal
ions such as rhenium165 and ruthenium166,167 is observed.

Cu(II) Complexes of Sulfur- and Selenium-Containing Amino Acids
Stability constants for Cu(I) with sulfur and selenium amino acids are limited to
two thiolates (Cys and Pen), only one thioether (Met), and no selenium-containing species
(Table 1.4). This paucity of data makes evaluation difficult, as does the fact that the Cu(I)Met results159 have not been replicated in sixty years, and no other Cu(I) stability constants
have been reported under these conditions. If these results are valid, only the CuI(Met)
species has a higher stability constant (log  = 9.1) than the analogous Cu(II) species,
[CuII(Met)]+ (log  = 7.85(1)).62 The higher stability of the Cu(I) complex may suggest
tridentate binding, or at least a different binding mode than the glycine-like coordination
of the [CuII(Met)]+ species. No X-ray diffraction structures are reported for CuI(Met), but
X-ray absorption spectroscopy studies supported by NMR results in aqueous solution
indicate Cu(I) coordination by the thioether sulfur and the amine nitrogen atoms in a
bidentate fashion.168
Cu(I)-Cys is one of the most thoroughly investigated Cu(I) systems, with stability
constant determination attempted using at least four different methods with vastly different
results. Using polargraphic methods, only the ML species was identified with a stability
constant of 19.19.169 By spectrophotometry, the stability constant for the same ML species
was reported as 11.38.170 In a review, Berthon50 highlighted the inconsistencies between
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these two reports, attributing the difference to interference by NH3 or redox issues in the
polargraphic determinations. More recently, Konigsberger158 attempted to determine
Cu(I)-Cys stability constants in a ternary system using potentiometric analyses with
penicillamine. Although penacillamine addition may expand the solubility range of the
system beyond pH 5.2, it adds multiple species into an already complicated model. Four
different species were reported to form throughout the full pH range, including species with
multiple cysteine protonation states and three dinuclear species. Polynuclear copperthiolate complexes are well known, but suggesting the formation of multiple dinuclear
species based on model fit alone is insufficient support. Adding to this complexity, kinetics
analyses suggest a dinuclear, mixed-valent Cu(II)/+-cysteine complex also may form as an
intermediate between the ML and ML2 species.171
Similar to Cys coordination, the Cu(I)-penicillamine system has also been
extensively studied,158,171-173 with no agreement on either the stability constants or species
present (Table 1.5). Again, the tendency of Cu(I) to form dinuclear and polynuclear
complexes significantly complicates species determination. Most notably, Persson and
coworkers172 determined stability constants of 39.18 and 101.5 for the [Cu(PenH)2]- and
[Cu5Pen4]3- species, respectively, high values that indicate penicillamine strongly stabilizes
Cu(I).
To explore differences in speciation between Cu(I) and Cu(II) in the presence of
penicillamine, a model of the speciation of copper (100 μM) with penicillamine (1000 mM)
was calculated using Geochemist’s Workbench174 using the stability constants and species
reported by Persson.172 Below pH 5, Cu(I) hydrolysis species predominate
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Table 1.5. Speciation and stability constants for Cu(I) with penicillamine (Pen)
Species

log β

Cu(Pen)

10.470(6)

Cu(PenH)

18.46(1)

Cu2(PenH)

20.48(1)

Cu(Pen)

12.25(2)

Cu(PenH)

18.34(1)

Cu(Pen)2

15.44(3)

Cu4(Pen)3

49.15(7)

Cu(Pen)2H2

39.18

Cu5(Pen)4

101.5

Ionic Strength

Temp(˚C)

Method

Ref.

1 M NaCl

25

Potentiometry

158

1 M NaCl

25

Potentiometry

173

0.5 M NaClO4

25

Potentiometry

172

(Figure 1.8A). As the pH increases and the thiolate of penicillamine deprotonates,
formation of Cu(II)- and Cu(I)-Pen species increases, but the Cu(II) species are the more
prevalent species, by a factor of 100. As the electrochemical potential decreases, Cu(I)-Pen
species are stabilized (Figure 1.8B).
Copper binding to selenium-containing amino acids is vastly understudied
compared to their sulfur analogs. Data for the Cu(II)-SeMet system are reported, with
stability constants of 7.77 and 14.50 for the ML and ML2 species, respectively. The Cu(II)MeSeCys stability constants have been recently determined,155 and are consistent with the
other thio- and selenoether amino acids with stability constants of 8.2(1) and 14.5(2) for
the ML and ML2 species, respectively. Because these stability constants are similar to those
of Cu(II) with methionine and to those for the bidentate-binding amino acids in Table 1.2,
Cu(II) likely binds selenomethionine and methylselenocysteine in a glycine-like manner.
No data could be found for other selenoamino acids such as selenocysteine. Selenocysteine
is highly redox sensitive,175 but stability constants with

39

Figure 1.8. A) Speciation comparison between Cu(II) and Cu(I) complexes of penicillamine at a 10:1 ligandto-metal ratio, showing the favorable stability of Cu(II) over Cu(I) complexes. B) As the electrochemical
potential decreases, Cu(I) complexes increase in stability.

copper would contribute to the greater body of knowledge regarding selenium species
incorporated into metalloproteins.

Challenges in Determining Copper Stability Constants with Sulfur- and SeleniumContaining Amino Acids
For the vast majority of Cu(II)-amino acid complexes, potentiometric analyses
indicate formation of ML and ML2 species with stability constants of approximately 8 and
14, respectively. Only histidine, glutamic acid, and penicillamine stability constants are
high enough to suggest tridentate or partially tridentate Cu(II) coordination in the ML
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species. In general, stability of glycine-like amino acid binding to Cu(II) is greater than to
Cu(I), although increased stability constants suggest that thiols, thioethers, and
selenoethers coordinate Cu(I) through the sulfur or selenium, either in addition to or in
place of the carboxylate oxygen. The difficulties in controlling the redox chemistry of Cu(I)
with thiols and selenols has discouraged researchers from pursuing the determination of
these stability constants with Cu(I). For both Cu(I) and Cu(II), formation of a variety of
multinuclear species with sulfur and selenium amino acids also significantly hinders
stability constant analysis and interpretation.

1.9 Stability Constants of Non-Sulfur and -Selenium-Containing Amino Acids
with Fe(II)
Labile Fe(II) pools contribute to reactive oxygen species formation and cellular
oxidative stress,176 and iron interactions with low-molecular-weight species such as amino
acids may alter this behavior. Although not as robust as Cu(II) due to its tendency to form
Fe(III) in the presence of oxygen, Fe(II) is fairly well-behaved in closed reaction vessels
or under an inert atmosphere of nitrogen or argon. Hydrolysis constants of Fe(II) ([FeOH]+
log  = -9.5 and Fe(OH)2 log  = -20.5)177 are low enough to be a factor only at high pH
and/or high metal-to-ligand ratios. Since Fe(II) is spectrophotometrically inactive, similar
to Cu(I), most stability constant measurements with this ion are performed using
potentiometric methods.
Stability constants have been determined for most amino acids with Fe(II);
however, a majority of these data are individual analyses, making accuracy evaluation
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difficult. For some amino acids, only one stability constant for either the ML or ML2
species is reported, with little analysis or attempts to identify minor species. Because all
the Fe(II)-amino-acid stability constants were determined using potentiometric analysis,
comparisons to other methods are not possible.

Fe(II) Complexes of Potentially Bidentate Amino Acids
Similar to Cu(II), Fe(II) stability constants with bidentate-coordinating amino acids
all fall within one log unit of each other (3.39 to 4.13 for the ML species, and 7.1 to 8.3 for
the ML2 species; Table 1.6). Glycine, with the relatively low log β values of 4.13 and 7.65
for the ML and ML2 species, respectively, forms the most stable Fe(II)-amino acid
species.66 Proof of speciation and details about coordination environment are scarce for
these potentially bidentate Fe(II)-amino-acid complexes, since Fe(Pro)2(phenanthroline)
(Figure 1.9) is the only reported Fe(II) structure with any single amino acid ligand.178 In
this complex, Fe(II) is coordinated in distorted octahedral geometry, with both bidentate
Pro ligands coordinating through the amine nitrogen and carboxylate oxygen atoms. Given
the similarity of ML2 stability constants for Fe(II) binding to all the potentially bidentate
amino acids, it is reasonable to assume similar amine and carboxylate coordination for all
the amino acids in Table 1.6.
A single study identifies ML3 species for phenylalanine and tryptophan with log β
values of 10.7(2) and ~9.5, respectively.179 Fe(II) binding to a third amino acid must outcompete formation of the [FeOH]+ and Fe(OH)2 species, the latter of which has limited
solubility. If all three ligands of the ML3 species bind in a bidentate fashion, they are almost
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certainly arranged in octahedral geometry around the Fe(II) center. Both Phe and Trp have
aromatic side chains that would result in considerable steric encumbrance to the complex.
The predictable stepwise formation constants (log K1 = 3.74, log K2 = 3.45, and log K3 =
3.5) suggests there is no enthalpic penalty due to increasing coordination, and the reported
potentiometric results are supported by calorimetry measurements.179 In all cases, the
stability constants for the [FeL]+ and FeL2 species are extremely weak and indicate that
high ligand-to-metal concentrations are required for complex formation.

Table 1.6. Stability constants of Fe(II) and Fe(III) with potentially bidentate amino acids
Stability Constants of Fe(II)
Ligand
ML
ML2
ML3
Temp
Ionic
Method
Ref.
(log β)a
(log
(log
(°C)
Strength
β2)b
β3)c
(M)
d
180
Alanine
3.54
20
1.0 KCl
Potentiometry
d
d
66
Glycine
4.13
7.65
25
0.1 KNO3
Potentiometry
d
180
Leucine
3.42
20
1.0 KCl
Potentiometry
179
Phenylalanine 3.74(1)
7.19(3) 10.7(2)
25
3.0 NaClO4
Potentiometry
181
Proline
8.3d
20
0.01e
Potentiometry
179
Tryptophan
3.92d
7.39d
~9.5d
25
3.0 NaClO4
Potentiometry
d
180
Valine
3.39
20
1.0 KCl
Potentiometry
Stability Constants of Fe(III)
182
Alanine
10.98d
30
1.0 KCl
Polarography
d
159
Glycine
10
25
1.0 NaClO4
Redox
d
159
Leucine
9.9
20
1.0 NaClO4
Redox
f
179
Phenylalanine 10.39(4) 19.1(1) 26.0(7)
25
3.0 NaClO4
Potentiometry
Proline
10.0(3)
20
1.0 NaClO4
Potentiometry
159
Tryptophan
9.0d
20
1.0 NaClO4
Redox
159
Valine
9.6d
20
1.0 NaClO4
Redox
a
d
log β = [M][L]/[ML] b log β2 = [M][L2]/[ML2] c log β3 = [M][L3]/[ML3]
No error reported by
author. e The identity of the electrolyte was not reported; titrations were run at approximately 0.01 M ligand.
f
Data also supported by calorimetry.
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Figure 1.9. Solid-state structure of Fe(Pro)2(phenanthroline),178 showing bidentate Pro coordination through
the carboxylate oxygen and the amine nitrogen atoms. Fe(II) is shown in orange, oxygen atoms are red,
carbon atoms are grey, and nitrogen atoms are blue.

Fe(II) Complexes of Potentially Tridentate Amino Acids
As for the bidentate amino acids, stability constant data for potentially tridentate
amino acids binding Fe(II) are incomplete. Most of the stability constants for ML (3.204.37) and ML2 complexes of these amino acids are similar to those for the bidentate amino
acids, consistent with glycine-like binding to Fe(II) without significant stability contributed
by the polar side chain. Many of the reported constants have not been replicated or
independently confirmed by other methods.
Histidine and aspartic acid have somewhat higher stability constants (5.88 and 5.34
for the ML species and 10.43 and 8.57 for the ML2 species, respectively) than the majority
of the other potentially tridentate amino acids, suggesting possible tridentate binding or
Fe(II) stabilization through bridging ligands. ML3 stability constants are determined for
asparagine183 and serine,184 further supporting bidentate coordination of these amino acids,
at a maximum. It is surprising that minor species have not been
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Table 1.7. Stability constants of Fe(II) and Fe(III) with potentially tridentate amino acids
Stability Constants of Fe(II)
Ligand
ML
ML2
ML3
Temp
Ionic Strength
(log βML )a (log βML2)b (log βML3)c
(°C)
(M)
Arginine
3.20d
20
0.01e
Asparagine
4.37(3)
7.57(3)
10.26(5)
25
3.0 NaClO4
Aspartic acid
5.34d
8.57d
25
0.1e
Glutamic acid
3.50d
20
1.0 KCl
Histidine
5.88d
10.43d
25
3.0 NaClO4
Lysine
4.5d
20
0.01e
d
d
d
Serine
4.299
7.377
10.299
20
3.0 NaClO4
Threonine
3.69d
6.50d
40
0.2 KNO3
Tyrosine
7.1d
20
0.01e
Stability Constants of Fe(III)
Arginine
8.7(3)
20
1.0 NaClO4
Asparagine
8.6(1)
20
1.0 NaClO4
Aspartic acid
11.4(3)
20
1.0 NaClO4
Glutamic acid
13.39d
20
1.0 NaClO4
Histidine
4.7(4)
20
1.0 NaClO4
Serine
9.2(4)
20
1.0 NaClO4
Threonine
8.6(3)
20
1.0 NaClO4
log β = [M][L]/[ML] b log β2 = [M][L2]/[ML2] c log β3 = [M][L3]/[ML3]
electrolyte was reported. Titrations were run at approximately 0.01 M ligand.
a

dNo

Method
Potentiometry
Potentiometry
Potentiometry
Potentiometry
Potentiometry
Potentiometry
Potentiometry
Potentiometry
Potentiometry
Potentiometry
Potentiometry
Potentiometry
Potentiometry
Potentiometry
Potentiometry
Potentiometry

Ref.
99
183
185
180
186
99
184
187
181

159
159
159
188
159
159
159

error reported by author. e No supporting
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identified in the low pH range for these iron-amino acid systems, but the stability of iron
hydrolysis species above pH 7 outcompetes weakly binding amino acid ligands. Fe(II)
stability constants with the majority of the potentially bidentate and tridentate amino acids
are fairly consistent: ML stability constants are approximately 3-4; ML2 stability constants
are approximately 7; and the few ML3 stability constants reported are approximately 10.
Extrapolating from scarce structural and supporting speciation data, it is likely that most
amino acids coordinate Fe(II) in a bidentate fashion through the carboxylate oxygen and
amine nitrogen atoms.

Aspartic acid and histidine have somewhat higher stability

constants for the ML (5.88 and 5.32, respectively) and ML2 (10.43 and 8.57, respectively)
species, suggesting that the His and Asp side chains participate significantly in
coordination.

Challenges in Determining Fe(II)-Amino Acid Stability Constants
Although stability constants of divalent metals with amino acids have been the
focus of a few comprehensive studies,99,180,181,187 most Fe(II) amino acid stability constants
are limited to these few studies with little speciation analysis. The majority of the published
data were obtained using potentiometric titrations. Although Fe(II) salts are water soluble,
Fe(II) oxidizes to Fe(III) in air, so oxygen-free conditions must be employed. This air
sensitivity limits analysis techniques to methods that can be performed in a glove box or in
closed cells. Fe(II) also forms hydrolysis compounds above pH 7. Although these
complexes are not as stable as Fe(III) hydrolysis products, they do compete with amino
acids for metal binding in the upper pH range. Fe(II) is also spectrochemically inactive,
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like Cu(I), and therefore not an option for spectrophotometric techniques with non-UVactive amino acids. As a whole, these issues have limited the data availability for Fe(II)
with amino acids.

Comparison of Cu(II) and Fe(II) Stability Constants of Non-Sulfur and-SeleniumContaining Amino Acids
Cu(II) and Fe(II) have the same valency and are both considered borderline Lewis
acids; both also have the potential to coordinate ligands in octahedral geometry. However,
stability constants of Cu(II) and Fe(II) with amino acids are significantly different, with
Cu(II)-amino acid complexes significantly more stable than analogous Fe(II)-complexes.
With ML constants of approximately 9 for [CuL]+ species (Table 1.3) and between 3 and
4 for most of the [FeL]+ complexes (Table 1.7), all of the non-sulfur- and non-seleniumcontaining amino acids show a higher affinity for the Cu(II) ion. A similar comparison can
be made for CuL2 and FeL2 species with stability constants of ~14 and 7-8, respectively.
With Cu(II), only His (ML log  = 9.75(1), ML2 log  = 17.49(1)) Asp (ML log  = 8.83,
ML2 log  =15.93(2)), and Glu (ML log  = 8.30(4), ML2 log  = 15.03(3)) have large
enough stability constants to suggest the potential for tridentate coordination. With Fe(II),
stability constants with His (ML log  = 5.88, ML2 log  = 10.43) and Asp (ML log  =
5.34, ML2 log  = 8.57) are somewhat elevated compared to bidentate-binding amino acids
but are still considerably lower than stability constants with Cu(II).
Although solid-state structural data supports tridentate His coordination in Cu(His)2
(Figure 1.5), no comparable Fe(II) structures exist to show tridentate amino acid
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coordination. His and Asp may be tridentate ligands binding Fe(II) through the amine,
carboxylate, and side-chain N or O atoms or, alternatively, adopt bidentate coordination
through the N or O atom of the side chain and either the amine nitrogen or carboxylate
oxygen atom. Regardless of coordination mode, the stability of Fe(II) with non-sulfur- or
selenium amino acids is significantly weaker than Cu(II) and therefore less biologically
significant.

1.10 Stability Constants of Non-Sulfur and –Selenium-Containing Amino Acids with
Fe(III)
Most Fe(III) in the cell is sequestered in ferritin storage as ferrihydrite,189 although
Fe(III) also exists in the mitochondria.32 Fe(III) does not generate hydroxyl radical as does
Fe(II), and it is poorly soluble and therefore not readily available in the aqueous
environment of a cell. Poor Fe(III) solubility, due to the stability of the hydrolysis species,
also contributes to a deficit of Fe(III) stability constants with amino acids, since it restricts
the use of potentiometric titrations to a very narrow pH range. The Fe(III) stability
constants reported in Table 1.7 were measured below pH 5.159

Fe(III) Complexes of Potentially Bidentate and Tridentate Amino Acids
For most amino acids, regardless of potential denticity, Fe(III) stability constants
for only the ML species have been quantified (Table 1.7) with the exception of a single
study by Williams.184 Many of these constants were determined using redox measurements
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in one 1958 report by Perrin,159 and the lack of precision inherent to the redox method is
reflected in the reported values.
Stability constants for the ML species of Fe(III) and a majority of the amino acids
are consistently in the 8-10 range (Tables 1.6 and 1.7). Notable exceptions to this trend are
glutamic acid, with a higher ML stability constant of 13.39, and histidine, with a lower ML
stability constant of 4.7(4), respectively. The considerably higher Fe(III)-Glu stability
constant was determined under different experimental conditions188 compared to most of
the other amino acids, but these experimental differences would not explain such a
significant disparity. The considerably lower stability constant for the [FeIII(His)]+ seems
to indicate that His coordination does not greatly stabilize Fe(III). In contrast, the only
solid-state structure of Fe(III) with an amino acid incorporates histidine in a tridentate
coordination mode: an oxo-bridged, binuclear complex, Fe2(His)2(biphenyl)2(μ-O) (Figure
1.10). Although this complex was not crystallized out of aqueous solution, it indicates that
histidine is certainly capable of tridentate coordination to Fe(III).

Determining Fe(III) Stability Constants Using the Solubility Method
One method that has not been discussed thus far but has been used in environmental
chemistry for determining Fe(III) stability constants is the solubility method. With this
technique, insoluble metal ions are slowly dissolved by complex formation with an
aqueous-phase ligand. The concentration of the soluble complex can then be determined
through methods such as inductively-coupled-plasma mass spectrometry or scintillation
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Figure 1.10. Solid-state structure of Fe2(His)2(biphenyl)2(μ-O), showing tridentate coordination of histidine
through a nitrogen atom of the imidazole side chain as well as the carboxylate oxygen and amine nitrogen
atoms. The Fe(III) ion is shown in orange, oxygen atoms are red, carbon atoms are grey, and nitrogen atoms
are blue.

techniques with radioisotopes. By varying the ratio of ligand to metal, a continuous plot
can be derived to track mass transfer from solid state to aqueous solution. Due to the
extreme insolubility and stability of Fe(III) hydrolysis products, the solubility method is an
optimal tool for stability constant determination in this system. In this method, competition
for the Fe(III) is measured through the addition of increasing concentration of ligand to a
suspension of Fe(OH)3. The amount of complex is then determined by the measurement of
pH and Fe(III) in solution. This method is by no means the easiest or the fastest, but it may
overcome the difficulties inherent in using most other methods for Fe(III) stability constant
determination due to the highly insoluble Fe(III) hydrolysis species.
A model Fe(III) solubility experiment was calculated using Geochemist
Workbench using low, moderate, and high amino acid stability constant values with Fe(III)
as exemplified by Met, Glu, and Phe.159,179,188 In this model, amino acid concentrations are
increased until the Fe(III)-amino-acid species out-compete the insoluble iron-hydrolysis
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species. In Figure 1.11A, a complex forming with a stability constant of 9.1, the same as
for [Fe(Met)]2+ and comparable to most of the other ML species reported by Perrin,159,180
has very little ability to dissolve the solid ferric hydrolysis species to form [Fe(Met)]2+ in
aqueous solution. Increasing the stability constant by four log units to 13.39, as reported
for [Fe(Glu)]+,188 significantly increases the amount of Fe(III) dissolved in solution (Figure
1.11B).
Utilizing the only multi-species data reported for Fe(III) complexes with non-sulfur
or selenoamino acids, [Fe(Phe)]2+, [Fe(Phe)2]+, and Fe(Phe)3 species with stability
constants of 10.39(4), 19.1(1), and 26.0(7), respectively,179 results in a significantly higher
amount of dissolved Fe(III) (Figure 1.11C) compared to that in the Fe(III)-Met and Fe(III)Glu systems (Figures 11A and 11B). It is entirely possible that multiple species form in all
of the Fe(III)-amino acid systems, but identification of these species may be hindered by
low-pH precipitation of iron hydrolysis species in the potentiometric and redox titrations.
Solubility titrations could provide insight into formation of additional species in these
systems, although this method is limited by the aqueous solubility of the resulting Fe(III)amino acid complexes. It is reasonable to expect, however, that even low-solubility
complexes would remain in solution at the extremely low total iron concentrations found
in these modeled systems (pM to nM range). Thus, solubility titrations represent a viable
but almost unexplored method for Fe(III) stability constant determination.
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1.11 Stability Constants of Sulfur- and Selenium-Containing Amino Acids
with Iron
Sulfur-containing metalloproteins such as rubredoxins, ferredoxins, and
hemerythrin play a crucial role in electron transfer through iron-sulfur interactions.130
Despite their biological importance, Fe(II) and Fe(III) stability constant determinations
with sulfur- and selenium containing amino acids are so limited, it is difficult to assess the
viability of the experimental results or to identify trends.

Figure 1.11. Modeled solubility method data for Fe(III) complexes with A) methionine (ML log  = 9.1),180
B) glutamate (ML log  = 13.39),190 and C) phenylalanine (ML log  = 10.39, ML2 log  = 19.11, and ML3
log  = 26).179 Comparing graphs A and B shows the effect a change in log β by 4 log units has on ferrihydrite
solubility. Comparing graphs B and C shows the significant effects of higher stability constants and multiple
species on aqueous Fe(III) solubility
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Fe(II) Complexes of Sulfur- and Selenium-Containing Amino Acids
In contrast to Cu(II), stability constants of thioether- and selenoether-containing
amino acids with Fe(II) are extremely low: 3.2 to 3.9 for the [FeL]+ species (Table 1.8).
These constants are consistent with those of Fe(II)-amino-acid species with bidentate
binding (Table 1.6), suggesting at most bidentate coordination and perhaps only amine or
carboxylate binding. Thus, it is unlikely that the thio- or selenoether S or Se atom plays a
significant role in Fe(II) coordination. Based on limited data, the selenoether-containing
amino acids have slightly higher stability constants with Fe(II) than analogous thioether
amino acids, although two data points (Met/SeMet and MeCys/MeSeCys) do not
necessarily make a trend.
In contrast, Fe(II) stability constants with the thiol-containing amino acids Cys and
Pen are significantly higher. Interestingly, these Cys and Pen stability constants are similar
to those of bidentate Cu(II)-amino acid complexes (Table 1.2), potentially indicating a
different coordination mode, possibly through the thiolate and amine groups, rather than
tridentate binding. Studies to confirm coordination modes for these amino acids have not
been performed, and there are no reported Fe(II) stability constants for selenol-containing
amino acids. The lack of independent characterization of the species identified in these
stability constant studies provides only a very indirect understanding of these coordination
complexes.
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Fe(III) Complexes of Sulfur- and Selenium-Containing Amino Acids
Only a handful of stability constant determinations with Fe(III) and sulfur amino
acids have been reported, and none are reported for selenoamino acids. A variety of
methods have been used for the few reported analyses, including potentiometric
titrations,181,191 paper electrophoresis,192 and redox methods.180 Where comparisons can be
made, the data conflict. For the Fe(III)-Met system, Tewari85 used paper electrophoresis to
identify two different species [Fe(Met)]2+ and [Fe(Met)2]+ with stability constants of
7.95(7) and 12.65(6), respectively (Table 1.8). In contrast, a 1958 study by Perrin and
coworkers159 reported a stability constant of 9.1 for the [Fe(Met)]2+ species using
potentiometric methods. Due to the limited competition of methionine binding with
formation of Fe(III) hydrolysis products (Figure 1.11), it is not surprising that a ML2
stability constant was not determined using this method. While paper electrophoresis is
limited to low pH (1-4) to maintain solubility, this method promotes separation of species
through electrophoresis, directly establishing the number of species formed.
The thiol-containing amino acids cysteine and penicillamine have Fe(III) stability
constants in the 10.8-11.3 range for the [ML]+ species, significantly higher than those with
thioether-containing amino acids. Thus, it is reasonable to assume that in aqueous solution,
Cys and Pen interact with Fe(III) through tridentate coordination of the thiolate sulfur,
amine nitrogen, and carboxylate oxygen atoms. This binding mode is supported by the
solid-state structure of Th[Fe(Pen)2], an [FeIII(Pen)2]- complex with a Th+ counterion
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Table 1.8. Stability constants of Fe(II) and Fe(III) with sulfur- and selenium-containing amino acids
Fe(II) Stability Constants
Ligand
ML
ML2
Temp
Ionic Strength
Method
Ref.
(log β)a
(log β2)b
(°C)
(M)
191
Cysteine
6.69(2)
11.90(3)
20
0.1 NaClO4
Potentiometry
159
Methionine
3.24c
20
1.0 KCl
Potentiometry
155
Methylcysteine
3.49(4)
25
0.1 NaCl
Potentiometry
155
Methylselenocysteine
3.84(1)
25
0.1 NaCl
Potentiometry
191
Penicillamine
7.58(1)
13.74(2)
20
0.1 NaClO4
Potentiometry
155
Selenomethionine
3.51(7)
25
0.1 NaCl
Potentiometry
10.85c
9.1c
8.37(5)

Cysteine
Methionine
Methylcysteine
Penicillamine
a

Fe(III) Stability Constants
14.49c
20
0.15 KNO3
20
1.0 NaClO4
13.92(1)
25
0.1 M KNO3
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11.27c
16.25c
log β = [M][L]/[ML]

b

Potentiometry
Redox
Electrophoresis

20
0.15 KNO3
Potentiometry
log β2 = [M][L2]/[ML2] cNo error reported.
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193
159
192
193

Figure 1.12. Solid-state structure for Th[Fe(Pen)2]. Hydrogen atoms are omitted for clarity. The Fe(II) ion
is shown in orange, oxygen atoms are red, carbon atoms are grey, nitrogen atoms are blue, and the sulfur
atoms are yellow. Counterion and hydrogen atoms are omitted for clarity.

(Figure 1.12).194 Both Pen ligands bind in tridentate fashion to Fe(III), with bond angles
closer to trigonal bipyrimidal than octahedral geometry.

Challenges in Determining Iron Stability Constants with Sulfur- and Selenium-Containing
Amino Acids
Determination of iron stability constants with sulfur- and selenium-containing
amino acids is plagued by issues common to Fe(II) and Fe(III) titrations with any amino
acid. With Fe(II), experiments must be conducted in oxygen-controlled environments, UVvisible analyses are limited to spectrochemically active ligands, and potentiometric
analyses are limited above pH 7. Fe(III) stability constant determinations with weakly
binding ligands are even more limited due to the high stability of Fe(III) hydroxide species.
In addition to these problems, cysteine and pencilliamine are also redox-active with
Fe(III).195,196 Although Fe(III) stability constants are reported for these amino acids,
conditions must be tightly controlled and data misinterpretation is not uncommon.
Sisley’s196 kinetic analysis of the interaction of redox-active metals, including iron, with
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these thiol-containing amino acids is detailed and specific. Due to these significant
limitations, few analyses are reported and stability constant values can vary depending on
experimental methods and conditions for these sensitive systems.

Comparison of Copper and Iron Stability Constant Determinations with Sulfur- and
Selenium-Containing Amino Acids
The most complete stability constant data with Cu(II), Cu(I), Fe(II), and Fe(III)
exists for the thiol-containing amino acids cysteine and penicillamine. Cu(II)-penicillamine
complexes are extremely stable with log β values of 16.5 and 21.7 for the ML and ML2
species, respectively156 (Table 1.4). The stepwise log K values for these constants, 16.5 for
ML and 5.2 for ML2, suggest that Pen may coordinate Cu(II) as a tridentate ligand in the
ML species. The significantly lower stability increase upon adding a second Pen ligand
suggests that the second ligand may have only mono- or bidentate binding. Mixed
tridentate and bidentate amino acid-Cu(II) complexes are structurally characterized,105-107
and rhenium-bound penicillamine adopts a structure where the two Pen ligands coordinate
in tridentate and bidentate fashion simultaneously.197 Fe(II)-Pen stability constants are
significantly lower than the analogous Cu(II) species (7.58(1) and 13.74(2) for the ML and
ML2 species, respectively;191 Table 1.8) but significantly higher than stability constants of
other Fe(II)-amino acid complexes (except Cys). These lower stability constants are most
consistent with bidentate coordination.

57

A comparison of stability constants for Cu(I), Fe(II), and Fe(III) with cysteine is
somewhat surprising (Tables 4 and 8). Cu(I) and Fe(III) have similar ML stability constants
of 10.164(6) and 10.85, respectively, but similar Fe(II) values are lower at 6.69(2).158,191,193
This trend is slightly surprising since Cu(I) is significantly softer than Fe(III), with Fe(II)
and Cu(II) falling in between. Comparing the ML2 stability constants, the Cu(I)-Cys
species has a considerably higher stability of 18.36(1), as compared to 14.49 with Fe(III)
and 11.90(3) with Fe(II). Perhaps this unexpected trend can be attributed to cysteine
binding all of the metal ions in a tridentate fashion, but the relative Lewis acidity of the
coordinating ligand atoms is also mixed, with hard carboxylate and amine group and a
relatively soft thiolate group. It should be noted that Pen stability constants exhibit the same
trends, with the Cu(II) species having the greatest stability compared to the other ions.
The thioether-containing methionine is the only other sulfur- or seleniumcontaining amino acid with analyses reported for Cu(II), Cu(I), Fe(II), and Fe(III). Cu(II)Met stability constants of 7.82(2) and 14.52(1) for the ML and ML2 species, respectively,
are well-supported by a variety of authors62,152,153 and are consistent with results obtained
for other amino acids with aliphatic side chains (Table 1.1). Methionine stability constants
with Cu(I), Fe(II), and Fe(III) were reported in a single 1958 study by Perrin,159 making
comparisons questionable. Met binding does not provide added stability compared to
amino acids with non-coordinating side chains, suggesting that the thioether sulfur atom
does not bind in the ML or ML2 species, a result supported by solid-state structures.160,161
Assuming Perrin’s results are accurate, the same trend is observed for Met as for Cys and
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Pen. Methionine binding to both Cu(I) and Fe(III) has higher stability for the ML species
(log  = 9.1 for both) than for the Fe(II) species (log  = 3.24).
Although Met and SeMet are also bidentate chelators of Cu(I), the soft sulfur or
selenium atom coordinates Cu(I) in addition to the amine nitrogen, with no bonding of the
carboxylate group. The best characterization has been obtained for the Cu(II)-Met and SeMet complexes, where IR and X-ray diffraction data support the bidentate coordination
of the amine and carboxylate groups. Differing amino acid coordination modes likely
change the measured stability constants, so evaluating trends across metals is not possible.

1.12 Iron and Copper Coordination to Weakly Binding Ligands: Biological
Relevance, Methods Development, and Outlook
With their similar structures and diversity of side-chain functional groups, amino
acids are an ideal system for developing more accurate methods to determine metal stability
constants with weakly binding ligands. The four metal ions treated in this review, Cu(II),
Cu(I), Fe(II), and Fe(III) also span the range between easy to examine (Cu(II)) and
extremely difficult to study due to redox activity and insoluble hydrolysis products (Cu(I)
and Fe(III)). Developing methods specifically designed to work around these issues, such
as solubility titrations for Fe(III) stability constant measurements, would provide a
substantial advance in this field and provide a foundation for stability constant
determination for metal complexes with any weakly binding ligands. In addition, accurate
determination of metal-amino-acid stability constants can then be used to model
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Figure 1.13. Percent complex formation of the ML species for aqueous solutions containing 10 μM metal
ion and 0-100 μM amino acid. Formation constants for the amino acid (AA) of 9.2 for HAA and 11.28 for
H2AA were included to model a representative amino acid with amine and carboxylate protons.

complex biological systems and predict competition concentrations that may be relevant
for maintaining metal homeostasis or in instances of metal mis-regulation.67,79,139,158,198
Taking into account the biological concentrations of metals and amino acids, we
can use established stability constants to predict the likelihood of complex formation in
binary systems. For this model, only ML species were considered with static protonation
constants of 9.2 and 11.2, corresponding to the approximate stability constants for the
amine and carboxylate groups of amino acids with non-protonating side chains. Figure
1.13A shows the percentage of complex formation as the amino acid ligand concentration
varies from 1 M to 500 M, the typical range of blood amino acid concentrations (as
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discussed in the Cellular Redox-Active Metal Ions and Amino Acids section), assuming 10
M of available metal ion. Figure 1.13B shows complex formation for the amino acid range
from 1-10 M, where the metal (10 M) is in excess of the ligand. Percent complex
formation for these binary systems is predicted, depending on stability constants for the
metal-amino-acid complexes.
Most of the Cu(II)-amino-acid complexes have [ML] stability constants of at least
7, indicating bidentate binding and resulting in approximately 40% to 70% of metal bound
within a 1:1 to 1:10 ligand-to-metal ratio. For thiol-containing amino acids and histidine
that have Cu(II) [ML] stability constants upward of 10, it would be expected that 90-100%
of the metal ion would be coordinated to the amino acid, assuming a 1:1 or greater metalto-amino-acid ratio. Ten-fold higher metal ion concentrations (100 M) with the same
amino acid concentration range result in decreased complex formation compared to 10 M
metal over the same stability constant range (Figure S1 in Supplementary Data). All of the
limited number of Cu(I)-amino-acid stability constants are higher than the Cu(II) stability
constants with the same amino acid, even for amino acids such as alanine and glycine that
are only bidentate chelators. Thus, in the reducing cellular environment, it is reasonable to
expect that available Cu(I) ions would likely be coordinated by free amino acids.
On the other end of the spectrum, the Fe(II)-amino-acid stability constants for the
[ML] species are very low, approximately 3-4. With these low stability constants, even at
a 10:1 ligand-to-metal ratio, less than 10% of Fe(II) would be bound (Figure 1.13). With
Fe(II), only cysteine and penicillamine with stability constants of 6.69 and 7.58,
respectively, would form an appreciable amount of complex. Although Fe(III)-amino-acid
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complexes have high enough stability constants (8-13) to expect amino acid coordination
at the modeled concentrations, amino acids could not outcompete formation of Fe(III)
hydrolysis products at reasonable biological pH ranges.
From these simple models, it is evident that amino acids with higher stability
constants will dominate complexation with labile metal ions. For Cu(I) and Cu(II),
histidine, aspartic acid, cysteine, and penicillamine would out-compete other amino acid
binding, as long as amino acid concentrations were relatively similar. For Fe(II) and
Fe(III), cysteine and penicillamine coordination would dominate, neglecting Fe(III)
hydrolysis.
From this overview, it is evident that there is a need for more complete analyses of
the redox active metals with sulfur- and selenium-containing amino acids. Although Cu(II)
has been extensively studied, the other metal ions, Cu(I), Fe(II), and Fe(III) are just as
biologically relevant and data are poor. Before beginning an amino acid stability constant
study, it is important to understand the advantages and disadvantages of not just the
methods used, but of the metal and ligands to be studied. Cu(II) is a robust ion with high
solubility in aqueous systems and its stability constants with a wide variety of amino acids
and other ligands have already been thoroughly examined. Using Cu(II) is ideal for new
methods development, since the breadth of data available would provide dependable
comparisons. Because it is a redox-active metal, the redox activity of the ligand must be
considered when selecting experimental parameters.
Cu(I) binds a variety of amino acids in metalloenzymes and also contributes to
oxidative damage within the cell, if not controlled through cellular mechanisms and
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complexation. Determining Cu(I) complex stabilities with available small molecules is a
wide-open field with significant biological implications. Cu(I) is extremely difficult to
work with due to redox activity, oxygen sensitivity, limited solubility, tendency for
disproportiation, and lack of spectrochemical activity. There is much need for methods
development for stability constant determination with this ion. Measuring stability in high
ionic strength media may provide the best path forward for potentiometric analysis. Other
methods, such as zero-current potentiometry and electrophoresis, under atmospherecontrolled conditions, are worth developing and validating.
Fe(II)- and Fe(III)-amino-acid stability constant data is also lacking. Since
potentiometric analysis is not ideal due to low solubility of iron hydrolysis products, other
methods need to be explored. The solubility method has the potential to open up the Fe(III)
determinations, especially with mass spectrometry techniques capable of detecting and
quantifying individual species.
Determining stability constants for copper and iron binding to sulfur and selenium
amino acids is also critical for understanding biological systems. Sulfur amino acids are
required for maintaining cellular redox balance, and modeling studies indicate that these
amino acids may bind both iron and copper. Selenoamino acids and related species have
been implicated in cancer prevention and as antioxidants to prevent metal-mediated
oxidative damage, yet selenium speciation and interaction with biometals is thoroughly
underexplored and requires more dedicated study.
“The difficulty lies not so much in developing new ideas as in escaping from old
ones” (John Maynard Keynes). One of the primary difficulties with this field is that the
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easiest systems have been thoroughly studied, but the more problematic ones only have
single analyses or no data at all. Revisiting some of the analyses that were performed 50
years ago and using and/or developing new methods to confirm these results and continue
the study of weakly binding ligands is worth exploring. Understanding and predicting the
interface between metal ions and small molecules can have far reaching effects into the
efficacy of drug development and oxidative-damage prevention in biological systems.
Chapter 1 reviews amino acid stability constants with the redox-active metal ions
Cu(I), Cu(II), Fe(II), and Fe(III). Although reviews of metal-amino-acid complexes have
been published previously, they tend to be data-heavy and make it difficult to identify the
most pertinent data. In addition, few reviews have focused significant attention on sulfurand selenium-containing amino acids. Chapter 1 is also intended to help elucidate the best
methods to determine stability constants for each metal ion, based on solubility limitations
and redox sensitivities.
The work in Chapter 2 focuses on the determination of stability constants for Cu(II)
and Fe(II) with sulfur and selenium amino acids and identifies the species and most likely
coordination modes for the complexes formed in these potentiometric titrations. [CuL] +
and CuL2 species, with stability constants of approximately 9 and 14, respectively, were
determined

for

the

amino

acids

glycine,

methylcysteine,

methionine,

selenomethylcysteine, and selenomethionine. In all cases, only the amine nitrogen and the
carboxylate oxygen atoms, but not the sulfur or selenium atom, are coordinated to Cu(II).
For the same amino acids, the Fe(II) species [FeL]+ and FeLOH were identified, with
significantly lower stability constants of approximately 3 and -5, respectively.
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Penicillamine, a thiol-containing amino acid, has significantly higher stability constants of
approximately 7.5 and 14 for the FePen and [Fe(Pen)]2- species, due to direct coordination
of the thiolate sulfur.
Reactions between copper and the thione methimazole, both redox-active species,
are explored in Chapter 3. Cu(II) is reduced by methimazole to form Cu(I) and
methimazole disulfide, and a wide variety of mono-, di-, and polynuclear copper complexes
are formed with these two ligands. The effects of oxygen availability, oxidation states of
the metal ion and ligand, and solvent on the reaction products is investigated. Under
anaerobic conditions, the products favor direct coordination of Cu(I) with bridging and
terminal methimazole ligands. In the presence of oxygen and water or methanol, sulfur
extrusion from the oxidized methimazole ligand is favored.

Direct coordination of

methimazole disulfide to Cu(I) without sulfur extrusion occurs under air-free conditions,
but this product is produced in low yield. Based on these results, a mechanism for sulfur
extrusion is proposed that incorporates copper coordination, oxidation by O2, and solvent
reactivity.
In Chapter 4, the interactions of copper and methimazole explored in Chapter 3 are
expanded to include the interactions of methimazole disulfides and diselenides with Cu(I).
Dinuclear, mixed ligand Cu(I) complexes containing both reduced and oxidized
methimazole or selenomethimazole ligands can be isolated, suggesting Cu(I)-mediated
reversibility of disulfide or diselenide bond formation. When Cu(I) was treated with
methimazole diselenide in air, two unusual products were crystallized from the same
reaction solution. Selenium migration is observed in one complex, and reaction with the
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dichloromethane solvent is observed in the other product. Methimazole and
selenomethimazole show reversible redox reactivity and unique elimination and insertion
reactions in the presence of copper. Sulfur- and selenium-containing amino acids and
imidazole thiones and selones coordinate to softer metal ions, such as Cu(I), Cu(II), and
Fe(II), and may have the potential to influence metal homeostasis, redox behavior, and
biological activity of these ions.

1.13 Supplementary Data
Table 1.9. Parameters added to the visual Mintec database for Use with Geochemist Workbench
to Generate the Fe(III) Solubility Models (Figure 1.11) and the Cu-penicillamine models (Figure 1.8)
Species
Reaction
log β
Reference
2+
159
2+
[Fe(Met)]
9.1
Fe(III) + Met ↔ [Fe(Met)]
+
188
2+
[Fe(Glu)]
13.39
Fe(III) + Glu ↔ [Fe(Glu)]
2+
179
2+
[Fe(Phe)]
10.39
Fe(III) + Phe ↔ [Fe(Phe)]
+
179
+
[Fe(Phe)2]
19.11
Fe(III) + 2 Phe ↔ [Fe(Phe)2]
179
Fe(Phe)3
26
Fe(III) + 3 Phe ↔ Fe(Phe)3
3172
23[Cu(HPen)2]
39.18
Cu(I) + 2 HPen ↔ [Cu(HPen)2]
3172
33[Cu5Pen4]
101.5
5 Cu(I) + 4 Pen ↔ [Cu5Pen4]

Figure 1.14. Percent complex formation for solutions containing 100 μM metal ion and 100-500 μM amino
acid for the formation of the ML species. Formation constants for the amino acid (AA) of 9.2 for HAA and
11.28 for H2AA were included in the modeling as a representative amino acid with amine and carboxylate
protons.
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CHAPTER TWO
STABILITY CONSTANT DETERMINATION OF SULFUR AND SELENIUM
AMINO ACIDS WITH Cu(II) AND Fe(II)

2.1 Introduction
Despite the ubiquity and importance of amino acids in biological systems, very
little is understood about coordination of labile (non-protein-bound) metal ions by free
amino acids. Determining aqueous stability constants for metal ions with biologically
relevant ligands, including amino acids, is one way in which more complex systems such
as biological fluids or ocean water can be modeled. Fifty years ago, Hallman and coworkers
simulated plasma speciation of Cu(II) and Zn2+ with seventeen amino acids,1 but
subsequent reviews and analysis of this plasma speciation model revealed deficiencies in
the underlying stability constant data, since the importance of minor species and redox
interactions were neglected.2,3 More recently, amino acid stability constant data and
speciation modeling have been used to help explain copper and zinc deficiencies that occur
with total parenternal nutrition,4 trace element speciation in phloem sap5 and xylem fluid,6
and copper speciation in the eye.7 Developing more accurate Cu(I) speciation models with
penicillamine, cysteine, and glutathione resulted in a better understanding of metallic
copper precipitation in the lens and cornea in patients with Wilson’s disease.7 Development
of these complex models relies heavily on the accuracy of measured metal-amino-acid
stability constants, a particular issue with potentially redox-active sulfur- and seleniumcontaining amino acids.
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Amino acid interactions with copper and iron may also play a crucial role in
preventing oxidative damage and diseases that arise due to oxidative stress. Loss of metal
homeostasis, mitochondrial malfunction, and the resulting oxidative stress is linked to
neurodegenerative disease development, but the mechanistic details that cause this
oxidative damage is poorly understood.8-10 Labile copper and iron produce reactive oxygen
species (ROS) such as hydroxyl radical that can damage nucleic acids, proteins, and lipids,
and this oxidative damage is catalytic in cells (Figure 2.1).11-13 Antioxidants capable of
disrupting catalytic ROS generation through metal chelation may lessen the oxidative
damage leading to Alzheimer’s, Parkinson’s, Huntington’s, and Wilson’s diseases.14 To
ascertain whether amino acid binding to copper and iron may affect their ability to generate
ROS, several factors must be determined: the amino acids and other small molecules most
likely to interact with labile metal ions, metal ion and amino acid concentrations in the
system, and stability constants for the metal-amino-acid complexes.

Figure 2.1. Catalytic hydroxyl radical generation by iron and copper in cells.

Naturally occurring and biomimetic sulfur and selenium amino acids with
thioether/selenoether and thiol/selenol groups are of significant interest due to their
abundance in the active sites of metalloenzymes, their presence in biofluids, and their
affinity for binding softer metal ions, such as Cu(I), Cu(II), and Fe(II). A variety of sulfur
and selenium amino acids are present naturally (Figure 2.2), including methionine (Met),
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cysteine (Cys), methylcysteine (MeCys), homocysteine (hCys), selenomethionine
(SeMet), selenocysteine (SeCys), and methylselenocysteine (MeSeCys). One of the most
prevalent sulfur amino acids,15 cysteine, has reported concentrations of 256 ± 15 μM in
human plasma16 and 180 ± 20 μM in muscle tissue.17 Methionine has somewhat lower
concentrations of 69 ± 15 μM16 and 110 ± 20 μM17 in plasma and muscle tissue,
respectively. Normal levels of homocysteine (hCys) in plasma are in the 5 – 18 μM range,18
and elevated hCys levels are an established risk factor for cardiovascular diseases,
cognitive impairment, and chronic renal failure.19-22 Methylcysteine is not typically used
for protein synthesis, but is occasionally incorporated into proteins.23 MeCys
concentrations are not quantified in plasma or cells, but are found at concentrations of 0.25 μM in human urine.24 Although not a natural amino acid, penicillamine (Pen; Figure 2.2)
is structurally similar to cysteine and is used to chelate and remove excess copper in
Wilson’s disease.25,26 When supplemented at 750 mg/day, penicillamine levels can reach
100 μM in human serum.27

Figure 2.2. Structures of common sulfur- and selenium-containing amino acids.
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Biological concentrations of selenium-containing amino acids are not determined,
although total selenium concentration in human plasma averages 1.5-1.6 μM with 90%
incorporated into selenoproteins as SeCys or SeMet.28

In humans, total selenium

concentration is unlikely to exceed 10 μM due to selenium toxicity.29 SeCys is the most
prevalent selenium amino acid in mammalian selenoproteins,30 but it is difficult to study
in solution because its low pKa (~5) results in dimerization to form the oxidized diselenide
species, selenocystine, at physiological pH.31 In contrast, MeSeCys is the most abundant
selenium metabolite in plants.32 Although selenoamino acids are required for selenoprotein
activity33,34 and can prevent ROS damage,35-37 their interaction with metal ions is not as
widely studied as their sulfur-containing analogs.
Labile iron is typically found in low concentrations but increases when the cell is
under oxidative stress.38 In Escherichia coli, the concentration can rise from 20 µM under
normal conditions up to 320 µM when stressed,39 increasing cellular damage. Labile iron
pools of up to 10 M are present in human lymphocytes.40 Iron accumulation in certain
regions of the brain41-43 is implicated in the pathology of Parkinson’s disease.44,45 Cellular
labile copper pools have been identified but not precisely measured,46,47 and total copper
has been reported as high as 100 μM in brain tissue.48,49 Labile copper causes increased
protein aggregation in Alzheimer’s disease, which may be a direct result of oxidative
protein damage.9,49,50
Many researchers have examined the antioxidant activity of sulfur- and seleniumamino acids,51-56 and Brumaghim, et al.37,57 established metal binding as a primary
antioxidant mechanism for sulfur- and selenium-amino acid prevention of in vitro metal-
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mediated oxidative DNA damage. Structural analyses and density functional theory
determinations established that the HOMO orbital energies of copper-amino-acid
complexes predict the observed antioxidant activity.58,59 However, it is not clear if the
stabilities of these amino-acid-metal complexes also correlate with DNA damage
prevention ability. Such an analysis is critically hampered by the lack of stability constants
for these amino acids with Cu(II) and Fe(II). To test this hypothesis, we determined
stability constants for Cu(II) and Fe(II) with sulfur- and selenium-amino acids by
potentiometric titration. In addition, metal binding modes of these amino acids with Cu(II)
a predicted based on speciation trends, infrared (IR) spectroscopy, mass spectrometry, and
solid-state structural determination. We use these measured stability constants and reported
metal ion and amino acid concentrations, to discuss the likelihood of metal-amino-acid
complex formation in biological systems. This work was a collaborative work. Andrea
Gaertner completed the IC50 gel electrophoresis analysis of copper and iron with
penicillamine. Tyler Williams performed the ESI-MS analyses of Cu(II) and Fe(II) with
methionine in solution.

Colin D. McMillen determined the XRD determination of

Cu(SeMet)2. Brian A. Powell provided expertise in the advisement of potentiometric
titrations and stability constant determination.

2.2 Results and Discussion
Stability constants measure the thermodynamic likelihood of metal complex
formation (Equations 1 and 2) and are directly related to the Gibbs free energy of a system
(Equation 3). A positive log β indicates favorable thermodynamic stability for complex
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formation. In this study, potentiometric titrations for multiple metal:ligand molar ratios at
25 °C and pH 3-9 were used to determine stability constants of sulfur and selenium amino
acids (L) with Cu(II) and Fe(II) (M), where x is the stoichiometric number of complexing
ligands.
M + xL

MLx
[MLx]
βML=
[M][L]x
ΔG= -2.30RTlogβML

(1)
(2)
(3)

Amino Acid Protonation Constant Determination

Protonation constants for Gly, Met, SeMet, MeCys, and MeSeCys were determined
prior to titrations with metal ions. Although several of these amino acids have established
protonation constants, precise determinations of these values under the exact conditions of
temperature, ionic strength, and ionic salt used for the Cu(II) and Fe(II) titrations were
required to ensure consistency and accuracy across all measurements (Table 2.1). The data
agree well with previously reported values, with minor variations due slightly different
analysis conditions, such as the solution composition or concentration. Speciation diagrams
for glycine and the thio- and selenoether amino acids, such as the example speciation
diagram for Met (Figure 2.3), indicate that three separate species (L-, LH, and LH2+) form
from pH 3 to 11, with the zwitterionic LH species as the primary species at pH 7.
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Table 2.1. Amino acid protonation constants; amine protonation is represented by K1 and carboxylate
protonation by K2.
log K1a
log K2b
Amino
Temp (˚C)
Ionic Strength
Reference
Acid
Gly
9.67(2)
2.28(5)
25
0.1 M NaClO4
This work
60
Gly
9.62
2.43
25
0.2 M NaClO4
Met
9.196(5)
2.09(1)
25
0.1 M NaClO4
This work
61
Met
9.12
2.22
25
0.2 M KCl
SeMet
9.29(2)
2.05(1)
25
0.1 M NaClO4
This work
62
SeMet
9.15
2.37
25
0.1 M NaNO3
MeCys
8.79(2)
2.02(5)
25
0.1 M NaClO4
This work
61
MeCys
8.72
2.2
25
0.2 M KCl
MeSeCys
8.86(2)
2.3(2)
25
0.1 M NaClO4
This work
a
+
b
+
+
log K1= [L ][H ]/[HL]
log K2 = [HL][H ]/[H2L ]

Figure 2.3. Representative titration and speciation diagrams for the potentiometric titration of the fully
protonated amino acids (LH2 with Met shown in this example; 0.1 M NaOH, I = 0.1 M NaClO4, 25˚C). The
solid blue line represents the modeled titration data with points indicating measured data (pH on the right yaxis); formation of Met-, MetH, and MetH2+ species are indicated as shown in the legend.
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Glycine has the highest log K1 values compared to the thio- and selenoether amino
acids, indicating the amine proton is less likely to dissociate. These data represent the first
reported protonation constants for methylselenocysteine. Structurally similar MeCys and
MeSeCys have the lowest log K1 values, indicating amine deprotonation at lower pH.
MeCys and MeSeCys protonation constants are also in close agreement, 8.79(2) and
2.02(5) for log K1 and 8.86(2) and 2.3(2) for log K2, respectively, indicating that selenium
substitution for sulfur has no significant effect on amine or carboxylate protonation. The
carboxylate dissociation constant (log K2) is similar for all amino acids (2.02 to 2.3), and
thus the carboxylate group is deprotonated at biologically relevant pH values.

Cu(II)-Amino Acid Stability Constants

Cu(II) stability constants with the sulfur-containing amino acids have been widely
studied,1,3,4,61,63-74 due to their bioavailability and their role in metal coordination in
metalloproteins. Two species are identified, [CuL]+ and CuL2, where L- represents the
amino acid with both amine and carboxylate groups deprotonated. For Met, SeMet, MeCys,
and MeSeCys, the S/Se atom in the side chain can potentially bind Cu(II) in addition to the
amine N and carboxylate O atoms, resulting in a tridentate species. Such tridentate binding
occurs for Cu(II)-amino acid complexes such as Cu(His)2 (His = L-histidine),75 and
[Cu(Asp)(phen)(H2O)] (Asp = aspartic acid; phen = 1,10-phenanthroline).76 Glycine is well
known to bind Cu(II) in a bidentate fashion77 but cannot bind through the side chain to
become a tridentate chelator; therefore, it was included in this study as a bidentate-binding
control. If the thio- or selenoether S/Se atom participates in tridentate binding to Cu(II),
higher stability constants are expected compared to those of the Cu(II)-glycine system.
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Cu(II) stability constants were determined for Gly, Met, SeMet, MeCys, and
MeSeCys at 25˚C with a constant ionic strength of 0.1 M NaClO4 to provide a selfconsistent data set. Titrations were performed in triplicate at metal-to-ligand ratios of 1:2
and 1:5, and stability constants describing metal-ligand binding are provided in Table 2.2.
For all the Cu(II) titrations, precipitation occurred above pH 8, except for the Cu(II)-SeMet
system in which precipitation began at pH 5. A representative speciation graph for the
Cu(II)-Met titrations at a 1:2 Cu:amino acid ratio is provided in Figure 2.4.
Only two species are present at pH 7, [CuMet]+ and Cu(Met)2 (Figure 2.4), and the
Cu(Met)2 species reaches a maximum concentration around pH 8, approximately the pH
that precipitation occurs. When the full data set (pH 2-10) was included in the modeling,
incorporation of a third species, Cu(Met)(OH), produced a better fit (Figure 2.9); however,
this species was excluded from the analysis because its log β value was extremely low.
Since this putative Cu(Met)(OH) species forms at pH 8 and above, it is more likely that
deviation in the fit reflects the instability of the system as Cu(II) and Met- are depleted due
to precipitation, rather than the presence of a new species. The precipitate was confirmed
as Cu(Met)2 by IR analysis (see Proof of Speciation for Cu(II) Complexes section). All the
thio- and selenoether amino acids as well as glycine form the same [CuL] + and CuL2
species.
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Table 2.2. Stability constants for Cu(II)- amino acid complexes determined by potentiometric titration
Cu(II) Stability Constants
Amino Acid
ML
ML2
MLOH
Temp
Ionic Strength
(log β)a
(log β2)b
(log β-1)c
(°C)
(M)
Gly
8.11
14.96
25
0.1
Met
MeCys
SeMet
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MeSeCys
hCys
Pen
Gly
Met
MeCys
SeMet
MeSeCys
Cys
Pen
a

Reference
78

8.26(1)

15.10(5)

25

0.1 NaClO4

This work

7.85(2)
7.96(5)
7.65d
8.05(5)
7.77d
8.02(2)
8.2(1)
11.92(1)
16.5d

14.52(1)
14.65(7)
14.13d
14.47(5)
14.50d
14.63(2)
14.5(2)
13.54(2)e
21.7d

25
25
25
25
25
25
25
25
25

0.1 KNO3
0.1 NaClO4
0.2 KCl
0.1 NaClO4
0.1 NaNO3
0.1 NaClO4
0.1 NaClO4
0.1 KNO3
0.15 KNO3

67,69,79

d

4.13
4.04(5)
3.24d
3.51(3)
3.49(4)
3.51(7)
3.84(1)
6.69(2)
7.58(1)
7.48(7)

7.57(1)

Fe(II) Stability Constants
7.65d
25
-4.24(2)
25
20
-4.9(1)
25
-5.7(1)
25
-5.3(3)
25
-5.08(2)
25
11.90(3)
20
13.74(2)
20
13.91(7)
25

log β = [M][L]/[ML] b log β2 = [M][L2]/[ML2] c log β-1 = [ML][OH]/[MLOH]
Reported as the [MHL] species, not the [ML2] species.

0.1 KNO3
0.1 NaClO4
1.0 KCl
0.1 NaClO4
0.1 NaClO4
0.1 NaClO4
0.1 NaClO4
0.1 NaClO4
0.1 NaClO4
0.1 NaClO4
d

e

90

No error reported.

This work
80

This work
62

This work
This work
81
82

83

This work
84

This work
This work
This work
This work
85
85

This work

Figure 2.4. Representative titration and speciation diagram for the potentiometric titration of Cu(II) and
methionine in a 1:2 metal-to-ligand ratio (0.1 M NaOH, I = 0.1 M NaClO4, 25°C. The solid blue line
represents the modeled titration and points represent the measured data. Formation of [Cu(Met)] + and
Cu(Met)2 species are indicated as shown in the legend.

Proof of Speciation for Cu(II) Complexes

Speciation in the Cu(II)-thio- and selenoether amino acid systems was confirmed
using a variety of solution and solid-state analyses. For the soluble Cu(II)-Met species,
electrospray ionization mass spectrometry (ESI-MS) confirmed the presence of [Cu(Met)]+
(212 m/z). The Cu(Met)(OH) (230 m/z) species was also identified; however, the samples
were prepared at pH 5, well below the pH where modelling indicates possible formation of
this species. Thus, this species is most likely arises from water coordination of the
[Cu(Met)]+ species. Since Gly, Met, SeMet, MeCys, and MeSeCys all have Cu(II) stability
constants within 0.5 log units, the resulting species are assumed to bind Cu(II) similarly.
Above pH 8, the Cu(II)-amino-acid complexes precipitated, and IR spectroscopy
was used to confirm CuL2 formation of the species and to compare with reported spectra
(Table 2.3).62,86-88 For Cu(Met)2 and Cu(SeMet)2, broad N-H stretching absorption bands
at 3077 and 3080 cm-1 for Met and SeMet, respectively, split into three distinct stretching
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vibrations for the corresponding Cu(II) complexes: 3300, 3241, and 3120 cm-1 for the Met
complex and 3281, 3233, and 3132 cm-1 for the SeMet analog. This N-H splitting confirms
participation of the amine nitrogen in Cu(II) binding, since the environment of the amine
protons change slightly to compensate for the loss of freedom due to the proximity of the
copper ion.62 Amine binding is further supported by a N-H deformation band that appears
at 1569 cm-1 for Met and 1570 cm-1 for SeMet. Carboxylate oxygen binding is also
indicated by the shift of the asymmetric C-O stretch from approximately 1610 cm-1 to 1622
and 1616 cm-1 for the Met and SeMet complexes, respectively.62,87 M-N and/or M-O bond
formation is also indicated by the presence of one or two absorbances in the 440-600 cm-1
region.
IR results for MeCys and MeSeCys are consistent with the trends observed with
the aforementioned Met and SeMet, although the C=O stretch observed at approximately
1620 cm-1 for the other complexes was shifted to 1640 cm-1 for the MeSeCys and no
discernible NH2 deformation was observed. Trends observed in the IR spectrum of
Cu(MeSeCys)2 can help confirm that the same structural confirmations are being formed
in the binding of the [MeSeCys]- ligand to the Cu(II) as has been shown with the other
thio- and selenoether amino acids. The stability constants indicate similar coordination for
all of the thio- and seleno-ether amino acids.
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Table 2.3. IR data for metal-amino-acid complex precipitates in potentiometric titrations (pH > 8; NR = not reported)
Cu(Met)286 Cu(Met)2a Cu(MeCys)287 Cu(MeCys)2a Cu(SeMet)2a
Vibration
Cu(MeSeCys)2a
-1
-1
-1
-1
-1
(cm )
(cm )
(cm )
(cm-1)
(cm )
(cm )
NH2 stretching

C=O stretch
NH2 deformation
C-N vibration
M-N and/or M-O
stretch
a
This work

3390
3230
3130
1620
1580
NR
NR

3300
3241
3120
1622
1569
1337
578

3300
3230
2990
1620
1570
NR
NR

3299
3232
3110
1618
1571
1340
576

93
93

3281
3233
3132
1616
1570
1399
497

3322
3221
3130
1640
1571
1335
521

Fe(Met)2a
(cm-1)
3410
3360
3289
1598
1562
1330
568

Amine nitrogen and carboxylate oxygen coordination to Cu(II) is strongly
supported by the solid-state structure of Cu(SeMet)2 (Figure 2.5 and Table 2.4), the first
structure for a Cu(II)-seleno amino acid complex. In Cu(SeMet)2, each SeMet ligand
coordinates the copper ion through bidentate binding of nitrogen and oxygen atoms in the
equatorial position, resulting in an overall distorted square planar geometry (τ4 = 0.043)
around Cu(II) (Cu-N = 1.980(6) and 1.992(6) Å; Cu-O = 1.950(5) and 1.954(5) Å). This is
similar to the thioether complexes Cu(Met)2 (Cu-N = 1.97(1) and 2.01(1) Å; Cu-O =
1.944(8) and 1.970(8) Å)86,89 and Cu(MeCys)2 (Cu-N = 1.994 and 2.000 Å; Cu-O =
1.936(1) and 1.951(1) Å).87 All other bond lengths and angles are comparable to those in
the Cu(Met)2 structure reported by Ou and coworkers,86 with the exception of a slight
lengthening in the carbon-chalcogen bonds, averaging 1.950(9) for the C-Se bonds in the
present study compared to 1.80(2) Å for the C-S bonds in Cu(Met)2. This lengthening also
results in a slightly longer c-axis of the selenoether complex (16.082(1) Å) compared to
the thioether complex (15.563(8) Å).

Figure 2.5. Structure of Cu(SeMet)2 shown with 70% probability ellipsoids for Cu(SeMet)2. Hydrogen atoms
are omitted for clarity.
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Table 2.4. Selected bond lengths (Å) and angles (˚) for Cu(SeMet) 2
Cu(L-SMet)2
Bond lengths (Å)
Angles (˚)
Cu1-N1
1.992(6)
O2-Cu1-O1
178.3(2)
Cu1-N2
1.980(6)
O2-Cu1-N2
84.4(2)
Cu1-O1
1.954(5)
O1-Cu1-N2
94.8(2)
Cu1-O2
1.950(5)
O2-Cu1-N1
96.2(2)
Cu1-O4a
2.640(4)
O1-Cu1-N1
84.4(2)
Cu1-O3 a
2.687(4)
N2-Cu1-N1
175.5(2)
C4-Se1
1.952(7)
C4-Se1-C5
98.4(3)
C5-Se1
1.953(9)
C10-Se2-C9
98.5(4)
C9-Se2
1.958(7)
C10-Se2
1.939(9)
a
Cu1-O3 and Cu1-O4 represent the carboxylate-bridged, apical bond distances in
the packing diagram (Figure 2.8).

Carboxylate oxygen atoms from neighboring molecules form axial bonds to the Cu
centers with extended copper-oxygen bond lengths of 2.640(4) and 2.687(4) Å,
significantly longer than the equatorial carbon-oxygen bonds of 1.950(5) and 1.954(5) Å.
These apical interactions result in the formation of sheets in the ab-plane (Figure 2.10).
Hydrophobic intermolecular interactions of the Se-CH3 side chains isolate neighboring
sheets from one another along the c-axis. The structures of Cu(Met)2 and Cu(MeCys)2 also
crystallize in space group P21 and feature similar long range motifs directed by the axial
interactions of Cu(II) with carboxylate groups (though in the case of Cu(MeCys)2, the
sheets occur in the bc-plane, and the  angle is expanded somewhat to 97.55(2)°.86,87,89
Similar elongated Cu-carboxylate axial interactions are observed in Cu(II)-glycinebased structures;90,91 however, some Cu(II)-glycine structures instead incorporate one92-95
or two77 water molecules in the axial positions. This water coordination in the solid state
suggests that Cu(II) would likely be hydrated in solution, especially for [Cu(Met)]+ and
similar amino acid species with open coordination sites around the central metal ion. Water
coordination at pH < 7 also suggests formation of species with hydroxide ligands at pH >
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7, although these species may not be readily identifiable in titrations due to complex
precipitation.

Structure-Stability Analysis for Cu(II)
Cu(II)-MeSeCys stability constants are reported for the first time as 8.2(1)
and14.5(2) for the [Cu(MeSeCys)]+ and Cu(MeSeCys)2 species, respectively (Table 2.2).
The higher error for these MeSeCys titrations relative to other thio- and selenoether amino
acid values is likely due to interactions of the soft selenoether species with the electrode.
To mitigate this issue, MeSeCys titrations were back-titrated to demonstrate reversibility.
Cu(II)-MeSeCys stability constants are within 0.5 log units of those for the other thioether
and selenoether amino acids, suggesting similar binding modes.
Stability constants of Cu(II) with Met, SeMet, and MeCys are within 0.2 log units
for the [ML]+ species (7.96(5) to 8.05(5) and ML2 species (14.47(5) to 14.65(7)), although
they are slightly higher than other reported results (Table 2.2), indicating little difference
in Gly, Met, MeCys, and SeMet thermodynamic stability upon Cu(II) binding. Small
variations in these values are likely due to differences in supporting electrolyte or in time
allowed for the titrations to reach equilibrium. The greater relative stability of Cu(II)
binding to Gly compared to thioether and selenoether amino acids corroborates the solidstate results that show no Cu(II)-S/Se interactions and suggests that the thio- and
selenoether side chains slightly destabilize these complexes in solution.
Cu(II) complexes of thiol-containing amino acids are more stable than their thioand selenoether counterparts (Table 2.2). In contrast to the thio- and selenoether functional
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groups, thiols have ionizable protons and thiol-containing amino acids have four possible
protonation states: [H3L]+, [H2L], [HL]-, and L2-. To date, no selenol copper stability
constants have been reported, likely due to the low pKa of selenols (~5) and the resulting
tendency to form diselenide species.31 In potentiometric titrations with Cu(II), both
homocysteine (hCys) and penicillamine (Pen) form CuL species (Table 2.2),81,82 and Rosen
and Kuchinkas82 also identified a [Cu(Pen)2]2- species.
Other reported Cu(II) complexes of thiol-containing amino acids are not consistent;
Pinto and coworkers81 identified [Cu(HhCys)]+ and [Cu(hCys)(OH)] species in a
potentiometric titration of a 1:1 Cu(II) to hCys (to prevent Cu(II)oxidation of hCys) and
identified Cu(hCys)2 as a precipitate at higher ligand-to-metal ratios. Based on our model
simulations using the stability constant values reported by Pinto, et al.,81 the Cu(hCys)(OH)
species is the dominant species above pH 4, with no evidence for formation of the
[Cu(HhCys)]+ species under the given experimental conditions. Solid-state analysis of
Cu(hCys)2 by IR and EPR spectroscopy indicated bidentate Cu(II) coordination of the
amine and thiolate groups, with no binding of the carboxylate group.
In contrast, tridentate Cu(II) coordination in the solid state is reported for
penicillamine, and in a unique polymeric structure supported by a goldbis(diphenylphosphino)alkane linker, Cu(II) coordinates two penicillamine ligands, one in
a tridentate fashion through the amine, carboxylate, and thiolate groups, and one in a
bidentate fashion through only the amine and thiolate.96 Higher stability constants for the
thiol-containing amino acids with Cu(II) indicate increased stability compared to thioether
and selenoether amino acids and glycine, either due to increased stability of an amine and
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side-chain thiolate coordination or tridentate chelation of the copper by the carboxylate,
amine, and thiolate groups.

Fe(II)-Amino Acid Stability Constants
Even though iron is the most abundant transition metal ion in the biological system,
stability constant data for Fe(II) with sulfur and selenium amino acids is much more limited
than for Cu(II). Since Fe(II) is more difficult to work with due to its tendency to oxidize in
air, titrations must be performed under nitrogen or argon to exclude oxygen during analysis.
In addition to oxygen sensitivity, Fe(II)-amino acid complexes precipitate above pH ~8,
limiting the analysis window for potentiometric titrations. Likely because of these
limitations, Met is the only thio- or selenoether amino acid with reported Fe(II) stability
constants,63,97 and data from these 1950s papers are inconsistent. Perrin97 reports a stability
constant of 3.42 for a [Fe(Met)]+ species; however, Albert63 reports formation of a Fe(Met)2
species with a stability constant of 6.7. In neither study were the identified species
investigated using alternative methods.
To address the paucity of Fe(II) stability constant data with sulfur and selenium
amino acids, potentiometric titrations of Fe(II) with Met, MeCys, SeMet, MeSeCys, and
penicillamine (Pen) at a 1:2 and 1:5 metal to ligand ratio were performed in a nitrogenatmosphere glovebox. Similar to the Cu(II) studies, glycine titrations with Fe(II) were
performed for comparison. Because precipitation is observed above pH 8, with the
exception of the Fe(II)-Pen system that shows no precipitation up to pH 10, titrations were
restricted to a maximum of pH 8. These titrations indicate formation of [FeL]+ and
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Fe(L)(OH) complexes with Gly, Met, SeMet, MeCys, and MeSeCys (Figure 2.6A and
Table 2.2). In contrast, Fe(II) titrations with thiol-containing Pen indicate formation of
Fe(Pen) and [Fe(Pen)2]2- species (Figure 2.6B) in excellent agreement with previous
analyses.85
Stability constants for the 1:1 [Fe(Gly)]+ and [Fe(Met)]+ agree with previously
reported data (Table 2.2).83,84,97-99 For Gly titrations, Gergely83 also identifies a Fe(Gly)2

Figure 2.6. Representative titrations (0.1 M NaOH, I = 0.1 M NaCl, 25˚C) and speciation diagrams for the
titration of A) Fe(II) and methionine in a 1:2 ratio and B) Fe(II) and penicillamine in a 1:2 ratio. The solid
blue line represents the modeled titration, and points represent the measured data. Formation of Fe(II)-aminoacid species are indicated as shown in the legend.
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species with a log β of 7.65, whereas Micskei99 identifies two additional species, Fe(Gly)2
with a log β of 6.65(1) and [Fe(Gly)3]- with a log β of 8.87(1). Under our titration
conditions, these Fe(Gly)2 and [Fe(Gly)3]- species are not present; instead, a Fe(Gly)(OH)
species is observed with a stability constant of -4.24(2). In Met titrations, a similar
Fe(Met)(OH) species is also identified, but the Fe(Met)2 species reported by Albert is not.63
Due to a lack of reported detail, it is unclear how these titrations differ from the analysis
by Albert, although the authors of these studies included data above the pH at which
precipitation begins to occur, perhaps skewing the fit of their models.
Stability constants for the 1:1 species of Fe(II) with MeCys, SeMet, and MeSeCys
were determined to be 3.49(4), 3.51(7), and 3.84(1), respectively (Table 2.2), representing
the first stability constant determinations for Fe(II) with these amino acids. These [FeL]+
stability constants are similar to those for [Fe(Gly)]+ (3.73(1)) and [Fe(Met)]+ (4.13).83,84
As noted for the Cu(II) titrations, the [Fe(Gly)]+ stability constant is slightly higher than
those for any of the thio- or selenoether amino acids, likely indicating no Fe(II)-S/Se
binding. In contrast to previous reports, presence of the Fe(L)(OH) species (L = Met,
SeMet, MeCys, MeSeCys) is identified in the best fit model for these systems, with this
species growing in above pH 4 as hydroxide becomes more readily available.
For Fe(II) titrations with the thiol-containing penicillamine, the [FePen] and
[Fe(Pen)2]2- species are present, with stability constants of 7.48(7) and 13.91(7),
respectively, closely matching results reported by Doornbas85 in 1964 (Table 2.2). The lack
of precipitation in this system up to pH 10 is due to strong Fe(II)-thiolate interactions as
well as the greater charge of [Fe(Pen)2]2- that makes it more soluble in aqueous solution
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than the [Fe(L)]+ species formed with the thio- and selenoether amino acids. These
speciation differences in the Fe(II)-Pen and Fe(II)-Met systems are obvious when
comparing their respective titration data (Figure 2.6) . In fact, Fe(II)-Pen complexes are
slightly more stable than Fe(II)-Cys complexes (Table 2.2).

Proof of Speciation for Fe(II) Complexes
Proof of speciation using mass spectrometry was more difficult for the
representative Fe(II)-Met system than for the analogous Cu(II)-Met system, likely due to
the weaker stability constants determined for the Fe(II) species. By ESI-MS only the Fe(III)
species, [Fe(Met)2]+ (m/z = 353), is observed due to Fe(II) oxidation during injection and
analysis. Precipitate formed during Fe(II)-Met titrations was analyzed using IR
spectroscopy to determine amino acid binding modes as a representative sample of the
Fe(II)-thioether and –selenoether interactions. As discussed in detail for the Cu(II)-amino
acid complexes, shifts in both the N-H and C=O stretches for Fe(Met)2 (Table 2.3)
compared to unbound Met indicate Fe(II) coordination through both the amine nitrogen
and the carboxylate oxygen atoms, similar to the IR spectrum of the fully characterized
Cu(Met)2. In addition, the absence of a broad absorption in the 3500-3700 cm-1 range
indicates that no hydroxide or water is coordinated. The Fe(II)-Pen species were not
confirmed by IR, because they do not precipitate in aqueous solution. The formation of the
complex as the thiol is deprotonated is consistent with coordination via the amine and the
thiol, as discussed by Doornbos and Faber.85
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The only single crystal structure for Fe(II) with any amino acid is Fe(Pro)2(phen)
(Pro = L-proline; phen = 1,10-phenanthroline,100) which binds Fe(II) through the amine N
and carboxylate O atoms. The only stability constant reported for the Fe(II)-Pro system is
for the ML2 complex (log β = 8.3), determined by Albert63 in 1950. This low stability
constant indicates extremely weak Fe(II) coordination, similar to those observed for the
thio- and seleno-ethers, but does indicate that bidentate binding of thio- and selenoether
amino acids is likely. As all of the FeL2 stability constants with the thio- and selenoether
amino acids were similarly low and approximately the same as the Fe(Pro)2 stability
constant, it is reasonable to assume that the coordination environments are similar. The
lack of reported solid-state structures for Fe(II)-amino-acid complexes is indicative of
weak coordination and difficulty in working with oxygen-sensitive Fe(II) complexes.

Structure-Stability Analysis for Fe(II)
Fe(II)-amino acid stability constants for the [FeL]+ species with the thio- and
selenoether amino acids are within 0.5 pH units of each other (3.49(4) to 3.84(1); Table
2.2), and stability constants for the Fe(L)(OH) complexes are in the range -4.9(1) to -5.7(1),
slightly less accurate due to precipitation at pH 8. The [Fe(Gly)]+ stability constant is
slightly higher (4.04(5)) than those of the thio- and selenoether amino acids, indicating that
the sulfur and selenium atoms of these amino acids do not contribute to complex stability.
In contrast, the thiol-containing Pen exhibits stronger binding to Fe(II), with
Fe(Pen) and [Fe(Pen)2]2- stability constants of 7.48(7) and 13.91(7), respectively, similar
to Cu(II) stability constants with the thio- and selenoether amino acids, but much higher
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than the stability constant for [Fe(Gly)]+ (Table 2.2). Similarities in the stability constants
for the Fe(II)-Pen and Cu(II)-Met systems suggest bidentate coordination, although Pen
likely binds through the thiolate sulfur, replacing either the amine nitrogen or the
carboxylate oxygen. Stability constants for Cu(II) with penicillamine have been reported
as 16.5 and 21.7 for the Cu(Pen) and [Cu(Pen)2]2- species, respectively (Table 2.2). This
significant increase in stability compared to Fe(II)-Pen complexes strongly suggests
tridentate Cu(II) coordination of the thiolate, amine, and carboxylate groups, a trait critical
for its use as a biological Cu(II) chelator to treat Wilson’s disease.
Greater binding stability for Cu(II) over Fe(II) coordination was determined for all
the sulfur and selenium amino acids in Table 2.2. Stability constants of approximately 8
for the [CuL]+ species and approximately 4 for the [FeL]+ species, indicates a much lower
affinity of the amino acid for Fe(II) in comparison to Cu(II). This may be due to differences
in electronic environment and/or preferred coordination geometries around these two
divalent metal ions. The extremely low [FeL]+ stability constants indicate unlikely complex
formation in a competitive environment of other biomolecules with much higher stability
constants.

Cu(II)/Fe(II) Competition for Sulfur- and Selenium-Containing Amino Acids at Biological
Concentrations
The sulfur- and selenium- containing amino acids form significantly more stable
complexes with Cu(II) than with Fe(II), as discussed previously. However, iron is
considered to be the most abundant transition metal ion in the biological system, with labile

103

pools believed to be as high as 10 μM.40 Copper is the third most abundant transition metal
ion, although discrete determination of copper pools has not been accurately
determined.47,101 Although the stability of the Fe(II) complexes is considerably weaker, the
higher concentrations available may allow Fe(II) to compete for the available amino acids,
especially with the thiol amino acids.
Penicillamine is routinely used as a chelating agent in the treatment of Wilson’s
disease25,26 and has been used in the treatment of copper and lead poisoning.102 As such, it
is not surprising that the stability constants for Cu(II) and penicillamine are significantly
higher (ML=16.5 and ML2=21.7, Table 2.2) than those reported for the thio- and
selenoether amino acids (ML=7.6-8.1 and ML2=14.5-14.7). The stability constants for the
Fe(Pen) (7.6) and [Fe(Pen)2]2- (13.7) also indicate much weaker coordination than those
for Cu(II), but if more Fe(II) is available, these complexes may form in significant
quantities. The penicillamine may be effective for removing excess copper, but may also
interfere with iron homeostasis.

Figure 2.7. The simulated speciation graph for the modeled solution of 1 μM Cu(II), 10 μM Fe(II), and 1100 μM Pen incorporating the stability constants for Cu(Pen), Fe(Pen), [Cu(Pen) 2]2-, and [Fe(Pen)2]2- species,
with less than 1% formation was observed for the [Cu(Pen) 2]2-, and [Fe(Pen)2]2- species.
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To demonstrate the preference of penicillamine for the Cu(II) ion over the Fe(II)
ion, a model solution was studied that incorporated 1 μM Cu(II), 10 μM Fe(II), and 1-100
μM Pen at pH=7. These concentrations were chosen based on approximate labile
concentrations for iron40 and reported concentrations for penicillamine for patients being
treated for Wilson’s disease.27 Although exact labile concentrations for Cu(II) have not
been reported,47,101 the concentration of 1 μM was chosen to examine the effect of a tenfold difference between copper and iron. The model can be seen in Figure 2.7.
From the model seen in Figure 2.7 at pH 7, the formation of the Cu(Pen) species is
unaffected by the availability of excess Fe(II). If the total concentrations are considered,
the Pen ligand is initially equimolar to the Cu(II) and ten times less concentrated than the
Fe(II). From these ratios, 99.8% of the Cu(II) (or 0.998 μM) is coordinated to the
penicillamine. As the penicillamine concentration rises with excess available for
coordination, limited Fe(II) coordination is observed, even when the pencillamine is ten
times more concentrated than the Fe(II). A maximum of 3.93% of the Fe(II) (or 0.393 μM)
is coordinated by penicillamine in this simulation. The [Cu(Pen)2]2- and [Fe(Pen)2]2species are only observed in trace amounts (<0.1 μM, not seen in Figure 2.7) at pH 7 and
do not seem to be a contributing species in this model. From this model, limited
coordination of labile Fe(II) is observed when the penicillamine is in 10x excess which
may affect iron homeostasis, but the Fe(II) would not outcompete or inhibit Cu(II)
complexation.
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Correlation of Stability Constants with Amino Acid Antioxidant Ability and Biological
Speciation
Iron- and copper-mediated DNA damage can lead to oxidative stress and cell death,
and sulfur and selenium compounds have been widely examined for their ability to inhibit

DNA damage by Fe(II) or Cu(II)-mediated hydroxyl radical generation (Figure 2.1). In vitro
gel electrophoresis studies quantified the concentration of thio- and selenoether amino
acids required to inhibit 50% of the DNA damage (IC50 values) caused by Fe(II) or Cu(I)
and hydrogen peroxide (Table 2.5). Brumaghim and coworkers37,57,103 established that this
antioxidant behavior was due to metal-amino-acid coordination, although they did not
attempt to correlate DNA damage prevention with stability constants.
Table 2.5. Inhibitory concentrations for metal-mediated DNA damage prevention by amino
acids.
Amino Acid
Gly
Met
SeMet
MeCys
MeSeCys
Pen

Cu(I) IC50
(µM)
22.4 ± 0.1
11.8 ± 1.3
25.1 ± 0.1
9.6 ± 1.0
8.64 ± 0.02
26.9 ± 0.1

Fe(II) IC50
(µM)
None
None
None
None
None
591±1

Reference
48
57
37
57
37

This work

To investigate potential correlations between metal-amino-acid binding and DNA
damage prevention, we examined the relationship between the IC50 data (Table 2.5) and
stability constants for the [CuL]+ and CuL2 species with Gly, Met, SeMet, MeCys, and
MeSeCys. Data for the Cu(II)-Pen system were excluded from this analysis due to the
differences in metal binding modes. Although stability of the ML species and inhibition of
metal-mediated DNA damage are not correlated (R2 = 0.045; Figure 2.8B), a weak
correlation exists between stability constants for the ML2 species and DNA damage
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prevention (R2 = 0.4742; Figure 2.8A). This limited correlation indicates that the stronger
the Cu(II)-amino-acid binding, the less effective the amino acid is at preventing metalmediated DNA damage.
These DNA damage inhibition assays use Cu(I)/H2O2 to generate damaging
hydroxyl radical, and Cu(I) complexes are not expected to have the same stability constants
as Cu(II). A comparison of Cu(I) stability constants with IC50 values would be ideal, but
only Cu(I) stability constants with and Cys,7 Pen,7 and Met84 are reported, due to the
difficulty of working with Cu(I) in aqueous systems. CuI(Met) has a higher log β than
[CuII(Met)]+ species, 9.1 vs. 7.65, respectively, so Met is more stable binding Cu(I) than
Cu(II), but data are too limited to establish trends.
Perhaps the most relevant general trend of complex stability with DNA damage
prevention can be elucidated from the poor stability of the Fe(II)-thioether and -selenoether
complexes. Thio- and selenoether amino acids do not inhibit DNA damage by Fe(II) (Table
2.5), but the more strongly binding Pen does. Although quantifiable trends cannot be
determined due to lack of IC50 values with Fe(II), it is possible that thio- and selenoether
ligands do not coordinate Fe(II) strongly enough to prevent iron-mediated DNA damage.
Based on the stability constants of Cu(II) with Met, SeMet, MeCys, MeSeCys, and
Gly, the models indicate approximately 100% coordination by at least one ligand at
biological pH (Figure 2.3). For the Fe(II) stability determinations with the same amino
acids, only the Fe(II)-Pen system shows appreciable coordination at biological pH (Figure
2.6). These low stability constants reflect the fact that very little Fe(II) is coordinated up to
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Figure 2.8. Graphs of A) stability constants of the CuL2 species and B) stability constants of the CuL
species vs. 50% inhibitory concentrations for oxidative DNA damage (IC50 values) for the amino acid
antioxidants (L) in Table 2.5. Solid lines show the best-fit linear trend line for the data with the
equations given.

pH 7, although a small change in pH to 8 results in >80% coordination of Fe(II) as [ML]+
or MLOH species. The Fe-penicillamine system indicates a much higher stability with
>90% coordination at pH 7, indicating probable coordination of the thiolate group to Fe(II).
Thus, sulfur and selenium amino acid binding may affect the biological chemistry of Cu(II)
significantly more than Fe(II).
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2.3 Conclusions
Stability constants were determined for Cu(II) with the thio- and selenoamino acids,
methylcysteine, methionine, methylselenocysteine, and selenomethionine, and stability
constants for the [Cu(MeSeCys)]+ and Cu(MeSeCys)2 species were reported for the first
time. Identity of these Cu(II)-amino acid species were independently confirmed by IR
spectroscopy, ESI-MS, and/or solid-state structural analysis, including the first Cu(II)
structure with a selenium-containing amino acid, Cu(SeMet)2. Cu(II) binds these amino
acids through the amine nitrogen and carboxylate oxygen atoms, and the thioether or
selenoether moiety does not coordinate or increase complex stability. Based on the Cu(II)
stability constants with these amino acids (log  = 8.0 to 8.2 for the [ML]+ species), all of
the available Cu(II) is coordinated at pH 7 in as the [ML]+ and [ML2] species, suggesting
that these complexes may potentially form in biological systems.
Stability constants of Fe(II) with methylcysteine, methylselenocysteine, and
selenomethionine also were determined for the first time. Fe(II) stability constants are
consistently lower than the Cu(II) constants for all sulfur and selenium amino acids tested,
including penicillamine. The [FeL]+ species was identified for all of the thio- and selenoether amino acids, consistent with previous reports for the Fe(II)-methionine system;
however, including a secondary [FeLOH] species provided a better match of the model to
the collected data. The low stability constants for the [FeL]+ species of the thioether and
selenoether amino acids (log  = 3-4) indicate much weaker binding than with Cu(II). As
with Cu(II), the similarity of the stability constants for Fe(II) with glycine and all of the
thio- and selenoamino acids indicates that the sulfur and selenium atoms do not interact
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with the metal ion. Of the sulfur- and selenoamino acids, only penicillamine is likely to
form complexes with the Fe(II) at pH 7.
In general, the higher stability constants of Cu(II) with the thio- and selenoether
amino acids indicates that amino acid binding to Cu(II) at pH 7 may inhibit copper
generation of hydroxyl radical, resulting in the weak correlation identified between Cu(II)
stability constant and DNA damage prevention abilities of these amino acids. With the
thio- and seleno-ether amino acids, the very weakly coordinated Fe(II) is more available
than the stronger-binding Cu(II) for redox cycling to generate hydroxyl radical. Although
sulfur- and selenium-containing amino acids are considered relatively weakly binding
ligands, they may have large-scale implications for the biological availability and reactivity
of redox-active metals such as Cu(II) and Fe(II).

2.4 Experimental Methods
Materials and Instrumentation
Concentrations of stock solutions of copper(II) nitrate trihydrate solutions and
iron(II) sulfate heptahydrate were confirmed by ICP-OES. Infrared spectra were recorded
using a Magna 550 IR spectrometer in the range 4000-450 cm-1 as Nujol mulls on KBr
plates. IR absorption abbreviations are vs, very strong; s, strong; m, medium; w, weak; sh,
shoulder.
ESI-MS analysis was carried out with a Thermo Scientific (San Jose, CA) TSQ
Quantum Access MAX triple quadrupole mass spectrometer. Sample solutions were
prepared in 50/50 mixture by volume of MeOH/H2O and NaClO4 (10 mM) at pH of 5.
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Samples were prepared by mixing Cu(II) or Fe(II) (2 mM) with of the amino acid (4 mM)
and introduced to the ESI source by direct infusion. A scan containing 5 micro scans was
taken every 0.5 seconds across a 10 to 1000 Da range. For each sample, 100 scans were
collected and averaged to obtain a final spectrum. TSQ Tune software (Thermo Scientific)
was used for data acquisition. ESI-MS data are shown in Figures 2.11-2.12, and both
mass/charge ratio and isotopic distribution match simulated envelope intensities.

Potentiometric Titrations
Titrations were performed using an 836 Titrando equipped with a 800 Dosino
autotitrater. A Thermo Sure-flow Ag/AgCl electrode with 0.1 M NaCl filling solution was
used to monitor potential of the solution during titration. Amino acid protonation constants
were determined by direct titration of 30 mL of a 2.0 mM solution of each amino acid in
NaClO4 (0.1 M ) to maintain a constant ionic strength. After bubbling with CO2-scrubbed
Ar, the solutions were titrated with CO2-free, NIST standardized 0.1002 M NaOH using
the 836 Titrando equipped with the 800 Dosino to autotitrate.
Cu(II) stability constants with the indicated amino acids were determined using
aqueous solutions of Cu(NO3)2·3H2O (1.0 mM) and each amino acid (2.0 mM or 3.0 mM)
in 1:2 and 1:3 ratios of Cu:ligand and a constant ionic strength of 0.1 M NaClO4. The
electrode was calibrated for the system utilizing NIST-standarized 0.1001 M HCl and
NIST-standarized 0.1002 M NaOH and the GLEE program104 to determine standard
reduction potentials in 0.1 M NaClO4. For all titrations, 0.1001 M HCl was added to the
metal-amino acid solution to bring the solution pH down to 2-3. Copper solutions were
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bubbled with argon for 15 min and maintained at a constant temperature of 25.0˚C with a
jacketed cell under a constant stream of argon to minimize CO2 contamination of the
reaction solutions. The solutions were then titrated as described above for the pure amino
acid system. Potentials were measured at 25˚C until precipitation was visible.
Fe(II) stability constants were determined by titrating aqueous solutions of
FeSO4·7H2O (1.0 mM) in 1:2 and 1:3 metal to ligand ratios with solutions of each amino
acid (2.0 mM or 3.0 mM) at a constant ionic strength of 0.1 M NaCl in a dry, nitrogenatmosphere glovebox. All solutions were prepared and titrations were performed in the
glovebox. Temperature was maintained at 25.0˚C with a jacketed cell and water circulator.
Iron solutions were then titrated with NIST standardized 0.0100 M NaOH utilizing the 836
Titrando and 800 Dosino autotitrator. Precipitation was observed above pH 8 during iron
titrations, except with penicillamine. The iron titrations were back-titrated from pH 10 to
3 to demonstrate reversibility and to improve stability of the electrode over multiple
analyses. For all amino acid, Cu(II), and Fe(II) titrations, data were collected in triplicate
with reported standard deviations. Potentiometric titration data were analyzed and modelmatched using HYPERQUAD2013.104

Synthesis of Cu(SeMet)2
A solution of L-selenomethionine (117.7 mg, 0.6 mmol) in water was added to a
solution of Cu(NO3)2·3H2O (72.5 mg, 0.3 mmol) in water. NaOH (0.1 M) was added
dropwise until the solution reached pH 6.0. The solution was evaporated in air over three
weeks, resulting in light-blue crystals as well as powder precipitate. Yield:106 mg, 78%.
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IR (cm-1): 3299 w, 3232 w, 3110 s, 1618 vs, 1571 sh, 1462 w, 1340 w, 1304 w, 1138 s,
1083 w, 1246 w, 1160 s, 818 w, 722 w, 671 s, 638 w, 576 s. ESI-MS (m/z): 251
[Cu(C5H11NO2Se)]+, 274 [Cu(C5H11NO2Se)(OH)]+, 456 [Cu(C5H11NO2Se)2H]+. Anal.
Calc. for C10H20CuN2Se2O4: C, 26.47; H, 4.44; N, 6.17. Found: C, 26.03; H, 4.66; N, 6.86.

X-ray crystallography
Single crystals for X-ray diffraction were obtained through slow evaporation of a
1:2 metal to ligand solution in water at pH 6, yielding blue, plate-like crystals. A single
crystal was mounted on a low background loop and quenched to 100 K in a cold nitrogen
stream. Data were collected at this temperature using a Bruker D8 Venture diffractometer
with Mo Kα radiation (λ = 0.71073 Å) and a Photon 100 CMOS detector; crystallographic
data are summarized in Table 2.6. A total of 10345 reflections were collected (3012
independent) using phi and omega scans. Data collection, processing (SAINT), and scaling
(SADABS) were performed using the Apex 3 software package.105 The monoclinic space
group P21 was determined from the systematic absences. The structure was solved using
intrinsic phasing (SHELXT) and refined using full matrix least squares techniques
(SHELXL) using the SHELXTL software suite.106 All non-hydrogen atoms were refined
anisotropically, and hydrogen atoms were then placed in geometrically optimized positions
using appropriate riding models. The presence of two hydrogen atoms on the amine
nitrogen atoms was confirmed on the difference electron density map prior to hydrogen
atom assignment at these positions. The proper absolute structure was confirmed by a
Flack parameter of 0.06(2).
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Table 2.6. Summary of crystallographic data for Cu(SeMet) 2.
Chemical formula
F.W. (g mol-1)
Temperature, K
Wavelength, Å
Crystal system
Space group
a, Å
b, Å
c, Å
β, ˚
V, Å3
Z
D, g cm-3
Absorption coefficient, mm-1
Crystal size, mm3
F(000)
2θ range, ˚
Collected reflections
Unique reflections
Rint
Final R (obs. data)α, R1; wR2
Final R (all data)α, R1; wR2
Flack parameter
Largest diff. peak/hole (e/Å3)

Cu(SeMet)2
C10H20CuN2O4Se2
453.74
100(2)
0.71073
Monoclinic
P21
9.4131(7)
4.9660(4)
16.0824(11)
90.897(2)
751.7(1)
2
2.005
6.305
0.021 × 0.124 × 0.268
446
2.16 to 26.38
10345
3012
0.0542
0.0382; 0.0700
0.0497; 0.0733
0.06(2)
0.506/-0.575

Plasmid DNA transfection, amplification, and purification.
Plasmid DNA (pBSSK) was purified from DH1 E. coli competent cells using a
ZyppyTM Plasmid Miniprep Kit (400 preps, Fisher). Plasmid was dialyzed against 130
mM NaCl for 24 h at 4°C to ensure all Tris-EDTA buffer and metal contaminates were
removed, and plasmid concentration was determined by UV-vis spectroscopy at a
wavelength of 260 nm. Absorbance ratios of A250/A260  0.95 and A260/A280  1.8 were
determined for DNA used in all experiments. Plasmid purity was determined through
digestion of plasmid (0.1 pmol) with Sac 1 and KpN1 in a 10x Fast Digest Buffer (Thermo
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Scientific) at 37°C for 90 minutes. Digested plasmids were compared to an undigested
plasmid sample and a 1 kb molecular weight marker using gel electrophoresis.

DNA damage gel electrophoresis experiments
For the DNA damage assays with copper, deionized water, MOPS buffer (10 mM,
pH 7.0), NaCl (130 mM), ethanol (100%), 10 mM), CuSO4∙5H2O, ascorbic acid (7.5 µM,
to reduce Cu(II) to Cu(I)), and penicillamine were combined in an acid-washed (1 M HCl
for ~ 1 h) and dried microcentrifuge tube and allowed to stand for 5 min at room
temperature. Plasmid (pBSSK, 0.1 pmol in 130 mmol NaCl) was then added to the reaction
mixture and allowed to stand for 5 min at room temperature. H2O2 (50 µM) was added and
allowed to react at room temperature for 30 min. EDTA (50 µM) was added after 30 min
to quench the reaction. For the Fe(II) DNA damage experiments, the 2 µM FeSO4∙7H2O
and MES buffer (10 mM, pH 6.0) were used. All concentrations are final concentrations in
a 10 µM volume. Samples were loaded into a 1% agarose gel in a TAE running buffer
(50); damaged and undamaged plasmid was separated by electrophoresis (140 V for 60
min). Gels were stained using ethidium bromide and imaged using UV light. The amounts
of nicked (damaged) and circular (undamaged) were analyzed using UViProMW software
(Jencons Scientific Inc.). Intensity of circular plasmid was multiplied by 1.24, due to the
lower binding affinity of ethidium bromide to supercoiled plasmid.107,108 Intensities of the
nicked and supercoiled DNA bands were normalized for each lane so that % nicked + %
supercoiled = 100%. Plots of percent inhibition of DNA damage versus log concentration
of amino acid were fit to a variable-slope, sigmoidal dose-response curve using SigmaPlot
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(v. 9.01, Systat Software, Inc., San Jose, CA). IC50 value errors represent standard
deviations of the values obtained from fits of three separate experiments. Data and IC50
plots for all gel electrophoresis experiments are provided in Tables 2.7-2.8 and Figures
2.11-2.12.

2.5 Supplementary Data

Figure 2.9 Representative titration (0.1 M NaOH, I = 0.1 M NaClO4, 25˚C) and speciation diagram for the
potentiometric titration of Cu(II) and methionine in a 1:2 ratio. The solid blue line represents the modeled
titration with the measured data points overlayed; formation of [Cu(Met)]+, Cu(Met)2, and Cu(Met)(OH)
species are indicated as shown in the legend.
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Figure 2.10 Crystal packing diagram for Cu(SeMet)2. The long range intermolecular interactions of the
carboxylate oxygens (red) with the copper ions (turquoise) in the axial positions are designated by dashed
bonds.

Figure 2.11ESI-MS data for Cu(NO3)2 (2 mM) and methionine (4 mM) with 0.01 M NaClO4 in
methanol/water at pH 5. The inset shows the isotopic distribution that confirms the identify of [Cu(Met)]+
and [Cu(Met)(OH)]+ species.
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Figure 2.12 ESI-MS of FeSO4 (2 mM) and methionine (4 mM) in 0.01 M NaClO4 in methanol/water at pH
5. The inset shows the isotopic distribution that confirms the identity of the [Fe(Met)2]+ species.

Figure 2.13 A) Gel electrophoresis image showing copper-mediated DNA damage inhibition by
penicillamine. MW: 1 kb molecular weight marker; lane 1: plasmid DNA (p); lane 2: p + H 2O2. lane 3: p +
penicillamine (100 μM) + H2O2; lane 4: p + CuSO4 (6 μM) + ascorbate (7.5 μM) H2O2; lanes 5-11: p + H2O2
+ Cu(II) + AA + 0.1, 1, 5, 10, 25, 50, 100 μM, respectively. B) A graph of log penicillamine concentration
vs. DNA damage inhibition showing the best-fit sigmoidal dose-response curve; IC50 value = 26.94 ± 0.07
M).
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Table 2.7 Gel electrophoresis results for DNA damage inhibition by penicillamine (Pen) with Cu(II), ascorbate, and
H2O2.a
%
% DNA
Gel
[Pen] % Supercoiled
Nicked
Damage
p Value
Contents
DNA
lane
(µM)
DNA
Inhibition
1
2
3
4

plasmid DNA (p)
p + H2O2 (50 µM)
p + penicillamine + H2O2
p + Cu(II) (6 µM) + ascorbate (7.5 µM) +
H2O2
p + Cu(II) + AA + H2O2 + Pen

0
0
100

99.58 ± 0.73
100 ± 0
99.86 ± 0.25

0

11.37 ± 4.91

0.42
0.00
0.14
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88.63
5
0.1
11.40 ± 2.03
88.60
6
1
16.61 ± 6.97
83.39
7
5
25.01 ± 7.55
74.99
8
10
33.93 ± 5.55
66.07
9
25
50.66 ± 3.13
49.34
10
50
73.02 ± 2.84
26.98
11
100
73.71 ± 4.11
26.29
a
Data are reported as the average of three trials with calculated standard deviations shown.
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-

-

-

-

0.03 ± 2.03
5.90 ± 6.94
15.38 ± 7.52
25.42 ± 5.57
44.30 ± 3.11
69.57 ± 2.84
70.33 ± 4.13

0.982
0.279
0.071
0.016
0.002
<0.001
<0.001

Figure 2.14 Gel electrophoresis image showing iron-mediated DNA damage inhibition by penicillamine.
MW: 1 kb molecular weight marker; lane 1: plasmid DNA (p); lane 2: p + H 2O2. lane 3: p + penicillamine
(2000 μM) + H2O2; lane 4: p + FeSO4 (2 μM) + H2O2; lanes 5-11: p + H2O2 + Fe(II) + 10, 100, 250, 500,
750, 1000, 2000 μM, respectively. B) A graph of log penicillamine concentration vs. DNA damage
inhibition showing the best-fit sigmoidal dose-response curve; IC50 value = 591 ± 1 M).
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Table 2.8 Gel electrophoresis results for DNA damage inhibition by penicillamine (Pen) with Fe(II), ascorbate, and H2O2.a
%
% DNA
Gel
[Pen]
% Nicked
Contents
Supercoiled
Damage
p Value
lane
(µM)
DNA
DNA
Inhibition
1
plasmid
0
100.0 ± 0
0.0
2
p + H2O2 (50 µM)
0
100 ± 0
0.0
3
p + penicillamine + H2O2
2000
100 ± 0
0.0
4
p + Fe(II) (2 µM) + H2O2
0
5.85 ±
94.15
5
p + Fe(II) + H2O2 + penicillamine
10
0.70 ± 0.7
99.30
- 5.47 ± 0.70
0.005
6
100
0.35 ± 0.35
99.65
-5.84 ± 3.61
0.107
7
250
4.53 ± 7.77
95.47
-1.40 ± 7.77
0.785
8
500
37.10 ± 4.40
62.90
33.19 ± 4.40
0.006
9
750
71.45 ± 4.45
28.55
69.68 ± 4.45
0.001
10
1000
82.10 ± 0.60
17.90
80.99 ± 0.60 < 0.001
11
2000
89.90 ± 2.95
10.10
89.27 ± 2.95 < 0.001
a
Data are reported as the average of three trials with calculated standard deviations shown.
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CHAPTER THREE
COORDINATION COMPLEXES OF METHIMAZOLE WITH COPPER:
CONTROLLING REDOX REACTIONS AND SULFUR EXTRUSION

3.1 Introduction
Immense diversity in stoichiometry and redox activity has been demonstrated for
the coordination of N-heterocyclic thioamides with softer metal centers such as Cu(I) and
Fe(II).1-4 This remarkable flexibility in redox activity has led to the exploration of
thioamides in catalysis,5,6 radiopharmaceuticals,7 energy production,8 corrosion
resistance,9,10 sensors,11 and organometallic and coordination chemistry.12,13 Although
thioether- and thiol-containing amino acids have attracted considerable attention as ligands
due to their bioavailability, imidazole thiones are of recent interest due to their sigma donor
bonding ability,4,14 potential for multidentate binding, and redox activity.15 Methimazole
(MMI), is the most widely prescribed hyperthyroid treatment in the U.S.16 and is believed
to bind Fe(II) in the heme protein, thyroid peroxidase.17 The exact mechanism of action for
MMI is poorly understood, and its biological redox activity and metal coordination has not
been investigated fully. MMI is also structurally similar to ergothioneine, a known
biological antioxidant.18 Upon oxidation, MMI forms the corresponding disulfide, MMIDS,
a reaction reminiscent of cysteine oxidation to cystine.
Under inert atmosphere conditions, Cu(I)-MMI coordination has been widely
studied, and a wide variety of mono-,19,20 di-,21-24 tetra-,25 and polynuclear26,27 complexes
are reported. The two mononuclear Cu(I) complexes [Cu(MMI)3][NO3]28 and
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Figure 1.1. N-heterocyclic thione and disulfide compounds discussed in this study: A) methimazole (MMI),
B) methimazole disulfide (MMIDS), C) methimazole monosulfide (MMIMS), and D) 2-mercaptoimidazole
(HMI).

[Cu(MMI3)Cl]29 have monodentate coordination through the MMI sulfur atom and
coordinate trigonal planar geometry. The multinuclear and polymeric complexes include
S-bridging methimazole ligands bound to Cu(I) in trigonal planar or tetrahedral geometry.
The dinuclear species form Cu2S2 rhombohedral cores, distorting the tetrahedral
coordination around Cu(I). The relatively short Cu-S bond lengths (2.3-2.5 Å) in these
dinuclear complexes are similar to the Cu-S(Cys) bond lengths observed in blue copper
proteins, and indicate high π-covalency.30
In an unusual reaction illustrating the facile redox chemistry of methimazole and
copper, copper promotes sulfur extrusion from methimazole disulfide (MMIDS) to form a
methimazole monosulfide ligand (MMIMS; Figure 3.1). In the first step, Cu(II) oxidizes
methimazole to its disulfide with and is reduced to Cu(I) (Scheme 3.1, reaction A).15 In the
presence of O2 from air, Lobana and coworkers31 established that Cu(I) was oxidized to
Cu(II) and the disulfide was oxidized to a sulfone, resulting in sulfur elimination (Scheme
3.1, reaction B) and formation of MMIMS, with mass spectroscopy data supporting the
formation of the disulfide, the sulfone, and the monosulfide. The in-situ-generated

131

Scheme 3.1. Reduction of Cu(II) by methimazole (A) and subsequent oxidation of Cu(I) with sulfur
extrusion (B) in air.

MMIMS ligand coordinates Cu(II) in a bidentate fashion through an N atom on each of the
heterocycles.27,32-37 To date, no Cu(II) or Cu(I) complexes incorporating the intact MMIDS
ligand are reported.
To determine the effects of oxygen on the coordination chemistry of copper and
methimazole, a series of reactions with Cu(II) or Cu(I) and MMI or MMIDS were performed
air-free and in air, yielding several novel dinuclear and polynuclear Cu(I)-MMI complexes.
Under aerobic conditions, a series of novel Cu(II) complexes with the sulfur-extruded
MMIMS ligand were obtained, resulting in a greater mechanistic understanding of this
unusual reaction. These goals were achieved through the contributions of Amanda Owen,
for the development of the MMIDS synthesis and crystallization, Sam Struder, for her part
in the synthesis of the 2-mercaptoimidazole polymer, {[CuI2(μ-HMI)3](NO3)2}n, and Colin
D. McMillan for his expertise in X-ray crystallography.
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3.2 Results and Discussion
Synthesis
The disulfide MMIDS can be generated in situ by air oxidation of MMI to yield the
Zn(MMIDS)Cl2 complex,38 and single crystal structures of the charged [MMIDSH2][ClO4]
species,39 where the imidazole nitrogen atoms are protonated or methylated,39 have been
isolated. However, direct synthesis of the neutral MMIDS ligand has not been previously
reported. By modifying a method for synthesis of the neutral t-butyl-substituted MMIDS40,
MMIDS(1) can be successfully synthesized in 49% yield.
Three variables were analyzed when exploring reactions between copper and
methimazole: the oxidation state of the copper, the monomeric (MMI) or oxidized dimeric
form of methimazole (MMIDS), and the presence of oxygen. To determine the effect of
copper oxidation state in the reaction, separate reactions of [Cu(NCCH3)4][BF4] or
Cu(BF4)2 was treated with methimazole in acetonitrile were performed (Scheme 3.2A and
3.2B). After stirring both reactions for 18 h, the same dinuclear copper(I) complex [Cu2(μMMI)2(MMI)4][BF4]2 (2) is the primary product. With the [Cu(NCCH3)4]+ starting
material, 2 forms in 68% yield and is air stable in the solid state for several weeks, although
sulfur extrusion is reported when the reaction is stirred for 3-4 days.31 With Cu(BF4)2 as
the copper source, the blue reaction solution becomes colorless, indicating reduction of
Cu(II) to Cu(I), with concomitant formation of MMIDS (Scheme 3.2B), and 2 was isolated
as a colorless solid in 36% yield. Formation of MMIDS in addition to 2 was verified by
MALDI-MS of the reaction solution (m/z 229 for [MMIDSH]+), but no Cu(I)-coordinated
MMIDS product was isolated. Raper23 previously synthesized complex 2
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Scheme 3.2. Reaction conditions used to evaluate the effects of copper oxidation state and counterions on
product formation.

from Cu(BF4)2 using similar methods, but MMIDS formation during the reaction was not
examined. Although O2 was readily available during synthesis, there was no indication of
sulfur elimination with acetonitrile as the solvent and tetrafluoroborate as the counterion,
either in analysis of the reaction mixture by MALDI-MS or in the isolated products.
Sulfur extrusion to form copper-coordinated MMIMS ligands is typically observed
for reactions performed in air with Cu(NO3)2 as the copper source.31,34-36,41 To examine the
oxygen dependence of MMIMS formation, Cu(NO3)2 and methimazole were combined
under air-free conditions. Upon Cu(NO3)2 addition, the blue reaction mixture immediately
becomes colorless, indicating Cu(II) reduction to Cu(I) by methimazole. MMIDS formation
was confirmed by mass spectrometry. The polymer, {[CuI(μ-MMI)(MMI)](NO3)}n (3;
10% yield) was isolated under air-free conditions (Scheme 3.2C). Subsequent attempts to
reproduce the synthesis of this product for further characterization were unsuccessful and
resulted in isolation of the previously reported, mononuclear [Cu(MMI)3][NO3] complex.28
A parallel, air-free reaction was also examined by combining Cu(NO3)2 with 2mercaptoimidazole (HMI; Scheme 3.2D), the structurally similar but unmethylated
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imidazole thione (Figure 3.1). This reaction also resulted in formation of a novel polymeric
Cu(I) complex, {[CuI2(μ-HMI)3](NO3)2}n (4) in 21% yield. No evidence for sulfur
extrusion was observed under air-free conditions, supporting the key role of oxygen in the
elimination of the sulfur from the disulfide.
A similar reaction was performed under aerobic conditions (Scheme 3.2B). When
MMI in acetonitrile is added to Cu(NO3)2 in methanol in a 4:1 ligand-to-metal ratio, the
blue Cu(II) solution turns light yellow, indicating the reduction of the copper ion to Cu(I).
After stirring for 12 hours, the solution turns back to light blue, due to oxidation of Cu(I)
back to Cu(II) in air. After stirring for 3 days, products were isolated under a variety of
conditions, using several different solvents (Scheme 3.3). One previously reported product,
[CuII(η2-MMIMS)2(H2O)2][NO3]2 (5),31 was obtained through ether diffusion into the
reaction mixture, and previously reported, CuII(η2-MMIMS)2(H2O)2][CH3SO4]2 (6)

42

as

well as the novel [CuII(η2-MMIMS)2(H2O)][CH3SO4][HSO4]·H2O (7) were obtained by
solvent evaporation. [CuII(η2-MMIMS)2(H2O)][CH3SO4]2 (8) was obtained by slow
evaporation after a reaction time of only 18 hours. The sulfate-bound [CuII(η2-MMIMS)(η2SO4)(CH3OH)] (9) and [Cu(η2-MMIMS)(η2-SO4)(DMSO)]·0.5 DMSO (10) complexes
were obtained when the ligand-to-metal ratio was reduced to 2:1. Mass spectrometry results
of the reaction solutions confirm the presence of a number of Cu-MMI and Cu-MMIDS
fragments with no evidence of MMIMS formation.
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Scheme 3.3. Treating methimazole (MMI) with Cu(NO3)2 under aerobic conditions results in a variety of
sulfur-extruded (MMIMS) products 5, 6, 7, 8, 9, and 10 that are dependent on MMI stoichiometry, reaction
duration, and crystallization conditions.

Although sulfate or methylsulfate ions were not present in the starting materials of
the reactions that yielded complexes 6-10, sulfate and methylsulfate counterions are
observed in the isolated products. This suggests that these counterions were formed from
oxidation of the extruded sulfur during the course of the reaction. In cases where only two
equivalents of MMI were used in this reaction, one of the two Cu(II)-coordinated MMIMS
ligands observed in complexes 5-8 is replaced with Cu(II)-coordinated sulfate in
complexes 9 and 10. In the reported synthesis of 6, copper(II) sulfate was used as a
reactant, so the source of the sulfate could not be positively identified.
To determine whether sulfur elimination to form complexes 5-10 is dependent on
copper oxidation state, MMIDS was treated with [Cu(NCCH3)4]+ under air-free conditions
(Scheme 3.4). After 3 h stirring, [CuI2(μ-MMIDS)(MMIDS)2](BF4)2 (11) was isolated in 22%
yield. In subsequent attempts to reproduce this synthesis, only the [Cu(NCCH3)4][BF4]
starting material was recovered. This suggests that [Cu(NCCH3)4][BF4] may be more
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Scheme 3.4. Treating MMIDS with Cu(I) under air-free conditions yields the novel, dinuclear Cu(I)
complex [Cu2(MMIDS)3][BF4]2 (11).

stable than 11, perhaps due to the strain on the disulfide bond induced in crystallization, as
discussed in the Structural analysis of Cu-methimazole complexes section.
From the reactions shown in Schemes 3.1, 3.2, and 3.3, it is evident that oxygen
availability, copper ionization state, and counter ion and solvent effects all influence the
products formed with these relatively straightforward reactants. Cu(I) forms complexes
with both the thione sulfur of MMI, as seen in complexes 1 and 2, as well as the nitrogens
of MMIDS, as seen in complex 11, but control of oxygen is crucial. Sulfur extrusion is only
observed under aerobic conditions, as exemplified by complexes 5-10. Although disulfide
oxidation to sulfinates or sulfonates is fairly common,43-46 sulfur elimination has only been
reported for MMI reactions. The identity of the metal also plays a critical role. Complexes
with imidazole disulfide ligands are reported with a variety of metals: Co(t-butylMMIDS)2Cl2,47

Zn(t-butyl-MMIDS)2Cl2,40

Fe(t-butyl-MMIDS)2Cl2,40

Ni(t-butyl-

MMIDS)2Cl2,40 and Zn(MMIDS)Cl238 All of these complexes are synthesized under aerobic
conditions with no evidence of sulfur oxidation or elimination. Aside from the Cu(II)
complexes mentioned above, no other metal complexes are reported with the MMIMS
ligand,

although

sulfur

extrusion

to

form

MMIMS

was

observed

when

hydrotris(thioimdiazolyl) borate was treated with iodine.48
After MMI coordination to redox-active Cu(I) and subsequent oxidation to the
MMIDS, the formation of monosulfide methimazole-Cu(II) complexes were consistently
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observed. Subsequent Cu(II) coordination of the monosulfide (MMIMS) is favored in a
bidentate fashion in the equatorial position, with a variety of solvents coordinating in the
axial positions. Disulfide oxidation to sulfinate is common,43,44,46 but this generally results
in the breaking of the disulfide bond rather than complete oxidation and elimination of a
sulfur atom. The presence of methylsulfate ions in 6-8 indicates that nucleophilic attack of
methanol on a sulfur atom may occur prior to sulfur elimination.

NMR spectroscopy
1

H NMR spectra were obtained only for Cu(I) complexes 2, 3, and 4 due to Cu(II)

paramagnetic effects in complexes 5, 6, 7, 8, 9, and 10. The 1H NMR spectrum of 2 shows
a small downfield shift for the MMI methyl resonance compared to unbound MMI (δ 3.53
vs. 3.42; Table 1), whereas the olefinic protons shift slightly upfield by an average of δ 0.1
compared to unbound methimazole. In contrast, similar dinuclear complexes, such as
[Cu2(ebit)2(MMI)2][BF4] (ebit = ethylene bis-imidazole thione),49 show a downfield shift
of the MMI olefinic protons upon copper coordination, indicating an increase in the
electron density of the heterocycle.
For the Cu(I) polymeric complexes 3 and 4, opposing shifts in the olefinic
resonances are observed. The MMI olefinic resonance shifts downfield upon complexation,
but the HMI olefinic responances shift slightly upfield. The imidazole –NH peak at δ 12.06
of the unbound methimazole is broad, indicating exchange. Upon complexation, this
resonance is no longer observed for the polymeric 3, and is shifted significantly upfield for
the dinuclear 2.
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Table 3.1. 1H NMR resonances (in CD3CN) for ligands and their Cu(I) complexes.
1
Compound
H NMR Resonances
δ CH3
δ CH
δ NH
MMI
3.42
6.87,7.05
12.06
3.54
6.83, 6.90
10.32
2
3.66
7.06, 7.13
3
HMI
7.10
12.56
6.85
11.98
4

Infrared spectroscopy
Compared to the C=S stretching band for unbound MMI in the infrared (IR)
spectrum (1273 cm-1), Cu(I) complex 2 has three separate C=S stretching bands at similar
energies (1267, 1279, and 1267 cm-1), consistent with IR data for 2 reported by Raper.23
Although little change in energy of the δ C=S vibration is observed upon copper-MMI
binding compared to MMI (674 vs, 673 cm-1, respectively), the π C-S band shifts to lower
energy (515 cm-1 for 2 and 529 cm-1 for MMI). This shift indicates that the double bond
character of the thione in the polymer is increased, which one would not expect as the
copper coordination occurs and is not indicated in the bond length of the complex, which
is significantly longer for 2 as compared to methimazole. Broadening in the 1020-1100 cm1

range typical of the tetrafluoroborate ion was observed in 2.

Structural analysis of MMIDS and Cu-methimazole complexes
N-heterocyclic disulfides with t-butyl and benzyl substituents on one nitrogen atom
have been reported by Figueroa and coworkers,40 and the ionic form of methimazole
disulfide, with protons on one or both of the heterocyclic nitrogen atoms, has also been
isolated. However, the structure of neutral MMIDS (Figure 3.2 and Table 3.2), is reported
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here for the first time. In contrast to [H(MMIDS)]+ and [H2(MMIDS)]2+, 1 has no observable
electron density around the unmethylated nitrogen of the imidazole ring, supporting the
lack of protonation at N2 (Figure 3.2B). The MMIDS molecules form layers along the baxis with dihedral angles of 90.2˚ along the C-S-S-C bonds, as seen in the packing diagram
in Figure 3.7.
Structures

were

MMI)2(MMI)4](BF4)2

also

(2),

obtained

for

the

Cu(I)

{[CuI(μ-MMI)(MMI)](NO3)}n

complexes,
(3),

and

[CuI2(μ{[CuI2(μ-

HMI)3](NO3)2}n (4), (Figure 3.3 and Table 3.3). X-ray data for 2 is consistent with previous

Figure 3.2. A) Crystal structure diagrams with 50% probability density ellipsoids for MMIDS (1). Hydrogen
atoms are omitted for clarity in A. B) Structure diagram showing hydrogen atoms, emphasizing the lack of
protonation at the N2 atom.

S1-S2
C1-S1
C1-N1
C1-N2

Table 3.2. Selected bond lengths (Å) and angles (˚) for 1.
Bond Angle (˚)
Bond length (Å)
2.1010(4)
C1-S1-S1
101.72(3)
1.7413(8)
S1-C1-N2
123.81(6)
1.3678(10)
1.3295(11)
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reports,23 although our unit cell dimensions are slightly smaller (Table 3.7), likely due to
structural determination at a lower temperature (100 K). Since all other structures in the
present study were collected at low temperature, data from this low temperature structure
of 1 will be used for comparisons.
The two polymeric methimazole complexes 2 and 3 have distorted tetrahedral
geometry (τ = 0.895) and trigonal planar geometry around Cu(I), respectively (Figure 3.3
and Table 3.3). Complex 2 exhibits an alternating Cu-S-Cu-S backbone incorporating one
terminal and two bridging MMI ligands. Cu-S bond lengths (2.2243(4) Å and 2.2620(4) Å
for terminal and bridging MMI, respectively) are shorter than the Cu-S bond lengths of 2
for both bridging (2.4394(4) Å) and terminal (2.3136(4) Å MMI ligands), due to the
difference in Cu(I) coordination geometry. Similar to 3, the polymeric structure of 4 with
HMI ligands also has trigonal planar geometry around Cu(I), but a double S-Cu-S-Cu
backbone is formed in which all of the S atoms are bridging (Figure 3.3B). The structures
of copper-methimazole coordination polymers with bridging halides, {Cu3Br3(MMI)3} and
{Cu2I2(MMI)2}n,41 are reported, but this is the first homoleptic Cu-methimazole polymer.
In the polymeric structures of 3 and 4, π-π interactions resulting in alignment of the
heterocyclic rings provides stability. Intermolecular and intramolecular π-π interactions are
of particular interest in polymer research, and the
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Figure 3.3. Crystal structure diagrams with 50% probability density ellipsoids for A) {[CuI(μMMI)(MMI)](NO3)}n 3 (top) and B) {[CuI2(μ-HMI)3](NO3)2}n 4 (top). Hydrogen atoms and counterions are
omitted for clarity. Diagrams showing the extended structures for A) 3 with a single Cu-S-Cu-S backbone
(bottom) and B) 4 with the bridging sulfurs creating a double Cu-S-Cu-S backbone (bottom.)
Table 3.3. Selected bond lengths (Å) and angles (˚) for 2, 3, and 4. Sb denotes a bridging sulfur and St
denotes a terminal sulfur.
2
3
4
2.2374(12)
2.2620(4)
Cu-Sb
2.3475(4)
2.2534(12)
2.2739(4)
2.2773(11)
Cu-St
2.4394(4)
2.2243(4)
1.728(4)
C-Sb
1.7157(11)
1.7243(16)
1.731(6)
C-St

1.7055(11)

1.7143(15)

-

Sb-Cu-St

117.154(13)

125.94(2)

Sb-Cu-Sb

103.029(10)

118.79(2)

C-Sb-Cu

99.40(4)

108.24(6)
104.11(5)

C-St-Cu

107.75(4)

105.03(5)

Cu-Sb-Cu

76.972(10)

106.00(2)

135.13(5)
118.45(5)
105.56(5)
109.56(15)
103.49(14)
106.22(12)
93.28(4)
108.23(7)
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incorporation of a redox active metal such as copper enhances both spectrochemical and
electrochemical properties.50-53
Six differentstructures incorporate the sulfur-extruded MMIMS ligand: [CuII(η2MMIMS)2(H2O)2][NO3]2

(5),

([CuII(η2-MMIMS)2(H2O)2][CH3SO4]2

MMIMS)2(H2O)][CH3SO4][HSO4]·H2O (7),

(6),

([CuII(η2-

([CuII(η2-MMIMS)2(H2O)][CH3SO4]2 (8),

CuII(η2-MMIMS)(η2-SO4)(CH3OH) (9), and Cu(η2-MMIMS)(η2-SO4)(DMSO)·0.5 DMSO
(10). These Cu(II) complexes can be grouped into three categories based on cationic
structure: 1) octahedral geometry with two MMIMS ligands in the equatorial positions
bound in a bidentate fashion through the nitrogen atoms and two waters in the axial
positions (5 and 6, Figure 3.4B and Table 3.4), 2) distorted square pyramidal geometry
with two MMIMS ligands in the equatorial positions and one water in the axial position (7
and 8, Figure 3.4A and Table 3.4), and 3) distorted tetrahedral geometry with one MMIMS
ligand in the equatorial position, one bidentate sulfate in the equatorial position, and a
solvent molecule (methanol or DMSO) in the axial position (9 and 10). Since the structure
of 5 is published,31 it will not be discussed in depth. Octahedral 6 is also reported,42 but it
will be used as a representative octahedral cation, to compare to 7 and 8, and for general
discussion of the fate of the extruded sulfur.
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Figure 3.4. Crystal structure diagrams with 50% probability density ellipsoids for A) ([CuII(η2MMIMS)2(H2O)][CH3SO4][HSO4]·H2O (7), showing the distorted square pyramidal geometry with an axial
water molecule, and B) ([CuII(η2-MMIMS)2(H2O)2][CH3SO4]2 (6), showing octahedral geometry with two
coordinated water molecules. Hydrogen atoms and counterions are omitted for clarity.

Table 3.4. Selected bond distances (Å) and angles (˚) for the [Cu(MMIMS)2(H2O)x]2+ complexes 5, 6, 7, and
8, with x = 2 for 5 and 6 and x = 1 for 7 and 8.
5
6
7
8
Cu-N1
2.0172(12)
2.000(2)
1.9969(17)
2.0034(18)
Cu-N3
2.0172(12)
2.002(2)
1.9998(17)
1.9943(18)
C1-S1
1.7474(15)
1.760(3)
1.746(2)
1.755(2)
C5-S1
1.7520(15)
1.768(3)
1.751(2)
1.756(2)
Cu-OW
2.4514(12)
2.4186(19)
2.1926(16)
2.1864(16)
N3-Cu-N5
180
180
169.86(7)
169.20(7)
N3-Cu-N7
91.58(5)
89.06(9)
91.97(7)
89.33(7)
N5-Cu-N7
88.42(5)
90.94(9)
87.16(7)
88.41(7)
N3-Cu-O1
88.61(5)
87.12(8)
100.09(7)
97.10(7)
N3-Cu-O2
91.39(5)
90.79(8)
---

Complexes 9 and 10 have distorted square pyramidal geometry about the copper
ion and only one molecule of MMIMS is coordinated in an equatorial position, (Figure 3.5
and Table 3.5). Equatorial coordination is completed by bidentate coordination of sulfate,
although the equatorial plane is distorted due to the ring strain inherent in the 4-membered
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chelate ring formed by the sulfate with copper. A solvent molecule coordinates in the axial
position for both 9 (CH3OH) and 10 (DMSO), varying depending on the solvent present
during crystallization. All of these products are solvent dependent, since H2O, CH3OH, and
DMSO stabilize the axial positions of the five-coordinate or six-coordinate complexes.
The coordinated water molecules are likely from the waters of hydration of the
Cu(NO3)2∙3H2O starting material, since dry solvents were used in all the reactions.
In the first copper structure with this ligand, the nitrogen atoms of one terminal,
bidentate MMIDS ligand in [CuI2(μ-MMIDS)(MMIDS)2][BF4]2 (11) and one nitrogen atom
of a bridging MMIDS ligand coordinate each Cu(I) center, resulting in trigonal planar

Figure 3.5. Crystal structure diagrams with 50% probability density ellipsoids for A) 9 and B) 10. Both
structures exhibit bidentate coordination of Cu(I) with in situ-generated sulfate and methanol (9) or DMSO
(10) coordination. Hydrogen atoms and counter ions are omitted for clarity.
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Table 3.5. Selected bond distances (Å) and angles (˚) for [Cu(MMIMS)(SO4)(L)]2+ complexes. For 9, L =
CH3OH and for 10, L = DMSO).
9
10
Cu-N1
1.9547(16)
1.959(3)
Cu-N3
1.9587(16)
1.957(3)
C1-S1
1.7473(19)
1.744(4)
C5-S1
1.7493(18)
1.746(4)
Cu-OW
2.2186(15)
2.259(3)
Cu-O1
2.0083(13)
1.992(3)
N3-Cu-O2
160.84(7)
160.00(12)
N3-Cu-O1
95.41(6)
94.65(12)
N1-Cu-N3
93.40(6)
93.95(13)
N3-Cu-O5
100.82(6)
101.05(12)
O2-Cu-O1
71.29(6)
71.73(11)

geometry (Figure 3.6 and Table 3.6). Complex 11 is folded over with the bend in the
molecule occurring through the C-S-S-C bond of the bridging molecule. The terminal
MMIDS ligands form a 7-membered ring with each Cu(I). The Cu(I) trigonal planar
geometry is distorted, with bond angles of 110.81(11)˚, 119.53(11)˚, and 129.64(12)˚. The
N-Cu-N angle closest to 120˚ (119.53(11) of the N4-Cu1-N1) is the ring-incorporated
angle, indicating that the distortion of the other two angles is due to the strain of the
bridging MMIDS. The C-S-S angle (101.25˚) of the terminal MMIDS ligands does not
change from unbound MMIDS (101.72(3)˚). However, the bridging MMIDS bond angle is
slightly broadened to 105.55(12)˚, indicating strain on the disulfide bond. The
intramolecular Cu-Cu distance is 3.521 Å in 11, and the intermolecular distance between
Cu(I) of adjacent molecules is 3.705 Å (Figure 3.8).
The S-S bond length for all three MMIDS ligands in 11 (2.0659(12)-2.0813(14) Å)
is slightly smaller than that of unbound MMIDS (2.1010(4) Å), but the C-S bonds do not
significantly change (1.7413(8) Å in unbound MMIDS (1) and 1.748(3) Å in 11). The C1N1 bond in the imidazole ring is 1.327(4) Å, compared to 1.470(4) Å for the N2-C4 bond
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Figure 3.6. Crystal structure diagram with 50% probability density ellipsoids for 11. Hydrogen atoms and
counterions are omitted for clarity. The side view of 11 is shown in B, showing the intramolecular stacking
and the disulfide ligand bridging the Cu(I) ions.

Table 3.6. Selected bond distances (Å) and angles (˚) for 11.
Bond Angle (˚)
Bond length (Å)
Cu1-N4
1.960(3)
N4-Cu1-N1
119.53(11)
Cu1-N1
2.021(3)
N4-Cu1-N5
129.64(12)
Cu1-N5
1.976(3)
N5-Cu1-N1
110.81(11)
S1-S2
2.0659(12)
C5-S2-S1
101.65(12)
C5-S2
1.748(3)
C1-S1-S2
101.25(11)
Cu-Cu
3.705
C9-S3-S4 (br)
105.55(12)
C1-N1
1.327(4)
C4-N2
1.470(4)
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to the methyl group. The shorter bond length is consistent with the aromaticity of the
imidazole ring and is consistent with the imidazole C-N of the unbound ligand (1.3295(11)
Å).
For all of the structures, little change is observed in the C-S bond length (1.75 Å), whether
the methimazole S is terminal, bridging, or in the monosulfide or disulfide ligands. This
bond length is significantly longer than the C=S bond in uncoordinated methimazole (1.686
Å54) or dimethylimidazole thione (1.698 Å55), and is shorter than the C-S single bonds of
thiols (1.86 Å). This suggests that the C-S bond is an extension of the electron
delocalization exhibited in the heterocycle. In addition, the bond length of the nonmethylated nitrogen of the imidazole ring and sulfur-bound carbon shortens upon
complexation compared to the protonated, unbound ligands. This shortening in bond length
suggests that electron density is shifted to the ring upon coordination for all complexes.
The thione exhibits a remarkable capacity to bridge copper ions, as seen in
complexes 1, 2, and 3. Even when MMIDS is formed in the reduction of Cu(II) (Scheme
3.2B and 3.2C), the resulting Cu(I) ion shows preference for coordination of the thione of
MMI over the imidazole nitrogen atoms in MMIDS. As seen in the Cu(I) polymers, the
imidazole moiety also increases stability to the three-dimensional structure through πstacking.

Revising the sulfur extrusion mechanism
Sulfur extrusion is observed for all reactions performed in air with the Cu(NO3)2
starting material (Scheme 3.3). MMIDS initially forms as Cu(II) is reduced by MMI
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(Scheme 3.1); however, in the reaction and/or crystallization process, a sulfur atom is
eliminated from the disulfide, and the resulting MMIMS coordinates Cu(II). Previous
groups have attributed oxidation of the disulfide bond to either water44 or dioxygen
exposure.31 Subsequent sulfur elimination is only observed in the presence of strong
oxidizers such as nitrate,56,57 or in the presence of electron-rich transition metals, such as
copper.31,33-36,58,59 The most detailed mechanism for sulfur extrusion from MMIDS to form
MMIMS is proposed by Lobana and coworkers,31 but this mechanism fails to 1) incorporate
the critical role of copper coordination, 2) does not address stoichiometry in the oxidation
of the sulfur, and 3) does not address the role of the solvent in formation of the methyl
sulfate counterion.
A revised mechanism for this sulfur extrusion reaction is proposed in Scheme 3.5.
As in the mechanism proposed by Lobana and coworkers,31 oxidation of MMI to MMIDS
is facilitated by Cu(II) reduction to Cu(I). Cu(I) coordinates MMIDS, similar to the
coordination we observe in complex 11. In the presence of oxygen, one of the MMIDS
sulfur atoms is then oxidized to the sulfone, with concomitant oxidation of Cu(I) to Cu(II).
Nucleophilic attack by water or methanol on the sulfone sulfur then initiates cleavage of
the S-S bond to form an imidazole thiolate. Cu(II) coordination is likely vital to keep the
nucleophilic imidazole thiolate in proximity to the now-separated, second imidazole ring.
Nucleophilic attack by the imidazole thiolate on the C=S carbon of the second imidazole
ring eliminates the extruded sulfur as sulfite or methylsulfite. Sulfite oxidation to sulfate
catalyzed by transition metals, including copper, is well known,60,61 and in this case,
possible formation of superoxide from the oxidation of Cu(I) to Cu(II) by oxygen may also
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contribute to sulfite oxidation.61 Incorporation of water or methanol to generate sulfate or
methylsulfate ions from the extruded sulfur is consistent with the sulfate and methylsulfate
ions present in complexes 6-10.

Overall, this nucleophilic aromatic substitution

mechanism is similar to that observed for thiolate deprotection of nitrobenzenesulfonyl.
Oxidation of disulfide bonds has been extensively studied under a variety of
conditions,62-66 and Cu(II) can oxidatively cleave disulfide bonds to form sulfinates.43,44
Oxygen from air participates in the oxidation of the disulfide bond, but Cu(II) is shown to
be crucial to disulfide oxidation, as opposed to other transition metals, such as Zn2+.37 Only
aromatic, heterocyclic thiones have demonstrated the ability to eliminate one of the
disulfide sulfur atoms by oxidation,31,33-36,59 giving support to the proposed nucleophilic
aromatic substitution mechanism as well as the importance of copper coordination to keep
the nucleophilic thiolate in proximity to the site of nucleophilic attack.
3.3 Conclusions
Control of Cu(I) and Cu(II) reactions with methimazole was explored utilizing a
variety of counterions, solvents, and the presence or absence of oxygen. In the absence of
oxygen, Cu(I) reacts with MMI to form multinuclear complexes stabilized by bridging
thiones and π-stacking, indicating an environment rich in electrons. In the presence of
oxygen with tetrafluoroborate counterion, the dinuclear [Cu2(MMI)6][BF4]2 complex is the
favored product with both Cu(I) and Cu(II) starting materials. In the presence of oxygen
and nitrate, sulfur extrusion by oxidation of the MMIDS ligand results in the formation of a
variety of Cu(II)-MMIMS complexes, with variation introduced by the solvent system and
molar ratios of ligand available. To form MMIMS, sulfur oxidation and elimination of
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Scheme 3.5. New proposed mechanism for formation of MMIDS by Cu(II) reduction, formation of the sulfone by
reaction with dioxygen, and eventual sulfur extrusion via nucleophilic aromatic substitution.
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sulfite or methylsulfite likely occurs to generate sulfate and methylsulfate ions,
catalytically oxidized by the available copper. Cu(II) coordination likely imposes entropic
control to align the resulting thiolate for nucleophilic aromatic substitution.
MMIDS is a bridging ligand in the dinuclear Cu(I) complex [Cu2(MMIDS)3][BF4],
but poor reaction yields and high recovery of the starting material suggest that this is not a
particularly stable complex. Based on the reaction conditions and complexes obtained,
Cu(I) coordination favors the thione of MMI, whereas Cu(II) favors bidentate coordination
of the MMIMS to form five-membered, almost planar, rings in the equatorial position.
The complexity of redox reactions between methimazole, copper, and other
oxidative sources such as solvents and oxygen indicates a wide range of potential
interactions within the cellular system. The propensity to coordinate copper ions in both
the oxidized and reduced state, along with the sensitivity to oxidative species, has potential
implications for biological MMI reactivity and catalysis with redox systems incorporating
copper.

3.4 Experimental Methods
General Methods
1-Methylimidazole thione (methimazole, MMI), copper(II) nitrate heptahydrate,
and

copper(II)

tetrafluoroborate

were

purchased

commercially.

Tetrakis(acetonitrile)copper(I) tetrafluoroborate was prepared according to published
procedures.67 Reactions were performed air-free where indicated, utilizing standard
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Schlenk techniques under argon. IR spectra of the ligands and complexes were acquired in
the range 4000-450 cm-1 as Nujol mulls on KBr plates or as KBr pressed pellets, as
indicated, on a Magna 550 IR spectrometer. IR absorption abbreviations are vs, very
strong; s, strong; m, medium; w, weak; b, broad; sh, shoulder. 1H and

13

C{1H} NMR

spectra were obtained using Bruker-AVANCE 300 and 500 MHz NMR spectrometers.
Chemical shifts are reported in δ relative to tetramethylsilane (δ 0) and referenced to
solvent. MALDI mass spectrometry experiments were performed using a Bruker Microflex
MALDI-TOF

mass

spectrometer

with

trans-2-3-(4-tert-butylphenyl)-2-methyl-2-

propenyldiene (m/z 250.3) as the matrix. All peak envelopes matched calculated values.

Synthesis of bis(1-methylimidazol)-2-yl-disulfide, MMIDS (1)
Synthesis of 1 was performed by adapting the published synthesis of the t-butylmethimazole disulfide.40 I2 (1.62 g, 6.4 mmol) was added in portions to a solution of 1-

methylimidazole thione (MMI; 1.46 g, 12.8 mmol) and NEt3 (1.86 mL, 13.4 mmol) in
CH2Cl2 (100 mL). The resulting orange mixture was stirred for 30 min and H2O (100 mL)
was added. The resulting layers were separated, and the CH2Cl2 layer was washed with
H2O (2 × 50 mL), dried over Na2SO4 for an additional 45 min, and filtered. After filtration,
the solvent was removed in vacuo to give MMIDS as a yellow powder (671 mg, 46 %).
Crystals suitable for X-ray diffraction were grown from chloroform in diethyl ether. 1H
NMR (300 MHz, d6-DMSO): δ 3.43 (s, 6H, CH3), 7.09 (s, 1H, CH), 7.46 (s, 1H, CH).
13

C{1H} NMR (d6-DMSO ):δ 33.4 (CH3), 126.0 (CH), 130.3 (CH), 138.1 (C=S). IR (Nujol,
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cm-1): 3902 w, 2725 w, 1313 w, 1283 s, 1159 w, 1128 s,b, 919 s, 794 s, 724 s, 683 s, 500
s.

Synthesis of [Cu2(MMI)4(μ-MMI)2](BF4)2 (2)
Method 1. Under air-free conditions, a solution of (MMI; 137 mg, 1.20 mmol) in
acetonitrile (10 mL) was transferred by cannula to a solution of Cu(BF4)2·6H2O (104 mg,
0.30 mmol) in acetonitrile (5 mL). As MMI was added a light green precipitate formed that
turned yellow-white upon filtration and drying under vacuum. The precipitate was washed
with diethyl ether (10 mL). Crystals of 2 were obtained by ether diffusion into an
acetonitrile solution. Yield: 566 mg, 57 %. IR (Nujol mull, cm-1): 3161 w, 3116 w, 2727 s,
1577 vs, 1517 w, 1462 vs, 1401 vs, 1350 s, 1289 s, 1279 s, 1267 s, 1246 w, 1160 s, 1108
b, 1063 b, 992 b, 918 w, 850 w, 763 s, 728 vs, 695 w, 673 s, 599 w, 515 s. 1H NMR (500
MHz, CD3CN): δ 3.54 (s, 18H, CH3), 6.83 and 6.90, (each, d, 6H, C-H), 10.32 (br s, 5.5 H,
N-H). 13C{1H} NMR (CD3CN): 34.1 (CH3), 115.1 (CH), 120.9 (CH), 156.5 (C=S). Anal.
Calc. for C24H36B2Cu2F8N12S6: C, 29.24; H, 3.68; N, 17.05. Found: C, 29.03; H, 3.66; N,
16.86.
Method 2. Complex 2 was also synthesized using the procedure outlined in method
1, except that [Cu(CH3CN)4]BF4 (94 mg, 0.30 mmol) was used in place of Cu(BF4)2·6H2O.
Yield: 566 mg, 57 %.
Method 3. A solution of MMI (137 mg, 1.20 mmol) in acetonitrile (10 mL) was
transferred via cannula into a solution of [Cu(CH3CN)4]BF4 (94 mg, 0.30 mmol) in
acetonitrile (10 mL) under argon. The solvent volume was reduced by half in vacuo, and
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then diethyl ether was added to precipitate out the product. The resulting white precipitate
was filtered, washed with diethyl ether, and dried in vacuo. This reaction was also
performed in air, affording the same product with a similar yield. Yield: 663 mg, 67%.

Synthesis of {[Cu(μ-MMI)(MMI)](NO3)}n (3)
Under argon, a solution of MMI (137 mg, 1.20 mmol) in acetonitrile (10 mL) was
transferred via cannula into a solution of Cu(NO3)2∙3H2O (73 mg, 0.30 mmol) in
acetonitrile (5 mL). The solution was stirred for 3 hours and an oil formed upon solvent
removal in vacuo. Methanol (5 mL) was added to dissolve the oil, and diethyl ether was
diffused into the solution to afford needle-like, colorless crystals. Yield: 39 mg, 10.%. 1H
NMR (500 MHz, CD3CN): 3.66 (s, 6 H, CH3), 7.06 (s, 2H, CH), 7.13 (s, 2H, CH). 13C{1H}
NMR (CD3CN): 34.3 (CH3), 120.2 (CH), 122.6 (CH), 150.6 (C=S).

Synthesis of {[Cu2(μ-HMI)3](NO3)2}n (4)
Under argon, a solution of HMI (120 mg, 1.20 mmol) in methanol (10 mL) was
transferred via cannula into a solution of Cu(NO3)2∙3H2O (73 mg, 0.30 mmol) in methanol
(10 mL). After stirring for 3 h, the blue solution became colorless, and a white precipitate
formed. The precipitate was filtered, washed with diethyl ether (10 mL), and dried in
vacuo. X-ray quality crystals were obtained by diffusion of diethyl ether into a methanolic
solution of 4. Yield: 118 mg, 21%. MALDI-MS (m/z): [Cu(C3H4N2S)2]+ 262.3,
[Cu(C3H4N2S)]+ 163.9. 1H NMR (500 MHz, CD3CN): 6.85 (s, 6H, CH), 11.98 (br s, 6H,
NH). IR (Nujol mull, cm-1): 3095 b,s, 2974 b,s, 2862 b,s, 2683 b,s, 1595 s, 1583 vs, 1459
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s, 1319 vs, 1288 s, 1251 w, 1231 w, 1223 w, 1084 w, 1041 w, 912 s, 873 b, 761 s, 727 s,
680 s, 498 w. Anal. Calc. for C9H12Cu2N8O6S3: C, 19.60; H, 2.19; N, 20.32. Found: C,
19.93; H, 2.25; N, 19.33.

Synthesis of [Cu(η2-MMIMS)2(H2O)2](NO3)2 (5)
A solution of MMI (137 mg, 1.20 mmol) in acetonitrile (6 mL) was slowly added
to a solution of Cu(NO3)2∙3H2O (73 mg, 0.30 mmol) in acetonitrile (5 mL), and the reaction
mixture slowly turned light green. After stirring in air for 3 d, the solution became bright
blue. The reaction mixture was allowed to slowly evaporate over a week to form blue
crystals of 5. Lighter blue crystals were also isolated and identified as CuSO4·5H2O. The
product obtained was consistent with that reported by Lobana and coworkers. Yield of 5:
110 mg, 18%. Anal. Calc. for C9H12Cu2N8O6S3: C, 19.60; H, 2.19; N, 20.32. Found: C,
19.93; H, 2.25; N, 19.33.

Synthesis of [Cu(η2-MMIMS)2(H2O)2](CH3SO4)2 (6)
A solution of MMI (228 mg, 2.00 mmol) in acetonitrile (10 mL) was added to a
solution of Cu(NO3)2∙3H2O (120 mg, 0.50 mmol) in acetonitrile (10 mL). The colorless
reaction mixture became blue after 1 h stirring, and a white precipitate formed. The
precipitate was filtered and dried in vacuo. Methanol (5 mL) was added to dissolve the oil,
and deep blue crystals of 6 formed upon solvent evaporation in air. The product obtained
was consistent with the reported complex by Baldwin and coworkers. Yield: 369 mg, 52%.
IR (Nujol mull, cm-1): 3435 b, 3139 w, 2728 w, 1634 s, 1588 sh, 1532 w, 1487 sh, 1254 s,
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1218 s, 1062 w, 1032 w, 1007 w, 960 w, 760 b, 710 sh, 655 w, 619 s, 576 w, 561 sh. Anal.
Calc. for C18H38CuN8O10S4: C, 30.10; H, 5.33; N, 15.60. Found: C, 29.32; H, 5.81; N,
15.53.

Synthesis of [Cu(η2-MMIMS)2(H2O)][CH3SO4][HSO4][H2O] (7)
A solution of MMI (137 mg, 1.20 mmol) in 10 mL of acetonitrile was slowly added
to a solution of Cu(NO3)2 ∙3H2O (73 mg, 0.30 mmol) in acetonitrile (10 mL), and the
reaction mixture initially turned a light green. Upon stirring for 7 d, the solution turned
blue, and the solvent was removed in vacuo to yield a dark-blue oil. Methanol (5 mL) was
added to dissolve the oil, and blue crystals of 7 formed upon evaporation in air. Yield: 334
mg, 48%. IR, (Nujol mull, cm-1): 3430 b, 3152 w, 3130 w, 2725 w, 2669 w, 1634 s, 1530
s, 1517 w, 1418 w, 1348 sh, 1307 w, 1286 w, 1234 s, 1147 b, 1059 s, 957 s, 867 sh, 849 s,
755 s, 708 w, 694 w, 687 w, 617 w, 581 s, 599 s, 521 w, 508 w, 460 w, 442 w. Anal. Calc.
for C17H28CuN8O10S4: C, 29.33; H, 4.05; N, 16.09. Found: C, 27.31; H, 3.82; N, 15.83.

Synthesis of [Cu(η2-MMIMS)2(H2O)](CH3SO4)2 (8)
A solution of MMI (137 mg, 1.20 mmol) in acetonitrile (6 mL) was slowly added
to a solution of Cu(NO3)2∙3H2O (73 mg, 0.30 mmol) in dichloromethane (2 mL). As the
MMI was added, a dark precipitate formed immediately and then redissolved with stirring,
and the reaction mixture then turned light green. After stirring in air for 3 d, the reaction
mixture turned bright blue, and a blue precipitate formed. The solution was filtered, and
the isolated blue precipitate was highly hygroscopic, so the precipitate was quickly
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dissolved in methanol (5 mL). Diethyl ether diffusion into the methanolic solution over the
period of a week yielded crystals of 8. Yield: 123 mg, 32%. MALDI-MS (m/z):
[Cu(C3H4N2S)2]+ 262.3, [Cu(C3H4N2S)]+ 163.9. IR (Nujol, cm-1) 3430 b, 2727 w, 1577 s,
1517 w, 1481 w, 1401 sh, 1246 s, 1160 w, 1108 w, 885 sh, 850 s, 768 s, 728 w, 516 w.

Synthesis of [Cu(η2-MMIMS)(SO4)(CH3OH)] (9)
A solution of MMI (137 mg, 1.20 mmol) in acetonitrile (6 mL) was slowly added
to a solution of Cu(NO3)2∙3H2O (146 mg, 0.60 mmol) in acetonitrile (5 mL). As MMI was
added, the reaction mixture slowly turned light green. After stirring in air for 3 d, the
solution turned a light blue, and the solvent was removed in vacuo. Methanol (5 mL) was
added to dissolve the resulting oil, and crystals were obtained by slow evaporation of the
methanolic solution in air. Yield: 90 mg, 13%.

Synthesis of [Cu(η2-MMIMS)(SO4)(DMSO)]∙ 0.5 DMSO (10)
A solution of MMI (137 mg, 1.20 mmol) in acetonitrile (6 mL) was slowly added
to a solution of Cu(NO3)2∙3H2O (73 mg, 0.30 mmol) in acetonitrile (5 mL). As MMI was
added, the reaction mixture slowly turned light green. After stirring in air for 3 d, the
solution turned a light green, and the solvent was removed in vacuo. Dimethylsulfoxide (5
mL) was added to dissolve the resulting oil, and crystals were obtained by tetrahydrofuran
diffusion into the DMSO mixture. Yield: 76 mg, 16%.
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Synthesis of [Cu2(η2-MMIDS)2(μ-MMIDS)](BF4)2 (11)
Under argon, a solution of bis(1-methylimidazol)-2-yl-disulfide (198 mg, 0.986
mmol) in methanol (6 mL) was slowly added to a solution of [Cu(CH3CN)4](BF4)2 (173
mg, 0.550 mmol) in dichloromethane (2 mL), and the resulting reaction mixture was
allowed to stir for 3 h. The solvent volume was then reduced to ~3 mL in vacuo, and
crystals of 11 were grown by ether diffusion. Yield: 223 mg, 22.3%.

X-ray crystallography
Single crystal X-ray diffraction measurements were performed at 100 K using Mo Kα
(λ = 0.71073 Å radiation on a Bruker D8 Venture diffractometer with an Incoatec
microfocus source and a Photon 100 CMOS detector. The Apex3 software suite was used
for data collection, processing, and scaling corrections.68,69 A summary of crystallographic
data for 1-4 is available in Table 3.7, data for 5-7 are in Table 3.8, and data for 8-11 are in
Table 3.9. Space group assignments were made based on systematic absences. Structures
were solved by intrinsic phasing (SHELXT), and refined to convergence by full-matrix
least squares using the SHELXTL software suite.70 All non-hydrogen atoms were refined
anisotropically. Hydrogen atoms attached to carbon atoms were placed geometrically and
treated using appropriate riding models. Positions of hydrogen atoms attached to nitrogen
and oxygen atoms were first verified using the difference electron density maps, and then
placed in geometrically optimized positions using riding models. The final positions of
these hydrogen atoms did not differ significantly from where their position was first
indicated on the difference electron density map.
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Several structures in the present study required somewhat special treatment during the
refinement process. In the case of 3, the nitrate counterion and methanol solvent molecule
were found to be disordered in several different orientations. Thus, their electron density
was best modeled using the SQUEEZE algorithm in the PLATON software package.71 For
7, the methyl sulfate counterion was modeled in two disordered orientations. In 10, the
coordinated DMSO molecule was found to be disordered, with the sulfur and carbon atoms
modeled over split positions and the occupancy values for the two disordered orientations
refined as free variables.

3.5 Supplementary Information

Figure 3.7 Packing diagram along the b-axis for MMIDS (1). Yellow atoms: sulfur; blue atoms: nitrogen;
grey atoms: carbon; white atoms: hydrogen.
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Figure 3.8. Packing diagram for [Cu2(MMIDS)3][BF4]2. Yellow atoms: sulfur; dark blue atoms: nitrogen; grey
atoms: carbon; white atoms: hydrogen; light blue atoms: copper; green atoms: fluorine; and dark grey atoms:
boron.
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Table 3.7. Summary of crystallographic data for MMIDS (1) and Cu(I) complexes 2, 3, and 4.
1
2
3
Chemical formula
C8H10N4S2
C24H36B2Cu2F8N12S6 C9H16CuN5O4S2
F.W. (g mol-1)
226.32
985.71
385.93
Temperature, K
100(2)
100(2)
100(2)
Wavelength, Å
0.71073
0.71073
0.7103
Crystal system
Monoclinic
Monoclinic
Monoclinic
Space group
C2/c
P2/c
P2/c
a, Å
12.2875(8)
14.4704(17)
16.3614(8)
b, Å
7.3836(5)
15.7849(17)
13.9033(7)
c, Å
11.2422(7)
8.3677(10)
6.9472(3)
α, ˚
90
90
90
β, ˚
98.514 (2)
94.269(3)
98.539(2)
γ, ˚
90
90
90
V, Å3
1008.72(11)
1906.0(4)
1562.81(13)
Z
4
2
4
D, g cm-3
1.490
1.718
1.640
Absorption coefficient, mm-1 0.492
1.523
1.686
Crystal size, mm3
0.2040.2090.311 0.020.4010.416
0.1670.1740.566
F(000)
472
1000
792
2θ range, ˚
3.23 to 33.23
2.76 to 31.00
2.52 to 29.99
Collected reflections
13154
58706
45916
Unique reflections
1919
6050
4546
Final R (obs. Data)α, R1
0.0256
0.0216
0.0282
wR2
0.0696
0.0593
0.0696
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4
C9H12Cu2N8O6S3
551.53
100(2)
0.71073
Orthorhombic
Pnma
6.4334(4)
30.109(2)
9.1569(7)
90
90
90
1773.7(2)
4
2.065
2.801
0.0330.1780.335
1104
2.33 to 26.00
13711
1770
0.0395
0.1140

Table 3.8. Summary of crystallographic data for complexes 5, 6, and 7.
5
6
Chemical formula
C16H24CuN10O8S2
C38H30CuN8O10S4
F.W. (g mol-1)
612.11
710.28
Temperature, K
100(2)
140(2)
Wavelength, Å
0.71073
0.71073
Crystal system
Monoclinic
Monoclinic
Space group
P 2/n
P 2/n
a, Å
8.6291(9)
8.3452(4)
b, Å
13.5838(16)
8.4167(5)
c, Å
10.3684(11)
20.3354(12)
α, ˚
90
90
β, ˚
100.436(4)
99.568(2)
γ, ˚
90
90
V, Å3
1195.2(2)
1408.47(14)
Z
2
2
D, g cm-3
1.701
1.675
Absorption coefficient, mm-1 1.154
1.138
Crystal size, mm3
0.0560.0640.122
0.0440.1120.176
F(000)
630
734
2θ range, ˚
2.83 to 27.50
2.62 to 25.50
Collected reflections
26649
33742
Unique reflections
2734
2613
Final R (obs. Data)α, R1
0.0253
0.0346
wR2
0.0592
0.0825
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7
C17H28CuN8O10S4
696.25
140(2)
0.71073
Triclinic
P-1
8.6675(13)
12.442(2)
13.658(2)
70.800(5)
79.904(5)
78.593(5)
1353.8(4)
2
1.708
1.182
0.0870.1680.204
718
2.70 to 26.50
57400
5596
0.0289
0.0706
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Table 3.9 Summary of crystallographic data for complexes 8, 9, 10 and 11.
8
9
10
Chemical formula
C9H14CuN4O5S2
C18H28CuN8O9S4
C11H19CuN4O5.56S3.50
F.W. (g mol-1)
385.90
692.26
471.05
Temperature, K
100(2)
100(2)
100(2)
Wavelength, Å
0.71073
0.71073
0.71073
Crystal system
Triclinic
Triclinic
Monoclinic
Space group
P1
P1
P 2/c
a, Å
7.2792(7)
9.0467(8)
12.4725(4)
b, Å
9.7671(9)
12.2650(11)
9.4873(3)
c, Å
10.1282(9)
13.2201(2)
15.3776(5)
α, ˚
95.449(3)
72.176(3)
90
β, ˚
104.276(3)
81.140(3)
96.3480(10)
γ, ˚
96.167(3)
74.176(3)
90
V, Å3
688.27(11)
1341.492)
1808.48(10)
Z
2
2
4
D, g cm-3
1.862
1.714
1.730
Absorption coefficient, mm-1 1.917
1.645
1.645
Crystal size, mm3
0.0820.0860.088 0.0310.1330.461 0.0310.1330.461
F(000)
394
968
968
2θ range, ˚
2.09 to 30.57
2.67 to 25.25
2.67 to 25.25
Collected reflections
33902
22581
22581
Unique reflections
4212
3276
3276
Final R (obs. Data) R1
0.0266
0.0427
0.0427
wR2
0.0886
0.0850
0.0850
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11
C25H31.50B2Cu2F8N12.50S6
1000.19
100(2)
0.7103
Monoclinic
P 2/c
7.0458(4)
24.9693(16)
22.3144(15)
90
96.468(2)
90
3900.8(4)
4
1.703
1.490
0.0480.1120.387
2020
2.46 to 25.50
70149
7276
0.0418
0.0941
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CHAPTER FOUR
REACTIVITY OF NON-INNOCENT IMIDAZOLE DISULFIDE AND DISELENIDE
LIGANDS WITH COPPER

4.1 Introduction
Disulfide bonds play crucial roles in the structure, function, and catalytic activity
of many proteins,1,2 and metal complexes with ligands that incorporate disulfide bonds have
been used in polymers,3-8 switches,9,10 and photodetectors.11 Their high bond-dissociation
energies contribute stability, and their redox properties can be tuned by steric strain, the
nature of the local environment, and oxygen availability.12,13 In thioredoxin enzymes, thioldisulfide exchange reactions involve electron transfer from a higher-potential disulfide
bond to redox-ready thiols, enabling a domino-effect of electron transfer using sulfur-sulfur
bonds.9 Disregulation of disulfide bond formation is implicated in development of
Creutzfeldt-Jakob disease, amyotrophic lateral sclerosis (ALS), Parkinson’s disease, and
various cancers.14-19
Diselenide bonds are not as prevalent in biological systems or in biomimetic
materials, although the diselenide bond has been identified in proteins20,21 and non-native
diselenides have been used to drive oxidative folding of proteins.22 Selenocysteine is an
essential component in a number of redox enzymes, including glutathione peroxidase,
iodothyronine diodinases, and thioredoxin reductases,23 but the redox mechanism in these
enzymes does not involve diselenide bond formation. Lower reduction potentials and
broader reactivity limit the stability of diselenide bonds in biological systems,24,25 but

171

diselenides are promising antioxidants due to their ability to react with thiol groups in a
glutathione peroxidase-like manner.26
Metals such as copper and iron serve as electron sinks for catalyzing disulfide-tothiol reductions in metalloproteins.9,27 Recently, heterocyclic thiones have attracted
attention for the similarity of their redox properties to thiols, their ability to bond softer
metals such as Cu(I) and Fe(II),28-30 and their ability to form disulfide bonds.31 Under
anaerobic conditions, a wide variety of mono-,32,33 di-,32,34-36 tetra-,35 and polynuclear37,38
complexes have been reported as products of reactions between Cu(I) and methimazole
(MMI;

Figure

4.1).

With

the

exception

of

two

mononuclear

complexes

[Cu(MMI)3][NO3]32 and [Cu(MMI3)Cl],34 the products are typically multinuclear
complexes that include bridging MMI ligands. Reactions of Cu(I) and the oxidized form of
methimazole, methimazole disulfide (MMIDS; Figure 4.1), have not been explored in depth.
Only two metal complexes with coordinated MMIDS are reported, [Cu(MMIDS)3][BF4]39
and Zn(MMIDS)Cl2,40 although Figueroa and coworkers41 synthesized complexes of Zn2+,
Fe(II), Cu(I), Co2+, and Ni2+ with t-butyl (tBu-MMIDS) and Co2+ with phenyl (Ph-MMIDS)
substituents in place of the methyl group. Structures with Cu(II), Cd2+, Hg2+, and Zn2+
coordinated to the selenium-containing methimazole diselenide (MMIDSe; Figure 4.1) are
also reported.42,43
In reactions of MMI with Cu(II), MMI is typically oxidized to MMIDS and copper
is reduced to Cu(I).31 It is believed that a similar reaction of MMISe with Cu(II) results in
formation of MMIDSe, but upon treating Cu(ClO4)2 with MMISe in air, a selenium atom is
eliminated from MMIDSe and the monoselenide complex [Cu(MMIMSe)2(H2O)2][ClO4]2 is
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isolated.44 In these studies, reactions were performed with Cu(I) and MMIDS or MMIDSe
under air-free conditions to explore the possibility of reversible disulfide/thione and
diselenide/selone formation. A similar reaction of Cu(I) with MMIDSe was performed in
air, resulting in three separate products isolated from the same reaction mixture and
demonstrating the variable chemistry that can occur when combining a redox-active metal
with a non-innocent ligand. The work in this chapter was performed in collaboration with
Dr. Colin McMillen, Managing Director of the Molecular Structure Center at Clemson
University.

Figure 4.1. Sulfur- and selenium-containing imidazole ligands discussed in this work.
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4.2 Results and Discussion
Synthesis
Transition metal complexes with heterocyclic thiones have been extensively
examined, but few complexes of the disulfide forms of these heterocycles exist.40,41,45
Formation of MMIDS in Zn(MMIDS)Cl2 was generated by air oxidation of MMI. Figueroa
and coworkers demonstrated that electron-rich Ni0 reduces the structurally-similar, tBuMMIDS (Figure 4.1) to the corresponding thione.41 Cu(II) oxidizes MMI to MMIDS with
concomitant reduction to Cu(I),31 but the reversibility of this redox reaction has never been
examined.
To investigate the reaction between Cu(I) and MMIDS, [Cu(CH3CN)4][BF4] and
MMIDS were combined under air-free conditions (Scheme 4.1). As MMIDS was added to
the Cu(I) solution, the reaction mixture initially turned blue, indicating Cu(II) formation.
Upon stirring for 1 hour, the reaction solution returned to a light yellow color, suggesting
Cu(II) reduction to Cu(I).Red-orange crystals of the [Cu2(MMI)2(MMIDS)2][BF4]2 (1)
product were collected, but yield of 1 was extremely low and attempts to re-isolate this
compound yielded crystals of the [Cu(CH3CN)4][BF4] starting material and a dark yellow
oil.

Scheme 4.1. Treating Cu(I) with MMIDS under air-free conditions affords the dimeric complex
[Cu2(MMI)2(MMIDS)2][BF4]2 (1).
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The analogous air-free treatment of [Cu(CH3CN)4][BF4] with MMIDSe was
performed under similar conditions (Scheme 4.2). Again, the reaction mixture turned blue
upon MMIDSe addition, but slowly became light red. Orange-red crystals of
[Cu2(MMI)2(MMIDS)2][BF4]2 (2) were obtained, but yield of 2 was also low, and efforts to
re-isolate this product were unsuccessful. In both complexes 1 and 2, the MMI or MMISe
ligands are protonated, as confirmed in the crystal structure (vide infra), but the origin of
these protons is not clear. The reduction of an imidazole disulfide to the monosulfide has
been observed in a reaction with tBu-MMIDS and Ni0, as described by Figueroa and
coworkers, however, the Ni0 bonded directly with the imidazole nitrogen, not the thione.
In this case, a Cu(I)-thione bond is observed, and the imidazole nitrogen is protonated. The
low yield and irreproducibility may be due to a limited proton source, such as adventitious
water present in the reaction. There is no obvious source of protons to contribute to the
protonation of the imidazole, but the most obvious source may be water contamination in
the solvent.
The formation of MMIDS or MMIDSe with Cu(I) from the reaction of MMI and
SeMMI with Cu(II), respectively, has been previously discussed in Chapter 3:Coordination
Complexes of Methimazole with Copper: Controlling Redox Reactions and Sulfur
Extrustion. The reactions that form complexes 1 and 2 involve cleavage of the
disulfide/diselenide bond to yield copper-coordinated MMI or MMISe. Formation of the
disulfide-containing MMIDS in the presence of copper also has been reported,
demonstrating the potential reversibility of thione/disulfide and selone/diselenide
formation in the presence of copper. Such reactivity is a result of the redox activity of
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copper in combination with the non-innocent character of the thione/selone ligands. Cu(I)
can donate electrons to cleave S-S or Se-Se bonds in MMIDS or MMIDSe, and Cu(II) can
accept electrons to oxidize MMI or MMISe to the corresponding disulfide/diselenide. While
the solid-state structure suggests that the bridging disulfide ligand (MMIDS) in [Cu2(N,Nμ-MMIDS)(MMIDS)2][BF4]2 is strained, it is likely that disulfide cleavage is due to electron
transfer of the Cu(I), with the metal ion playing a role by ligand association. The same
reversibility was observed in the Cu(I)-MMIDSe reaction, once again resulting in a mixed
ligand, dinuclear complex.

Scheme 4.2. Copper coordination complexes formed by treating Cu(I) with MMIDSe.
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Upon treatment of Cu(NO3)2 with MMI in air, the resulting Cu(II)-containing
products are coordinated to methimazole monosulfide (MMIMS) ligands that form by sulfur
elimination from MMIDS.31,46-50 The only comparable reaction of MMIDSe and Cu(ClO4)2
in air similarly yields [Cu(MMIMSe)2(H2O)2][ClO4]2 with a monoselenide ligand.44
Treating Cu(BF4)2 with MMI does not lead to sulfur elimination products, since it contains
the non-oxidizing BF4- ion,39so using Cu(BF4)2 in place of Cu(NO3)2 as a starting material
is useful for examining the coordination chemistry of MMIDS and MMIDSe without
chalcogen extrusion.
To determine whether selenium elimination from MMIDSe occurs when starting
with Cu(I) rather than Cu(II), [Cu(CH3CN)4][BF4] was treated with MMIDSe in air (Scheme
4.2). Initial formation of a blue solution upon MMIDSe addition indicates Cu(I) oxidation
to Cu(II), but upon stirring for 1 h in air, the reaction mixture became the same orange-red
color as described for the synthesis of 2. Upon stirring for 24 h in air, the reaction mixture
slowly turned green, and four different types of crystals were obtained from slow
evaporation of the dichloromethane/acetonitrile solution: colorless crystals of the
[Cu(NCCH3)4][BF4]

starting

material,

purple

crystals

of

[Cu(MMIMSe)(MMITSe)(CH3CN)][BF4]2 (3), green crystals incorporating two mononuclear
cations in one asymmetric unit, [Cu(MMIDSe)2][Cu(MMISe-CH2-MMISe)2][BF4]4 (4a and
4b, respectively), and yellow-green columns of [Cu(MMISe-CH2-MMISe)2][BF4]2.
The mixed ligand Cu(II) complex [Cu(MMIMSe)(MMITSe)(CH3CN)][BF4]2 (3)
forms by oxidation of Cu(I) to Cu(II) in air, with concomitant selenium elimination from
one copper-coordinated MMIDSe ligand and selenium addition to a second coordinated
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MMIDSe ligand. It is the first complex where Cu(II) coordinates both a monoselenide
(MMIMSe) and a triselenide (MMITSe) ligand. Roy and coworkers44 observed selenide
elimination from MMIDSe in the formation of [Cu(MMIMSe)2(H2O)2][ClO4]2, but the
eliminated selenium was recovered as a CuSeO3 salt.
A small number of green crystals were also isolated from the Cu-MMIDSe reaction
mixture. This product crystallizes with two different, mononuclear, Cu(II) cationic
structures per unit cell, [Cu(MMIDSe)2]2+ (4a) and [Cu(MMISe-CH2-MMISe)2] (4b; Scheme
4.2). In the MMISe-CH2-MMISe ligands of 4b, a -CH2 group bridges between selenium
atoms of the original MMIDSe ligand. It is postulated that this ligand forms upon two
consecutive substitution reactions of MMISe with the dichloromethane solvent. The yellowgreen columns were identified as [Cu(MMISe-CH2-MMISe)2][BF4]2, with the same cationic
structure as 4b. The identity of the columns was confirmed, but the diffraction quality was
poor, and the chemical aspects have already been discussed with 4b.

Structural Analyses
Although yields were limited, the identity of products 1-4 are confirmed by X-ray
crystallographic analysis. [Cu2(MMIDS)2(MMI)2][BF4]2 (1) crystallizes in the C2/c space
group. This mixed-ligand, dinuclear Cu(I) complex incorporates two sulfur-bridged
methimazole ligands to create a rhombic Cu2S2 core (Figure 4.2, with selected bond lengths
and angles in Table 4.1), similar to the homoleptic [Cu2(μ-MMI)2(MMI)4][BF4]2 complex
reported by Raper and coworkers.35 The terminal, bidentate MMIDS ligands bind Cu(I)
through the imidazole nitrogen atoms, creating a 7-membered chelate ring. The bridging
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MMI ligand is protonated, as determined by 1) electron density near the nitrogen, 2) the
long range H-F interactions between the hydrogen and the fluoride of the tetrafluoroborate,
seen in the crystal packing structure (Figure 4.2A), and 3) the lengthened C1-N1 bond
distance (1.349(3) Å) in the imidazole ring, compared to the C=N double bond seen in the
MMIDS ligand (1.328(3) Å39).
In 1, each Cu(I) ion is coordinated by two N and two S atoms in a distorted
tetrahedral geometry, with angles ranging from 101.5˚ to 117.2˚. Cu-N bond lengths are a
consistent 2.013(2)-2.014(2) Å, but the Cu-S bond lengths are inequivalent at 2.3511(6) Å
and 2.4461(6) Å. No significant change is observed in the C-S bond lengths for the MMIDS
ligand (1.746(2) Å and 1.750(2) Å) compared to unbound MMIDS (1.7413(8) Å39) however,
the bridging MMI ligand had a shorter C-S distance of 1.715(2) Å, consistent with the shift
of electron density into the imidazole ring. Ring strain is reflected in the stretch of the N3C5-S2 (126.23(18)˚) and N5-C9-S3 (126.09(18)˚) bond angles compared to 123.81(6)˚
observed in uncoordinated MMIDS.
The disulfide S1-S2 bond length in 1 is 2.0676(10) Å, consistent with the terminal
MMIDS

ligands

(2.0659(12)

Å

and

2.06673(13)

Å)

in

[Cu2(N,N-μ-

MMIDS)(MMIDS)2][BF4]2 but slightly shorter than the bridging MMIDS (2.0813(14) Å) of
the same molecule. The S-S bond length in 1 (2.0676(10) Å) is also slightly shorter than in
unbound MMIDS (2.1010(4) Å39), but is consistent with S-S bond lengths in disulfide the
same molecule. The S-S bond length in 1 (2.0676(10) Å) is also slightly shorter than in
unbound MMIDS (2.1010(4) Å39), but is consistent with S-S bond lengths in disulfide
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Figure 4.2. Crystal structure diagrams of
A) [Cu2(MMIDS)2(MMI)2][BF4]2 (1) and B)
DSe
Se
[Cu2(MMI )2(MMI )2][BF4]2 (2) with 50% probability density ellipsoids. Hydrogen atoms and counterions
are omitted for clarity.

Table 4.1. Selected bond distances (Å) and angles (˚) for 1 and 2.
1
2
Cu1-N3
2.013(2)
Cu1-N1
2.0264(16)
C5-S2
1.746(2)
C1-Se1
1.8971(18)
S2-S3
2.068(1)
Se1-Se2
2.3361(3)
Cu1-S1
2.3511(6)
Cu1-Se3
2.4680(3)
S1-C1
1.715(2)
Se3-C9
1.862(2)
C1-N2
1.349(3)
C9-N5
C5-N3
1.328(3)
C1-N1
Cu-Cu
3.0368(6)
Cu-Cu
N3-Cu1-N5
117.23(8)
N1-Cu1-N3
118.83(6)
C5-S2-S3
103.49(8)
C1-Se1-Se2
101.26(6)
S2-S3-C9
102.92(9)
Se1-Se2-C5
97.18(6)
S1-Cu1-S1
101.48(2)
Se3-Cu1-Se3
91.946(11)
Cu1-S1-Cu1
78.52(2)
Cu1-Se3-Cu
88.055(11)

180

complexes of other transition metals (Fe(II), Co2+, Ni2+, Zn2+).41 In a survey of structural
data for disulfide bonds in extracellular globular proteins, the average S-S bond distance
was found to be 2.02 Å,2 significantly shorter than the disulfide bonds in coordinated
imidazole disulfides. C-S-S bond angles of the terminal MMIDS ligands of [Cu(N,N-μMMIDS)(MMIDS)2[BF4]2 do not change from those of unbound MMIDS (101.72(3)˚39), but
there is a significant widening in the bridging MMIDS C-S-S angles ( 105.55(12)˚105.65(12˚). Complex 1 falls in the middle, with an average C-S-S bond angle of 103.2˚.
Torsion angles (χ) for 1 are 92.33˚, 99.22˚ and 98.23˚ for the terminal MMIDS ligands in
[Cu(N,N-μ-MMIDS)(MMIDS)2[BF4]2 and 86.36˚ for the bridging disulfide. In a study by
Craig and coworkers,51 ranges of 87˚ to 97˚ were measured for torsion angles of structural
disulfides in a survey of proteins, and deviations from these angles can result in energy
strain of several kcal/mol.52,53

Figure 4.3. Packing diagrams for 1 showing A) the F-H interactions between the BF4- anions and the protons
on the terminal MMIDS and B) the layering of the BF4- ions along the b-axis. Color scheme: dark blue –
nitrogen; yellow – sulfur; light blue – copper; grey – carbon; white – hydrogen; green – fluorine; and brown
– boron.
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[Cu2(MMIDSe)2(MMISe)2][BF4]2 (2) is the first reported Cu(I)-MMIDSe complex.
Similar to 1, it also features a dinuclear Cu(I) core, with two MMISe ligands bridging
through the Se atom (Figure 4.2, with selected bond lengths and angles in Table 4.1) and a
rhombic Cu2Se2 core. The distorted tetrahedral geometry with a τ4 of 0.921 around each
Cu(I) atom is nearly identical tothat found in 1. However, 2 crystalizes in space group P2/n
as a result of the expansion of the cation structure due to the increased length of the Cu-Se,
C-Se, and Se-Se bonds compared to 1. Increased bond length is also observed in a longer
Cu-Cu distance (3.492(4)) for 2 compared to 1 (3.0368(6)). Once again, the imidazole
nitrogen of the selone is protonated, as indicated by the electron density around the
imidazole nitrogen atom; the longer bond length of C12-N6 (1.460(3) Å) of the imidazole
selone ring compared to the C1-N1 (1.329(2) Å) of the imidazole ring of the disulfide; and
the H-F hydrogen bonding interactions with the BF4- counterion.
Structurally, MMIDSe does not change to a large extent upon Cu(I) coordination.
Strain on the diselenide bond is only detected through the slight opening of the N1-C1-Se1
angle (127.85(14)˚) compared to unbound MMIDSe (122.8(3)˚).54 Similar to the Cu(II)
complex [TpmiPrCu(MMIDSe)][OTf]2,43 the Se-Se bond is slightly shorter in 2 (2.3361(3)
Å) compared to unbound MMIDSe (2.3568(15).54 The C-Se bond length of the bridging
MMISe ligands are slightly shorter (1.862(2) Å) than the C-Se bond length of the MMIDSe
ligands (1.8971(18) and 1.8859(19) Å), consistent with greater double-bond character in
the bridging MMISe ligand.
From the packing structures of 1 and 2 (Figures 3B and 4), the similarity between
the cations can be seen. However, the crystal packing is slightly different for these two
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complexes, since they crystalize in different in the space groups, C2/c (1) and P2/n (2).
Although the bond angles and metal coordination geometry are similar for both structures,
the packing effects of the longer Se-Se, Se-C, and Cu-Se bonds, as compared to the sulfur
analogs, results in changes to the alignment of the BF4- counterion that changes the
symmetry of crystal packing.
In the structure of [Cu(MMIMSe)(MMITSe)(CH3CN)][BF4]2 (3; Figure 4.5, with
selected bond lengths and angles in Table 4.2), the MMIMSe and MMITSe ligands both
coordinate the Cu(II) center in a bidentate fashion through the imidazole nitrogen atoms.
Cu(II) adopts near perfect square pyramidal geometry (τ5 = 0.069), with an acetonitrile
molecule in the axial position. The MMIMSe ligand forms a 6-membered chelate ring with
a N3-Cu1-N1 internal angle of 90.81(16)˚. The MMITSe ligand forms an 8-membered
chelate ring with a similar N7-Cu1-N5 internal angle of 90.03(17)˚. Cu(II) coordination

Figure 4.4. Packing diagram for 2 viewed along the b-axis. Color scheme: dark blue – nitrogen; orange –
selenium; light blue – copper; grey – carbon; white – hydrogen; green – fluorine; and brown – boron.
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Figure 4.5. Crystal structure diagram of [Cu(MMIMSe)(MMITSe)(CH3CN)][BF4]2 (3) with 50% probability
density ellipsoids. Hydrogen atoms and counter ions are omitted for clarity.

Table 4.2. Selected bond distances (Å) and angles (˚) for 3.
Bond Length (Å)
Bond Angle (˚)
Se4-Se3
2.3319(8)
C13-Se4-Se3
99.01(14)
Se3-Se2
2.3323(9)
Se4-Se3-Se2
103.46(3)
C13-Se4
1.902(5)
Se3-Se2-C9
99.61(15)
C9-Se2
1.908(5)
N7-Cu1-N3
90.03(17)
Cu1-N7
2.011(4)
N7-Cu1-N5
90.02(16)
Cu1-N5
2.007(4)
N3-Cu1-N1
90.81(16)
Cu1-N3
1.989(4)
N5-Cu1-N1
88.04(16)
Cu1-N1
1.998(4)
N7-Cu1-N9
92.80(16)
C5-Se1
1.893(5)
N1-Cu1-N9
93.27(16)
C1-Se1
1.895(5)
N3-Cu1-N9
96.56(16)
Cu1-N9
2.285(4)
N5-Cu1-N9
93.82(19)
C5-Se1-C1
93.41(19)

in 3 shows a surprising rigidity, maintaining the 90˚ angle expected for equatorial ligands
and resulting in observed ring buckling to incorporate the triselenide.
Although unbound MMIMSe is not reported, Roy and coworkers44 performed DFT
calculations to predict the structure of this compound. C-Se bond lengths in the MMIMSe
ligands of 3 range from 1.893(5) to 1.908(5) Å, consistent with the DFT-calculated C-Se
distance of 1.908 Å for unbound MMIMSe and the C-Se distance of 1.897 Å for coppercoordinated MMIMSe in [Cu(MMIMSe)2(H2O)2][ClO4]2.44 The MMIMSe ligands in 3 have
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longer C-Se bond lengths than the bridging MMISe ligands in 2 (1.862(5) Å), consistent
with the greater double-bond character of the MMISe ligand. The C5-Se-C1 bond angle of
93.41(19)˚ in 3 is smaller than the DFT-calculated value of 97.1˚ for the C-Se-C angle in
unbound MMIMSe.
The MMITSe ligand features a triselenide moiety generated in situ. The chelate ring
is buckled (Figure 4.2) to accommodate the additional Se atom in a ring with little
flexibility afforded by the N-C bonds of the imidazole rings. The copper-coordinated
MMITSe ligand in 3 is structurally similar to that in Ru(MMITSe)(PPh3)Cl2,55 although the
triselenide buckle is inverted in the ruthenium complex, and a direct ruthenium-selenium
bond to the central selenium creates two five-membered rings. Significant lengthening of
the Se-Se bonds (2.4311(11) and 2.4161(11) Å) is observed in the ruthenium complex
compared to Se-Se bond lengths of 2.3323(9) and 2.33191(8) Å in 3.
The crystal packing diagram of 3 (Figure 4.6) clearly shows the nearly 90˚ dihedral
angle observed for the triselenide along the C-Se-Se-Se angles. The orientation of the
monoselenide and triselenide away from the coordination plane of the Cu(II), indicates
relative proximity of the selenium atoms to the other diselenide. This spatial orientation is
supportive of selenium migration from one ligand to the other. The BF4- counterions
provide structural support for the bulky cation, with minimal interactions with the
imidazole-carbon protons.
The co-crystallized product [Cu(MMIDSe)2][Cu(MMISe-CH2-MMISe)2][BF4]4 (4)
formed in the same reaction as 3. The unit cell contains three unique cations,
[Cu(MMIDSe)2]2+ (4a) and two structural forms of [Cu(MMISe-CH2-MMISe)2]2+ that are
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Figure 4.6. Packing diagram for 3 along the a-axis. Color scheme: dark blue – nitrogen; orange – selenium;
light blue – copper; grey – carbon; white – hydrogen; green – fluorine; and brown – boron.

Figure 4.7. Crystal structure diagram of co-crystallized 4a and 4b with 50% probability density ellipsoids.
Hydrogen atoms and counter ions are omitted for clarity.

very similar, such that the cation containing the Cu2 atom will be used for discussion
purposes (4b; Figure 4.7 and Table 4.3). The packing diagram can be seen in Figure 4.8.
Variable coordination geometries and oxidation states are notable features of copper. A
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four-coordinate Cu(II) cation would typically be expected to be nearly square planar,56 but
4a exhibits significant shifts toward see-saw geometry with bond angles of 96.7(4)˚ –
99.7(4)˚ for the pseudo-equatorial bonds and a significant in-plane distortion of 137˚,
resulting in a τ4 value of 0.609. The bidentate MMIDSe ligands are identical and coordinate
the central Cu(II) through the imidazole nitrogen atoms. MMIDSe coordination forms a 7membered chelate ring with a 92˚ torsion angle, contributing to distortion of the Cu(II)
equatorial plane.
In 4b, the [Cu(MMISe-CH2-MMISe)2] complex contains two unusual CH2-bridged
MMIDSe ligands. These ligands coordinate the Cu(II) center, affording distorted squareplanar geometry with bond angles of 94.5˚-98.9˚ and a planar distortion of 141.8(4)˚,
similar to 4a (τ4 = 0.553). The Se-C-Se bond angles of 115.8(11) and 117.4(7)˚ in the
MMISe-CH2-MMISe ligand are significantly broader than the Se-Se-Se bond angle of
103.46(5)˚ in 3.
The packing diagram of 4 (Figure 4.8) illustrates the complexity of the crystal
structure and reaction products. Two unique molecules with the ligands containing the SeC-Se bridge are located on the center of symmetry, so only half of each molecule is unique.
The cations then alternate in sheets, with the tetrafluoroborate counterions and water
molecules layering between the sheets. The hydrogen-bond interaction between the water
and tetrafluoroborate ions can be seen in the packing diagram. The formation of multiple
of Cu-selone complexes obtained from this two-reactant reaction emphasizes the varied
and interesting nature of selone chemistry.

187

Figure 4.8 Packing diagram for 4 along the b-axis. Color scheme: dark blue – nitrogen; orange – selenium;
light blue – copper; grey – carbon; white – hydrogen; green – fluorine; red – oxygen, and brown – boron.

4.3 Conclusions
Control of formation and cleavage of disulfide and diselenide bonds with electronrich metals such as Cu(I) and Ni0 has significant implications for catalysis and protein
engineering. In this work, copper-mediated cleavage of the disulfide or diselenide bonds
in MMIDS or MMIDSe was observed. This is essentially the reverse of the reaction that
yields Cu(I) and MMIDS from Cu(II) and MMI starting materials under airfree conditions.
Comparable reactions with methimazole diselenide exhibit a greater diversity of ligandrearranged products. In one reaction, products containing monoselenide diselenide,
triselenide, and carbon-bridged selenide ligands coordinated to Cu(II) were obtained
simultaneously. While true thione/disulfide and selone/diselenide reversibility may be
obtainable, both these reactions and control over sulfur or selenium elimination and
insertion reactions need further investigation. The role of copper in initiating the disulfide
bond formation and/or cleavage with the thione and selone imidazole ligands highlights
the potential for interaction of these non-innocent ligands within biological systems.
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4.4 Experimental Methods
General Methods
All reactions were performed under an argon atmosphere of Ar using standard airfree procedures. Acetonitrile and dichloromethane were purified using standard procedures
and were freshly distilled under an argon atmosphere prior to use. [Cu(CH3CN)4][BF4],57
bis(1-methylimidazolyl)disulfide

(MMIDS),41

and

bis(1-methylimidazolyl)diselenide

(MMIDSe)54 were synthesized according to published procedures.

Synthesis of [Cu2(MMIDS)2(MMI)2][BF4] 2 (1)
A solution of MMIDS (0.90 mmol, 133 mg) in acetonitrile (10 mL) was added via
cannula to a solution of [Cu(CH3CN)4][BF4] (0.60 mmol, 189 mg) in acetonitrile (10 mL)
under argon. Upon addition of the yellow MMIDS solution, the reaction mixture
immediately turned a green-blue color that slowly changed back to light yellow over the
course of 1 h. The reaction mixture was stirred for an additional 3 h and diethyl ether (30
mL) was added. Orange-red crystals of 1 formed overnight and were filtered and dried.
Yield: 20 mg, 6.8%.

Synthesis of [Cu2(MMIDSe)2(MMISe)2][BF4] 2 (2)
A solution of MMIDSe (0.90 mmol, 289 mg) was dissolved in dichloromethane (10
mL) and then added via cannula to a solution of [Cu(CH3CN)4][BF4] (0.60 mmol, 189 mg)
in acetonitrile (10 mL) under argon. Upon addition of the orange MMIDSe solution, the
reaction mixture formed a green precipitate that immediately redissolved and then became
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light green. After stirring for 1 h, the reaction became a light orange-red. After stirring for
an additional 2 h, the solvent was reduced to approximately 5 mL in vacuo, and crystals
were obtained from diethyl ether diffusion over the course of 3 d. After filtration, a few
crystals of 2 suitable for X-ray diffraction analysis were isolated from a larger amount of
crystallized [Cu(CH3CN)4][BF4] starting material. Yield: 42 mg, 11%.

Synthesis of [Cu(MMIMSe)(MMITSe)(CH3CN)][BF4] 2 (3) and [Cu(MMIDSe)2][Cu(MMISeCH2-MMISe)2][BF4] 4 (4)
In air, a solution of MMIDSe (1.0 mmol, 322 mg) in of dichloromethane (15 mL)
was added to [Cu(CH3CN)4][BF4] (0.50 mmol, 315 mg) in acetonitrile (15 mL). Upon
MMIDSe addition, the reaction mixture became green. After stirring for 24 h, the reaction
solution was slowly evaporated over 3 d to yield multiple crystaline products: colorless
crystals of [Cu(CH3CN)4][BF4], purple crystals of 3, green crystals of 4a and 4b, and
yellow-green columns of 4b identified but of poor resolution. Crystals of these different
products were manually separated for analysis, and no overall yields were determined.

X-ray crystallography
Single crystal X-ray diffraction measurements were collected at 100-140 K with Mo
Kα (λ = 0.71073 Å) radiation. A Bruker D8 Venture diffractometer with Incoatec
microfocus source and a Photon 100 CMOS detector was utilized in the data collection.
The Apex3 software suite was used for processing and scaling corrections. 58,59 Based on
systematic absences, space group assignments were made. The structures were solved by
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intrinsic phasing (SHELXT), and refined to convergence by full-matrix least squares using
the SHELXTL software suite.60 All non-hydrogen atoms were refined anisotropically.
Hydrogen atoms attached to carbon atoms were placed geometrically and treated using
appropriate riding models. Positions of hydrogen atoms attached to nitrogen and oxygen
atoms were first verified using the difference electron density maps, and then placed in
geometrically optimized positions using riding models. The final positions of these
hydrogen atoms did not differ significantly from where their position was first indicated
on the difference electron density map.
The tetrafluoroborate anion in 1 was found to be disordered, and the fluorine atom site
occupancies were allowed to freely refine with appropriate similarity restraints placed on
their anisotropic displacement parameters. In the case of 3, some disorder was observed
in the triselenide bridging units. In these cases the site occupancies of the disordered Se
atoms were allowed to refine as free variables, with appropriate similarity restraints used
for their anisotropic displacement parameters. All crystals of 4 tested proved to be nonmerohedral twins, and the reflections of the twin components were distinguished using the
program Cell_Now (Sheldrick, G. M. (2008). CELL_NOW. Version 2008/4. GeorgAugust-Universität Göttingen, Göttingen, Germany), and processed using the TWINABS
algorithm of Apex3. The structure was refined as a two component twin with the minor
twin component contribution refined as 33% according to the batch scale factor.
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Table 4.3. Summary of crystallographic data for complexes 1 and 2.
1
Chemical formula
C24H32B2Cu2F8N12S6
F.W. (g mol-1)
981.67
Temperature, K
100(2)
Wavelength, Å
0.71073
Crystal system
Monoclinic
Space group
C2/c
a, Å
26.164(2)
b, Å
11.5872(8)
c, Å
15.383(1)
α, ˚
90
β, ˚
125.60(2)
γ, ˚
90
V, Å3
1195.2(2)
Z
4
D, g cm-3
1.721
Absorption coefficient, mm-1
1.531
Crystal size, mm3
0.046  0.136  0.157
F(000)
1984
2θ range, ˚
2.00 to 26.50
Collected reflections
46086
Unique reflections
3923
Final R (obs. Data)α, R1
0.0294
wR2
0.0830

2
C24H32B2Cu2F8N12Se6
1263.07
100(2)
0.71073
Monoclinic
P21/n
14.950(1)
8.1531(6)
16.101(1)
90
95.801(3)
90
1952.5(3)
2
2.148
6.758
0.116  0.120  0.289
1208
2.54 to 26.50
64485
4050
0.0169
0.0389

Table 4.4. Summary of crystallographic data for complexes 3 and 4.
3
4
Chemical formula
C18H24.43B2CuF8N9O0.72Se4 C32H40B4Cu2F16N16O3Se8
F.W. (g mol-1)
931.38
1802.80
Temperature, K
140(2)
140(2)
Wavelength, Å
0.71073
0.71073
Crystal system
Triclinic
Monoclinic
Space group
P-1
C2/c
a, Å
8.1558(4)
23.8666(15)
b, Å
19.5369(8)
23.8404(15)
c, Å
19.7370(9)
21.1884(14)
α, ˚
79.287(2)
90
β, ˚
89.674(2)
107.908(2)
γ, ˚
88.918(2)
90
V, Å3
1195.2(2)
11471.9(13)
Z
4
8
D, g cm-3
2.002
2.088
Absorption coefficient, mm-1 5.498
5.920
Crystal size, mm3
0.156  0.177  0.302
0.087  0.145  0.151
F(000)
1793
6896
2θ range, ˚
2.19 to 26.50
2.12 to 25.50
Collected reflections
123328
18847
Unique reflections
12805
Final R (obs. Data)α, R1
0.0416
0.0694
wR2
0.0936
0.1443
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CHAPTER FIVE
EFFECTS OF SULFUR- AND SELENIUM-CONTAINING LIGANDS ON COPPER
AND IRON COORDINATION

5.1 Conclusions
Sulfur- and selenium-containing amino acids and other compounds play critical
roles in the redox properties of metalloproteins1 and control of cellular reactive oxygen
species.2 Metal-binding by these compounds is one mechanism by which generation of
reactive oxygen species is controlled.3-5 Redox-active metals such as copper and iron are
two of the most abundant6,7 and potentially damaging8,9 transition metals in the cell, and
loss of homeostasis for these metals that occurs with oxidative stress, protein dysfunction,
and cell signaling in the brain has serious biological repercussions.10 Production of
hydroxyl radical via Fenton and Fenton-like reactions and redox-cycling of copper and iron
can lead to oxidative damage that is an underlying cause of Parkinson’s, Alzheimer’s, and
cardiovascular diseases.9,11,12
Due to their radical scavenging and metal binding abilities, sulfur and selenium
amino acids as well as imidazole thiones and selones have been identified as potential
antioxidants that prevent both copper- and iron-mediated oxidative damage,3,13-15 but the
mechanisms responsible for their antioxidant behavior are unclear and likely differ based
on both the metal ion and the type of sulfur or selenium compound. Determination of
thermodynamic parameters to predict the likelihood of complex formation and
investigations into the redox reactions of copper with imidazole thiones can provide insight
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into the cellular behavior of sulfur- and selenium-containing compounds and mechanisms
for their prevention of oxidative damage.
Stability constants of Cu(II) with glycine, methionine, methylcysteine,
selenomethionine, and methylselenocysteine were determined by potentiometric titration.
(Chapter 2). Two species were identified in the best-fit models, [CuL]+ and CuL2, with
stability constants of approximately 9 and 14, respectively. A novel crystal structure for
Cu(SeMet)2 was also reported, confirming bidentate coordination of the carboxylate and
amine groups of selenomethioneine, with no coordination of the selenium atom. Based on
similarities in IR results and the consistency of stability constants, it can be assumed that
all the thio- and selenoether complexes bind Cu(II) in a similar fashion.
Under oxygen-free conditions, stability constants of Fe(II) with glycine,
methionine, methylcysteine, selenomethionine, methylselenocysteine, and penicillamine
were also determined by potentiometric titration. In contrast to Cu(II) titration results, the
two identified Fe(II) species are [FeL]+ and FeL(OH), highlighting the stability of Fe(II)
hydrolysis products. Compared to Cu(II), these Fe(II) complexes have significantly lower
stability constants with the thio- and selenoether-containing amino acids, approximately 3
and -5 for the [FeL]+ and FeL(OH) species, respectively. IR analyses indicate bidentate
binding through the carboxylate and amine groups, similar to binding in the Cu(II)
complexes. The thiol-containing penicillamine has considerably higher Fe(II) stability
constants than the thio- and selenoether amino acids: 7.48(7) and 13.91(7) for the Fe(Pen)
and [Fe(Pen)2]2- species, respectively. This considerable difference in stability is likely due

199

to direct coordination of the thiolate group, either in place of the carboxylate oxygen or in
addition to amine and carboxylate coordination, resulting in tridentate coordination.
The stability constants determined in Chapter 2 can be combined with the projected
speciation graphs in Chapter 1 (Figure 1.13) to predict percent complexation of Cu(II) and
Fe(II) at biological pH by these amino acids. With stability constants of approximately 9
and 14 for the Cu(II)-thioether-amino-acid complexes and assumed concentrations of 10
μM Cu(II) and at least 10 μM of amino acid, 90-100% of available Cu(II) would be
coordinated by these amino acids in a binary system. In a competitive environment such as
the cell, other small molecules with higher stability constants, such as histidine or cysteine,
would outcompete the bindentate-only binding in thio- or selenoamino acids, but labile
metal ions would almost definitely interact with available, coordinating small molecules.
Such binding correlates with in vitro inhibition of copper-mediated oxidative DNA damage
(Figure 2.6).
When considering the Fe(II) stability constants of 3 and -5 for thio- and selenoether
amino acid binding, it is unlikely that any Fe(II) would be coordinated at pH 7. However,
Fe(II)-penicillamine stability constants are similar to those for Cu(II) binding to thio- and
selenoether amino acids, so 90-100% of available Fe(II) would be bound by penicillamine
at pH 7. The inability of thio- and selenoether amino acids to prevent Fe(II)-mediated
oxidative damage in the biological pH range is consistent with this lack of amino acid
coordination. When Fe(II) coordination is likely at pH 7, as seen for pencillamine,
prevention of metal-mediated damage is observed (Table 2.5).
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Copper exists both in the +2 and +1 oxidation state, and Cu(I) is more prevalent in
the reducing cellular environment.16 Cu(I) is also a softer Lewis acid than Cu(II), with
greater affinity for binding the soft thio- and selenoether groups of amino acids, and it
produces hydroxyl radical in the presence of hydrogen peroxide. Cu(I) is however,
extremely difficult to work with in aqueous systems (Chapter 1). Sharma and cowokers17
suggest sufficient chloride support (>1.0 M) can support the Cu(I) ion so that it does not
disproportionate in solution. Strict avoidance of oxygen would still be needed if this
method were to be pursued for stability constant determination. Other methods that have
proven successful for Cu(I) stability constant determination include competition methods,
such as the fluorimetric analysis developed for the determination of Cu(I) with cysteine
and glutathione,18 although weakly binding ligands may not effectively outcompete the
fluormetric probes. Given the predominance of Cu(I) in cells, the body of knowledge
needed to accurately predict interactions of transition metal ions with small biomolecules
will not be complete, or particularly useful, until methods to determine Cu(I) stability
constants are more fully developed and a more complete database of Cu(I) stability
constants is available.
Methimazole (MMI) is a imidazole thione drug used to treat hyperthyroidism, with
blood serum concentrations of 5-10 μM in treated patients.19 Although this redox-active
drug reduces Cu(II) to Cu(I),20 it strongly inhibits Cu(I)-mediated DNA damage in in vitro
antioxidant assays.13 A variety of mononuclear,21,22 dinuclear,23-26 and polymeric27,28
complexes of copper with methimazole are reported, and sulfur extrusion from
methamidazole disulfide also occurs29-33 upon methimazole oxidation in the presence of
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Cu(II) and oxygen. Studies of copper-methimazole reactions were performed in an effort
to more completely understand the role of oxygen, solvent, and copper oxidation state in
the resulting products (Chapter 3).
With tetrafluoroborate as a counterion, both Cu(II) and Cu(I) reactions with
methimazole(MMI)

result

in

formation

of

the

dinculear

Cu(I)

complex,

[Cu2(MMI)6][BF4]2, with two bridging and four terminal methimazole ligands coordinated
solely through the sulfur atoms (Chapter 3). This product was isolated in both air and airfree reactions and has been previously reported by Raper.34 When the copper source was
changed to Cu(NO3)2 and the same reaction was performed under air-free conditions, the
polymeric {[CuI(MMI)2](NO3)}n was generated along with uncoordinated methimazole
disulfide (MMIDS). The same reaction in air resulted in Cu(I) oxidation to Cu(II) and
extrusion of a sulfur atom, affording a variety of [CuII(MMIMS)2(H2O)x]2+ (x = 1 or 2)
complexes with different counterions, including NO3-, CH3SO4-, and HSO4-. When the
molar ratio of the reaction was reduced to 2:1 methimazole-to-copper, only one MMIMS
ligand coordinated copper, and direct coordination of a bidentate SO42- ligand was
observed. Treatment of [CuI(CH3CN)4][BF4] with MMIDS under air-free conditions
resulted in no sulfur elimination products, instead yielding [Cu2(MMIDS)3][BF4]2, the first
example of complex with copper coordination to this ligand.
From the results of these reactions, the mechanism for sulfur extrusion proposed
by Lobana29 was further developed (Chapter 3). The requirement for copper coordination
to promote sulfur elimination and ligand rearrangement was incorporated. The central role
of the solvent molecule, either water or methanol, in imidazole thiolate formation and
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sulfate or methylsulfate generation is also indicated from the reaction products. Two areas
in which the mechanism can be further developed include 1) proof of superoxide formation
as Cu(I) is oxidized by O2, which could be examined by EPR spectroscopy, and 2)
determination of Cu(I) oxidation kinetics and the kinetics of subsequent sulfur elimination
using UV-vis spectrophotometry.
In Chapter 4, the potential for reversibility in copper-disulfide and -diselenide
reduction and oxidation was explored. The air-free reaction of [Cu(CH3CN)4][BF4] and
MMIDS and the parallel reaction with its selenium analog, MMIDSe, afford
[Cu2(MMIDS)2(MMI)][BF4]2 and [Cu2(MMIDSe)2(Se-MMI)][BF4]2 in low yields. These
mixed-ligand products suggest that the reaction between electron-rich Cu(I) and the
imidazole disulfide or diselenide may be reversible if protons are available to generate
MMI and MMISe. Treatment of [Cu(CH3CN)4][BF4] with MMIDSe in air yielded multiple
products from the same reaction mixture, including a mixed tri- and monoselenide Cu(II)
complex, and formation of a Cu(II) complex with an unusual dimeric methimazole selonederived ligand containing a bridging CH2 group between the selenium atoms of two
methimazole selones. The diverse redox chemistry of both copper and Se likely aids in
forming such product mixtures and highlights the difficulty in controlling the synthesis of
specific selenium-containing species.
From the studies presented in this dissertation, thermodynamic interactions
between sulfur- and selenium-containing amino acids and biologically relevant transition
metals were determined and the biological consequences of these interactions were
explored. Sulfur- and selenium-containing amino acids are much more likely to coordinate
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Cu(II) over the Fe(II) in aqueous systems, which is likely related to the antioxidant
properties of these amino acids. Thiol-containing amino acids show more stable copper
and iron binding compared to those with thio- and selenoether side chains, but selenolcontaining amino acid stability constants are still undetermined due to the instability and
redox activity of these compounds.
Similar difficulties with redox reactions and complex stability are observed with
the thione and selone imidazoles in their reactions with copper. In the presence of Cu(I),
methimazole directly binds this soft metal ion through the thione sulfur, and Cu(I)-bridging
thiones are observed in dinuclear complexes. Sulfur elimination from the methimazole
disulfide ligand is observed and is dependent upon copper coordination, the presence of
oxygen, and the availability of protic solvents, such as methanol and water. This sulfur
extrusion is a phenomenon that seems unique to copper, since it is not observed with other
transition metal ions under similar reaction conditions.35,36 Finally, formation of
methimazole disulfides and diselenides with concomitant Cu(II) reduction to Cu(I) may be
reversible with a proton source and in an air-free environment. Better understanding these
copper-methimazole and selenomethimazole reactions will shed light on the diversity of
coordination chemistry in systems with redox-active metals and non-innocent ligands,
knowledge that may lead to advances in catalysis and may have implications for the
biological activity of methimazole.
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